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  Abstract III
Abstract
A  suitable  method  is  the  prerequisite  for  comprehensive  screening  performances.
Therefore, an analytical method for high-throughput metabolome analysis on basis of our
well  established  standard  method was  developed.  Fast  metabolome analysis  was  done
using gas chromatography/mass spectrometry. Two major advantages were parallelization
of operations and partial automation. In short this means a clear reduction of time needed
for the pre-analytical steps. The standard error between independent samples of the model
organism  Corynebacterium glutamicum raised on the same plate was decreased to 13%.
Additionally, the runtime of a single measurement was decreased, allowing an increased
number of measurements per day. The adaptation of our internal standard library achieved
650 quantifiable peaks per single GC/MS run. 
With this method around 320 transposon mutants of  Corynebacterium glutamicum were
investigated,  and  suitable  screening  criteria  were  developed  to  identify  mutants  with
significant changes of their phenotype. First indicators regarding this research came from a
comparison of mutant and wild type raised on the same plate. But for a clear differentiation
of changes caused by gene deletion and those resulting from biological and environmental
variations,  a  wild type reference list  was created.  A threshold for  each metabolite  was
calculated revealing significant differences.
The last part of this thesis deals with the development of a quenching method applicable
for different microorganisms. An ethanol quenching procedure, established earlier in our
group, was optimized, and evaluated against results coming from published quenching tests
for  three  different  organisms:  Corynebacterium  glutamicum,  Escherichia  coli  and
Saccharomyces  cerevisiae.  The  ethanol  quenching  method in  most  cases  produced  the
highest number of detected metabolites, and had a low standard error. Also, this samples
showed the highest range of relative concentrations of identified metabolites.
IV   Kurzzusammenfassung
Kurzzusammenfassung
Ein  umfassendes  und  erfolgreiches  Screening ist  nur  mit  einer  geeigneten  Methode
möglich.  Deshalb  wurde  im  Rahmen  dieser  Arbeit  eine  Hochdurchsatzmethode  zur
Metabolomanalyse entwickelt. Grundlage war die Standardmethode unserer Arbeitsgruppe.
Die  Metabolomanalyse  wurde  unter  Verwendung  der  Gaschromatographie/Massen-
spektrometrie durchgeführt. Hauptvorteile waren Parallelisierung und Teilautomatisierung,
die  zu  einer  Verringerung der  benötigten  Zeit  für  die  Probenvorbereitung  führten.  Der
Standardfehler unabhängiger Proben des Modellorganismus Corynebacterium glutamicum
wurde auf 13% reduziert. Außerdem wurde die Laufzeit einer Messung verkürzt und so die
Anzahl pro Tag erhöht. Die Anpassung unserer internen Standardbibliothek führte zu 650
quantifizierbaren Peaks je GC/MS-Lauf. 
Diese  Methode  wurde  verwendet,  um  zirka  320  Transposonmutanten  von
Corynebacterium glutamicum zu untersuchen und geeignete Kriterien für das  Screening
nach  Mutanten  mit  signifikanten  Veränderungen  des  Phänotyps  zu  entwickeln.  Zuerst
erfolgte  der  direkte  Vergleich  gemeinsam  kultivierter  Mutanten-  und  Wildtypproben.
Allerdings konnte nicht zwischen Veränderungen durch Gendeletion und biologischen und
umweltbedingten Schwankungen unterschieden werden. Deshalb wurde eine Referenzliste
erstellt.  Die  Ermittlung  eines  für  jeden  Metaboliten  spezifischen  Schwellenwerts  ließ
signifikante Veränderungen erkennen.
Im  letzten  Teil  der  Arbeit  wurde  eine  Quenchingmethode  für  unterschiedliche  Mikro-
organismen  untersucht.  Dafür  wurde  eine  bereits  vorhandene  Ethanolquenchmethode
unserer  Arbeitsgruppe  optimiert  und  an  verschiedenen  Organismen  -  Corynebacterium
glutamicum, Escherichia coli und Saccharomyces cerevisiae - sowie im direkten Vergleich
zu publizierten Methoden evaluiert.  Das Quenchen mit  Ethanol  lieferte  in  den meisten
Fällen  die  höchste  Anzahl  sowie  die  höchsten  relativen  Konzentrationen  identifizierter
Metabolite verbunden mit geringen Standardfehlern.
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Abbreviations & Formula
2D-PAGE two-dimensional polyacrylamid gel electrophoresis
A diffusion influenced by packing of the column
Abs. absolute
ADC analog to digital conversion
AMDIS Automated Mass Spectral Deconvolution and Identification System
AMP Adenosine-5'-monophosphate 
APCI atmospheric pressure chemical ionization
B longitudinal diffusion
B2P6 bank 2 plate 6
BHI brain heart infusion medium (complex medium)
BLAST Basic Local Alignment Search Tool
bp base pair(s)
BRENDA Braunschweiger Enzymdatenbank (Braunschweig enzyme database)
BSA N,O-bis(trimethylsilyl)acetamid
BSTFA N,O-bis(trimethylsilyl)trifuoracetamid
b0.5 width in half height of the peak 
C term for reaching the equilibrium
CDW cell dry weight
CE capillary electrophoresis
C. glutamicum Corynebacterium glutamicum
CI chemical ionization
∆ delta, difference
DB-5MS chromatographic column, fused silica 
DNA deoxyribonucleic acid
e unit charge 
eV electron voltage
E. coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid 
EI electron ionization, electron impact ionization
Ekin kinetic energy
VI   Abbreviations & Formula
ErrorRef standard error of a metabolite from the wild type reference list
ESI electrospray ionization
ESOMs emergent self organizing maps
EQ ethanol quenching
g acceleration of gravity
GC gas chromatography, gas chromatograph
GC-GC tandem gas chromatography
GSQ cold glycerin saline quenching
h hour
Heff height of effective theoretical plates
i control variable
IS6100 insertion sequence 6100
KD distribution coefficient
KanR kanamycin resistance marker
KEGG Kyoto Encyclopedia of Genes and Genomes 
L length of GC column in mm
l length of the flight tube
LB Luria-Bertani medium
LC liquid chromatography
m ion mass 
Mb mega bases
ml, l milliliter, liter 
mm millimeter
MM1 minimal medium
MALDI matrix assisted laser desorption ionization
MCP micro channel plate
mM milli-molar
mRNA messenger ribonucleic acid
MS mass spectrometry, mass spectrometer 
MS/MS tandem mass spectrometry
MSTFA N-methyl-N-trimethylsilyltrifluoroacetamid
MT relative concentration of metabolite in mutant sample
  Abbreviations & Formula VII
MudPIT multidimensional protein identification technology
MQ methanol quenching
n series of measurements
NCBI National Center for Biotechnology Information
Neff number of effective theoretical plates
NIST National Institute of Standards and Technology
NMR nuclear magnetic resonance spectroscopy
OD optical density
ori origin of replication
pAT6100 plasmid 6100
PP polypropylene
PS polystyrene
PTV programmed temperature vaporizer
r Pearson correlation coefficient
Ref relative concentration of the metabolite from the wild type reference 
list
RI retention index, Kovàts' index 
RNA ribonucleic acid
RP4mob mobilizable part of the cloning vector pK18mob2
pK18mob2 vector
pM pico-molar
s standard deviation
srel relative error
sf Gauss error after
sx standard error
T temperature
TAE Tris-Acetate-EDTA
TE Tris-EDTA
TMet metabolite threshold
t flight time of an ion 
ti retention time of the unknown substance i
tS net retention time
VIII   Abbreviations & Formula
tR gross retention time
tT dead time
tx retention time of alkane eluting before elution of unknown substance
ty retention time of alkane eluting after elution of unknown substance
TIC total ion current
TMS trimethylsilyl
TOF time of flight mass spectrometer 
u carrier velocity
U acceleration velocity
UQ unquenched, standard method
U/ml units per milliliter
v/v volume per volume
w/v weight per volume
x number of carbon atoms contained in alkane eluting before elution of
unknown substance 
xi single measurement 
x mean value
y number of carbon atoms contained in alkane eluting after elution of 
unknown substance 
z ion charge 
µm micrometer
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1 Introduction
In the continually growing field of systems biology knowledge about all gene functions
present within an organism is an important task. This is necessary for the construction of
complete regulatory networks and e.g. predictions by computer models. But information
available so far from genome data and annotation are incomplete. Further information is
necessary  to  close  existing  gaps  in  networks.  Hence,  analyzing  the  changes  in  the
metabolome of mutants will contribute to enhanced knowledge. The metabolome is farther
way from gene expression and thus more closely reflects cell activity on a functional level,
comprising the potential to map the function of unknown genes and to characterize the
phenotype (Garcia et al., 2008, Plassmeier et al., 2007). 
Below a short introduction into the “omics”-technologies is presented, with a special focus
on metabolomics and its potential in functional genomics. The organisms on which the
research is based are introduced afterwards.
1.1 Systems biology
Only  a  few  years  ago  each  cellular  and  biochemical  component  (genes,  proteins  or
metabolites) was studied as a single subject (De Keersmaecker et al., 2006). Now in the
field of systems biology the so called “omics“-technologies (genomics,  transcriptomics,
proteomics  and  metabolomics)  have  been  combined,  with  the  intention  to  provide
explanations of biologic phenomena by using information from all components (e.g. DNA,
RNA, proteins, metabolites) within a cell or an organism (Liu, 2005). Main objectives are
the understanding of the structure and the dynamic of the system (Kitano, 2002).
1.1.1 Genomics
The genome is the entirety of all genes present in an organism. In the field of genomics
intensive research is going on to identify the whole DNA sequence of a microorganism.
Bioinformatics  tools  are  used  for  the  prediction  of  genes  and  operons.  Databases  are
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searched to identify homologous proteins and functions for the predicted genes.  Whole
genome sequences are completed by annotation (Wendisch et al., 2006). In contrast to all
other “omics”-technologies, genomics is the one dealing with the stable genome, defining
the phenotype of an organism.
1.1.2 Transcriptomics
The messenger RNAs represent the transcriptome of a microorganism which is studied in
transcriptomics. All mRNAs as well as their relative abundance inside a cell at a given time
and under a defined set of conditions are investigated in the transcriptomics approach. The
high-throughput  technology of  microarrays  is  mostly used  for  investigation,  where  the
expression of the genes is monitored (Schena et al., 1995). Analyses are made with gene
chips. Models of transcriptional regulatory and metabolic networks are generated to predict
the results of phenotyping and gene expression experiments. Furthermore, these models are
used to identify gaps and unknown components as well as interactions in such networks
(Covert et al., 2004).
1.1.3 Proteomics
The proteome of a cell or organism comprises all existing proteins at a specific time as well
as under defined conditions - and it is the subject of investigation in proteomics. In contrast
to the genome, which is static, the proteome is highly dynamic what means it responds on
environmental  changes  or  exposure of  agents  and  its  composition underlies  permanent
adaptation in a qualitative and quantitative manner; new proteins become synthesized and
others degraded. 
Proteomics  can lead  to  information about  biological  mechanisms  much faster  than  the
single-protein approach (Abbott, 1999).
Proteins  are  composed  of  20  different  amino  acids,  leading  to  highly  diverse
physicochemical  properties.  Furthermore,  they  fulfill  different  and  very  important
functions: proteins are, for example, catalysts of metabolism and regulators of processes
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(Wendisch et al, 2006).
Today, the protein composition of a cell is normally analyzed with one of the two following
techniques:  two-dimensional  polyacrylamid  gel  electrophoresis  (2D-PAGE)  and  mass
spectometry (MALDI-TOF, ESI-MS/MS) (O'Farrell, 1975, Wendisch et al, 2006). Whereas
2D-PAGE  is  commonly  applied  for  protein  expression  studies,  MS  is  suitable  for
identification  and  quantification  of  translated  proteins.  Another  method,  the  so  called
multidimensional  protein  identification  technology  (MudPIT),  is  based  on  liquid
chromatography/mass  spectrometry  (LC/MS).  The  advantage  of  this  approach  is  the
possibility  to  analyze  complex  protein  mixtures  (e.g.  whole  cell  lysates)  without  prior
separation (Weckwerth, 2008).
All the procedures mentioned can be used for comparison of protein compositions. The
decision depends on the certain set of conditions available.
1.1.4 Metabolomics
The metabolome comprises all metabolites present in the cell at a defined time and under
controlled conditions. It  is investigated in metabolomics studies. Like the transcriptome
and  the  proteome  the  metabolome  responds  on  changes  in  the  genome  or  in  the
environment, and therefore it is not static. Consequently, a comprehensive analysis of the
metabolome allows a highly sensible phenotype characterization.
The analysis of the metabolome belongs to the subject area of this thesis, and it is therefore
described in more detail below (section 1.2).
1.2 Metabolomics in functional genomics
After decades of intensive but mostly independent research in the above described fields
the focus started to shift towards functional genomics, to a post-genomic era. The aim is
the  analysis  of  genes  and  their  products  on  a  more  functional  level.  For  the  study of
complex  biological  systems  the  mentioned  procedures  and  techniques  are  used
complementary and in combination. The goal is to correlate the vast amount of data and
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knowledge available in order to obtain a better understanding of regulatory mechanisms.
With  the  great  progress  in  sequencing  of  organisms,  for  over  750  microorganisms  a
complete or nearly complete genome sequence is now available (NCBI). And currently, the
identification  of  gene  functions  is  in  main focus.  Therefore,  multi-parallel  analyses  of
transcriptomics  and proteomics  are  often applied  (Celis  et  al.,  2000,  Somerville  et  al.,
1999). However, a direct connection of changes in mRNA and protein levels and a change
in biological function can not often be revealed. In contrast, metabolome analysis offers the
possibility  for  a  direct  correlation  between  a  gene  sequence  and  the  function  of  the
metabolic network (Fiehn et al., 2000, Weckwerth, 2003, Kell, 2004, Villas-Bôas et al.,
2005). The creation of  in silico models becomes possible (Sweetlove et al.,  2003, Kell,
2006).
1.2.1 Methods in metabolome analysis
Methods in metabolome analysis have to meet certain requirements in order to be valuable
in the field of functional genomics (Fiehn et al., 2000, Weckwerth, 2003). They have to be:
● reliable
● reproducible
● robust
● sensitive
● fast
● suitable for automation
● suitable for analysis of a significant number of metabolites.
Different  approaches  for  metabolome  analysis  exist.  The  untargeted  identification  and
quantification of all metabolites present in a biological sample under defined conditions is
the overall goal. However, due to the high diversity of chemical properties as well as the
different behavior of the individual compound classes most applications use the targeted
approach instead (Weckwerth, 2003). 
So  far,  no  single  method  exists  which  covers  all  metabolites  within  a  cell  in  one
measurement.  Differences  are  not  only  caused  by  varieties  in  chemical  nature  of  the
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substances but also due to the range of metabolite concentrations. It  can vary over nine
orders  of  magnitude  (pM-mM) in a  cell  (Dunn et  al.,  2005).  In  addition,  metabolome
analysis in the field of plants (Fiehn et al., 2000a and Fiehn, 2002, Roessner et al., 2000
and 2001) and microorganisms (Fox, 1999, Buchholz et al., 2001, Raamsdonk et al., 2001,
Strelkov  et  al.,  2004,  Ishii  et  al.,  2005) is  a  still  growing area  of  research.  So far  no
complete  network  of  all  metabolites  for  a  single  organism  exists.  Additionally
bioinformatics  approaches  are  used.  Databases  of  biological  data  are  searched  (e.g.
BRENDA (Schomburg  et  al.,  2002)).  Organism specific  information  is  investigated  in
order to gain a new understanding of the metabolic network of a defined organism. The
Pathway Hunter Tool is only one example for application (Rahman et al., 2005).
The most applicable methods for metabolome analysis are NMR spectroscopy (Raamsdonk
et al., 2001) and mass spectrometry (MS) or tandem mass spectrometry (MS/MS) (Feng et
al., 2008). They are suitable for detection of metabolites in complex matrices. The MS is
used mostly coupled to gas chromatography (GC) (Fox, 1999, Fiehn et al., 2000a, Roessner
et al.,  2000, Strelkov et al.,  2004, Börner et al., 2007) or GC-GC (Dunn, 2008), liquid
chromatography (LC) (Buchholz et al., 2001 and 2002) or capillary electrophoresis (CE)
(Soga et al., 2002 and 2003, Edwards et al., 2006). Figure 1 shows the different ways of
mass spectrometric methods in metabolome analysis. The GC/MS approach is described in
detail afterwards.
Figure 1. Possible ways of mass spectrometry analysis in metabolomics. The sample can
either be directly analyzed or after separation (Villas-Bôas et al., 2005, modified).
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Gas chromatography/mass spectrometry (GC/MS)
Gas  chromatography  coupled  to  mass  spectrometry  is  a  highly  efficient  approach  in
metabolome analyses in order to separate samples. It is suitable to resolve very complex
biological compositions (Villas-Bôas et al., 2005). Applying GC/MS allows a fast analysis
of volatile polar and lipophilic metabolites of low molecular mass to be performed in short
time.  The separation is  caused by volatility,  size and  structure.  Consequently,  it  is  not
suitable  for  organic  diphosphates,  cofactors,  or  metabolites  larger  than  tri-  to
tetrasaccharides (Weckwerth, 2003). For analyzing such big and non volatile substances
necessarily  LC/MS  has  to  be  used.  Small  but  non  volatile  compounds  can  be  made
available for GC/MS by derivatization (see section 1.2.2). 
The complete assembly required for GC/MS analysis is shown in figure 2, and consists of
three main parts: injector, gas chromatograph with a selected column that is suitable for the
separation requirements of the sample, and detector, which is the mass spectrometer.
Figure 2. Assembly for a GC/MS analysis.
For analysis of cell extracts a programmed temperature vaporizer (PTV)-injector was used.
The sample is indirectly injected onto the column. That means the sample is given into an
evaporation chamber first and is transferred partly (split) or completely (splitless) onto the
column afterwards. In figure 3 the scheme of a PTV-injector is shown.
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Figure 3. Scheme of a PTV-injector. The sample is indirectly transferred to the column.
In traditional techniques the sample is directly transferred to the column and vaporized at
the same moment. In contrast, with PTV the sample is injected into a vaporizer chamber
with a temperature below the boiling point. A temperature profile is applied afterwards to
increase the temperature of the chamber very fast and to transfer the vaporized sample onto
the column.
During gas  chromatographic separation the analyte (sample extract)  is  carried with the
mobile phase (carrier gas) over the stationary phase on the column. The eluting substances
are detected and visualized as chromatographic peaks according to their retention time at
the outlet.  For the separation of sample extracts special  columns are available.  For the
research underlying this thesis a DB-5MS column was used. It is a fused silica capillary
with  a  coating  of  polyimide  to  increase  flexibility  and  protect  from  chemical  and
mechanical influences. Inside there is a liquid, highly viscous polysiloxan (5 %-Phenyl)-
dimethylpolysiloxan)  (figure 4).  The  used  column  was  30 m  in  length,  with  an  inner
diameter of 0.25 mm, and the thickness of the stationary film was 0.25 µm.
Figure 4. Chemical structure of Poly(dimethylsiloxy)poly(1,4-bis(dimethyl-siloxy)phenyl).
In the used polymer, m has a value of 5%, n a value of 95%.
8 1  Introduction
With such a DB-5MS column Strelkov et al. could demonstrate good results for analysis of
cell extracts of  Corynebacterium glutamicum. Around 1000 peaks were identified in the
chromatograms (Strelkov et al.,  2004).  However,  it  is necessary to be very precise and
careful choosing stationary phase and thickness and pay special attention to polarity and
volatility of the compounds to be separated (Grob et al., 1993).
The mobile phase in such an approach is an inert gas. It must not interact with analyte or
stationary  phase.  Therefore,  helium,  nitrogen  or  hydrogen  are  often  used.  Also  very
important issues are the flow properties of the carrier and the fact that it is not to viscous at
high temperatures. 
A chromatographic separation is caused by the retention. The retention time is specific for
each substance.  Compounds are transported over the separation distance by the mobile
phase. During transport a substance can interact with the stationary phase and therefore
stick to it. The retention behavior depends on the distribution coefficient KD (equation 1.1).
KD is  the ratio of the analyte concentration in liquid and gas phase.  It  depends on the
analyte,  the  liquid  phase  and  the  temperature.  The  time  needed  from  the  moment  of
injection till the maximum of intensity of the eluting peak is the gross retention time tR,
which describes the overall time of a substance on the column.
K D=
concentration per volumeunit liquid phase
concentration per volume unit gas phase (1.1)
The efficiency of a separation is defined by the peak enlarging (e.g. by diffusion) and the
relation of the retention times. The number of effective theoretical plates Neff describes this
efficiency (equation 1.2), with Heff giving the height of effective theoretical plates and L
giving the length of the column in mm. If the column is quite long, the number of effective
theoretical plates is high. The smaller the diameter of the column, the less the height of
effective theoretical plates. Efficiency of separation is increased with decreasing Heff and
increasing Neff.
N eff=
L
H eff
=5.54  t Sb0.5

2
(1.2)
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The number of effective theoretical plates can also be calculated using the net retention
time tS and the width of the peak in half of its height b0.5 (see equation 1.2). 
The net retention time is calculated from the gross retention time tR diminished by the dead
time tT (equation 1.3). The dead time is the time needed by the carrier gas to get through
the column.
t S=t RtT (1.3)
In order to estimate the optimal height of effective theoretical  plates the Van-Deemter-
estimation  can  be  used  (equation  1.4).  It  describes  the  connection  between  Heff,  the
diffusion A, which displays the influence of the packing of the column on the width of the
peak. However, because of the used capillary this term has to be neglected. Furthermore,
the longitudinal diffusion B represents the diffusion of substances on their way through the
column. Term C is the rate for reaching the equilibrium and u is the velocity of the carrier
gas.
H eff=A
B
u
Cu (1.4)
The separation in gas chromatography is done in different dimensions. A vaporized mixture
is  introduced  with  the  carrier  into  the  temperature-regulated  capillary.  With  increasing
temperature of the column the equilibrium of the aggregate state of a substance is moved
from the stationary phase to the mobile phase. Because of the applied temperature gradient,
where  the  temperature  is  constantly  increased,  components  with  a  low  boiling  point
vaporize first and are carried over the column by the mobile phase. Substances with higher
boiling points volatilize at a later moment. Therefore, the separation is due to the substance
specific affinity to the stationary phase, but also according to the vapor pressure. 
To perform a quantitative analysis with a GC/MS a calibration is necessary. A mixture of
eight uniformly distributed alkanes was used. Because of their chemical nature alkanes are
highly volatile and thus do not have to be derivatitized before measurement. Each alkane
has a defined  retention index  (RI).  The number of  carbon atoms multiplied by 100 is
equivalent to RI. When a substance is identified it is also given a retention index which is
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calculated using the Kovàts' equation (see equation 1.5) and related to the RI values of the
alkanes  (Kovàts,  1956).  The  calculation  according  to  equation  1.5  is  suitable  for
compounds separated with the help of a temperature gradient. The advantage of applying
retention indices  rather  than  using the  retention  times  is  the  possible  compensation of
shiftings in retention times. Such kinds of offsets might occur after routinely maintenance
performances. Another advantage of using the retention index is the high reproducibility,
and moreover  the index  only depends  on dimensions  of  the  column,  liquid  phase  and
temperature. 
RI T =100[ y x
tit x
t yt x
 x ] (1.5)
containing: RI retention index 
T temperature
x number of carbon atoms in the alkane eluting before elution of the 
unknown substance
y number of carbon atoms in the alkane eluting after elution of the 
unknown substance
ti retention time of the unknown substance 
tx retention time of the alkane eluting before the elution of the 
unknown substance
ty retention time of the alkane eluting after the elution of the unknown 
substance
The intersection between gas chromatograph and mass spectrometer is a special interface.
It permits the transfer of the analyte from atmospheric pressure to high vacuum (10-4 Pa).
The ionization caused by electron impact as well as the mass separation are only possible
at pressures below 10-2 Pa (Hübschmann, 2001).
The ionization process takes place in the EI (electron ionization) source. The assembly of
such an EI source is  shown in figure 5.  Electrons are emitted from a filament into the
electric  field  with  a  potential  difference  of  70 eV.  Furthermore,  the  electrons  are
accelerated and hit the molecules of the sample which enter the ion volume. 
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Figure 5. Schematic layout of an electron impact source (EI) (Gross, 2004)
The voltage is high enough to produce a high-energy radical cation. But due to the overrun
of  energy  the  cation  resolves  into  smaller,  charged  and  characteristic  mass  fragments
(reaction 1.6).
(1.6)
The energy for ionization of 70 eV is chosen, because the yield of ions is high and stable
even  if  the  voltage  varies  slightly.  Afterwards,  the  ionized  fragments  are  continuously
pushed by the repeller (see figure 5).
Ions generated in the ion source are focused to form an almost parallel ion beam and are
introduced into the  analyzer  (in  this  case  an  AccuTOF machine  was used).  In  the ion
acceleration unit, the so called launcher (figure 6), they are brought to the pusher plate. The
applied pulse voltages (7 kV) to the pusher plate and a stack of multiple electrodes with
different voltage cause a change of the direction of the ions. They are pushed orthogonally
into the flight tube. At the beginning ions are constantly accelerated but when they reach
the  flight  tube  they  are  in  free  flight  with  constant  velocity.  The  ions  fly  at  a  speed
depending on their mass because all of them got the same kinetic energy. The separation of
the ions is according to their mass to charge ratio (m/z) (Gross, 2004, Jeol Instructions). 
e-
AB AB+° A+ + B°
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Figure 6. The Jeol AccuTOF launcher (Jeol Instructions, modified).
After acceleration with a defined voltage U all ions have the same kinetic energy Ekin which
can be calculated using equation 1.7 (Gross, 2004). 
Ekin=
1
2
m v
2
= zeU (1.7)
containing: m mass of the ion
v velocity of the ion after acceleration
z ion charge
e unit charge
U acceleration voltage
The velocity of an ion after acceleration v can be calculated from the length of the flight
tube l and the time t needed till ion reaches the detector (see equation 1.8) (Gross, 2004).
v=
l
t
(1.8)
The combination of both equations 1.7 and 1.8 leads to the flight time t as function of the
mass (see equation 1.9). Furthermore, the mass to charge ratio is proportional to the square
of the flight time (Gross, 2004, Jeol Instructions).
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m
z
=
2eU
l 2
t 2 (1.9)
The conversion of flight time into the depending mass to charge ratio is done by a special
hardware called fast flight. 
Time of flight  spectrometer have the advantage of high mass resolution. The used Jeol
AccuTOF provides an accuracy of four decimal places. The ion kinetic energy in the beam
after the ion source is only slightly varying in a range of 10...100 eV. Consequently, even
ions with identical mass are differing slightly in their velocity. This affects the width of the
peaks. A compensation of these energy differences can be done with a reflector composed
of several reflector lenses (see figure 7). Focusing is achieved, because ions with higher
kinetic energy submerge deeper into the area of the reflector than those of same mass but
lower energy. Thereby, all ions with the same mass can reach the detector almost at the
same time resulting in an increased peak sharpness. 
Figure 7. The scheme of the reflector of the Jeol AccuTOF (Jeol Instructions).
The detector of the AccuTOF consists of micro channel plate (MCP) detector, impedance
converter, and preamplifier. The MCP detector is a unit comprising the secondary electron
multiplier  (dynode,  MCP)  and  the  electrode  anode  which  detects  the  electrons  (see
figure 8). 
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Figure 8.  The  operational  principle  of  the  MCP detector  of  the  Jeol  AccuTOF (Jeol
Instructions). 1 is the MCP and 2 is the anode.
Arriving ions collide with the inside wall of a micro channel on surface of the MCP and
generate secondary electrons. Because of the strong electric field applied to the MCP the
generated electrons are accelerated and collide again with the micro channels. Due to the
repetition of acceleration and collision the number of secondary ions increases. Afterwards,
these ions pass the MCP and collide with the anode. The anode sends the current pulse
signals to the impedance converter.  The introduced electrical  signal is  converted into a
voltage, the measurement variable which is sent to the preamplifier. Signals are amplified
and transmitted to the  fast  flight (a  continuous averager)  afterwards.  The amplification
factor is a constant value of 5. Data acquisition protocol of the system applies the ADC
(analog to digital conversion) method. Reconstruction of the intensities of all signals is
done from the TIC (total ion current). Applying these technique allows the detection even
of low ion currents.
Advantages  of  using  GC/MS  for  metabolome  analysis  are  a  high  reproducibility  of
measurement  and  a  precise  identification  by  deconvolution  of  overlapping
chromatographic peaks (Villas-Bôas et al., 2005). This can be done for example with an
automated mass spectral deconvolution and identification system (AMDIS) (Stein et al.,
1999). Furthermore, data resulting from GC/MS not only provide the required quality but
also  allow quantification  when applying compound specific  calibration  curves.  Spectra
(from 70 eV standard ionization energy) can be collected in databases, for example NIST
(National Institute of Standards and Technology),  and are available for identification of
substances (Schauer et al., 2005). 
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1.2.2 Pre-analytical  sample  preparation  for  metabolome  analysis  with
Gas Chromatography/Mass Spectrometry
An important prerequisite for representative and reliable metabolome analysis is a strict
protocol. In microbial metabolomics the sample size is quite small, and only low amounts
of metabolites (3 to 5% cell dry weight) are present within a cell (Neidhardt et al., 1996,
Wendisch et al, 2006). Also important is to work with replicates, because biological and
analytical variations have to be incorporated and assessed. Generally, differences between
samples of the same biological origin (biological variance) can be expected as significantly
greater than those from multiple analyses of the same sample (analytical variance) (Dunn
et al., 2005).
Quenching of microorganisms
The sampling stage has to be fast and reproducible. Additionally, it is very important that
the  inherent  enzymatic  activity  is  stopped  rapidly.  Otherwise  the  metabolome  would
continuously  change  during  sample  preparation,  leading  to  a  metabolic  profile  not
representative for the moment of harvesting. Therefore methods like immediate freezing in
liquid nitrogen (Buziol et al., 2002, Mashego et al., 2003) or acidic treatments using nitric
or perchloric acid (Larsson et al., 1996, Weuster-Botz, 1997) as well as alkali treatments
are used. The most important problem of acidic treatments are difficulties that arise in the
analytical methods following afterwards (Fiehn, 2002). 
The basic requirement for a reliable quenching method is that no cell leakage should occur
or if leakage occurs, the leaked metabolites should be quantifiable (Mashego et al., 2007).
The currently most common method is quenching with cold methanol solution (de Koning
et al., 1992, Schäfer et al., 1999, Jensen et al., 1999, Moritz et al., 2000, Villas-Bôas et al.,
2005a, Loret et al., 2007). This protocol was first developed for yeast by de Koning (de
Koning  et  al,  1992).  Until  today  this  method  had  been  tested  for  many  different
microorganisms, generally resulting in different behavior of prokaryotes and eukaryotes.
Prokaryotic cells tend to leak intracellular metabolites. This observation is now well known
as “cold-shock” and was first  described for  Corynebacterium glutamicum by Wittmann
(Wittmann et al., 2004), but similar results were obtained for Escherichia coli (Winder et
al., 2008). Additionally, even for yeast the results are controvers. Whereas in some studies
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cell leakage was detected (Maharjan et al., 2003, Villas-Bôas et al., 2005a) others could not
approve this (Loret et al., 2007).
However, due to extensive research on this field a variety of methods exist. But so far none
of them achieved satisfying results for different microorganisms. Published methods are,
for example: quenching with boiling absolute ethanol (90°C) (Winder et al., 2008), cold
pure methanol (Hans et al., 2001, Castrillo et al., 2003, Dunn et al, 2005, Canelas et al.,
2008) or the use of a cold glycerol saline solution (Villas-Bôas et al., 2007).
Also, fast filtration often is applied to separate supernatant and cells. But sampling time in
this approach takes several seconds. Therefore it is only suitable for metabolites with high
intracellular  levels  and  low  turnover.  Another  method  used  nowadays  is  whole  broth
quenching. In this method cells and supernatant are not separated but prepared together
(Canelas et  al.,  2008).  The huge problem regarding this technique is the differentiation
between intra- and extracellular metabolites. Additionally, the assumption that metabolites
of central pathways are exclusively present inside the cells is not true and will lead to large
errors (Bolten et al., 2007).
Extraction of metabolites
Whereas  the  analysis  of  the  exometabolome  (excreted  metabolites  into  the  growth
medium) does not need any additionally extraction, this step is necessary for analysis of the
endometabolome (metabolites inside the cells). The aim is to extract the maximum number
of metabolites from different chemical classes in a quantitative way and minimize any loss
(Dunn et al., 2005). When working with microorganisms it is necessary to disrupt the cell
wall (lysation) to release internal metabolites. 
A big difficulty is the extraction of phosphorylated compounds. Reasons are cleavage of
phosphate groups in highly aqueous environments, interactions with phospholipids in the
cell, and hydrolysis of triphosphates (Garcia et al., 2008).
Mostly organic solvents like methanol and ethanol, pure or diluted in water are used for
metabolite  extraction  (Gonzalez  et  al.,  1997,  Fiehn  et  al.,  2002).  Performances  with
perchloric acid (Buchholz, et al., 2002) or potassium hydroxide also exist (Maharjan et al.,
2003, Mashego et al., 2007). Furthermore, an additional step is performed adding a non-
polar  solvent  (e.g.  chloroform)  to  extract  lipophilic  components.  Often  efficiency  is
enhanced  by  applying  additional  energy  (e.g.  heat,  sonication,  microwave  techniques)
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(Fiehn  et  al.,  2002).  A comparison  of  different  methods  is  mostly  done  for  a  defined
organism only (e.g. Winder et al., 2008, Villas-Bôas et al., 2002).
Derivatization of compounds
In order to analyze semi- and non-volatile metabolites with gas chromatography coupled to
mass spectrometry,  substances have to be derivatized to improve volatility and thermal
stability. A properly working reaction is the prerequisite but not always easy to achieve.
Sterical hindrance can lead to mixtures of fully and partially derivatized analytes (Halket et
al., 2005). Furthermore, a derivatization method has to be simple, efficient and fast (Villas-
Bôas et al., 2005). 
The cell extract of a microorganism contains several sugars. These sugars have different
isomers.  If  each  isomer  is  derivatized  this  will  increase  the  complexity  of  the
chromatogram dramatically.  To reduce the complexity a reaction of sugar, precisely the
carbonyl  group,  with  methoxyamin  is  often  performed  as  first  step  in  derivatization
protocol (see figure 9). With this oximation the open-chain form is stabilized (Adams et al.,
1999). Oximation is done with aldehyd and keto groups (Halket et al., 2005).
Figure 9. Reactions of D-fructose with methoxyamin (Thielen, 2007)
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Often  a  silylation  reaction  with  MSTFA (N-methyl-N-trimethylsilyltrifluoroacetamid),
BSA (N,O-bis(trimethylsilyl)acetamid) or BSTFA (N,O-bis(trimethylsilyl)trifuoracetamid)
is performed. This reaction takes place in pyridine under anhydrous conditions and heating.
During  silylation a  silyl  group  is  introduced  into the  molecule  through substitution  of
active hydrogen. This hydrogen was part of a hydroxyl, thiol, amino or carboxylic acid
group. An alkyl-silyl group (e.g. trimethylsilyl (TMS)) is introduced instead (Villas-Bôas et
al., 2005) (see example for glycine, figure 10). The most important metabolites derivatized
by silylation are sugars and sugar derivatives, e.g. sugar alcohols, phosphorylated sugars
and amino sugars. The advantage of silylation is its efficiency and the production of stable
derivatives  as  well  as  its  high reproducibility.  A critical  fact  is  the performance under
anhydrous conditions which requires the complete removal of water.
Figure 10. Trimethylsilylation of glycine (Thielen, 2007, modified)
Besides silylation alkylation or esterification are also derivatization techniques. With the
use of chloroformate derivatives, polyfunctional amines and organic acids are derivatized.
The reaction can be done in aqueous solutions at room temperature. Alkylation can also be
performed  using  diazomethane.  The  disadvantage  of  this  method  is  the  smaller
applicability (Villas-Bôas et al., 2003). 
Another  problem that  might  occur besides  the  formation of  byproducts  is  the  possible
conversion of analytes.  For example arginine can be converted to ornithine or the final
product can degrade, e.g. the hydrolysis of trimethylsilyl derivatives (Garcia et al., 2008). 
Some samples  show ongoing reactions or even instabilities  during longer time periods.
Consequently,  differences  in  the  time  needed  from  the  end  of  derivatization  till
measurement  are  problematic  for  samples  of  a  set.  Therefore,  “just-in-time”  sample
preparation is advantageous (Dunn, 2008).
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1.2.3 High-throughput performances in metabolome analysis
So far, the understanding of high-throughput in metabolome analysis is always limited to a
certain part of the performance. There was no complete high-throughput method available
before this work. Nevertheless, small-scale cultivations of microorganisms could be found
in literature (e.g. Zimmermann et al.,  2003, Kumar et al.,  2004, Duetz et al., 2000 and
2004) but only few examples for the use in metabolome analysis (e.g. Wittmann et al.,
2004a).  The  problem  is  the  limited  cell  mass  after  cultivation  in  micro  titer  plates.
Furthermore, good aeration and agitation has to be assured to obtain equal growth in all
wells and no well specific limitations.
High-throughput in metabolome studies is mostly regarded to the high amount of produced
samples. Also often designated as high-throughput is the measurement performance itself
and the high number of revealed metabolites.
1.2.4 Transposon mutagenesis and the construction of a mutant bank
Besides the traditional methods of random or targeted mutagenesis followed by screening
for the development and identification of mutants with desired properties another technique
rose attention. Transposon mutagenesis is now a well established approach (Grindley et al.,
1985, Vertès et al.,  1994, Hamer et  al.,  2001) for the generation of large mutant banks
(Mormann et al., 2006, Suzuki et al., 2006). Especially since the first complete genome
sequences  were  available,  transposon  mutagenesis  became  an  advantageous  tool  for
functional genome analysis (Hayes,  2003).  The principle of this type of mutagenesis is
based on the random integration of a mobile transposon element. A loss of gene function
can be caused, but only in cases where a gene itself or its control sequence is affected. If -
statistically  seen  -  enough  mutants  are  produced  (depending  on  the  number  of  genes
annotated for the organism), every open reading frame can be effected by a gene knock-out
(Ross-Macdonald et al., 1999).
For this study a transposon mutant bank of  Corynebacterium glutamicum was used. This
mutant bank was developed using the IS6100 transposon element of the plasmid pAT6100
(figure 11). Insertion sequences are the simplest transposable elements. They only consist
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of a gene for transposition which is bounded by inverted repeat sequences (Hayes, 2003).
The  element  IS6100 belongs  to  the  IS6  family  which  is  exclusively  integrated  by  a
cointegrative mechanism forming two directly repeated IS copies. It was naturally found in
the chromosome of Mycobacterium fortuitum and is 880 bp in length (Mahillo et al., 1998).
It could be demonstrated that this insertion sequence is able to randomly integrate into the
genome of different organisms, e.g. Corynebacterium glutamicum. For the development of
the transposon mutant bank for C. glutamicum the restriction deficient mutant res- 167 of
the wild type strain ATCC 13032 was used. So, enzymatic cleavage during conjugation
could be avoided (Tauch et al., 2002). 
The plasmid pAT6100 (see figure 11) was generated by cloning a copy of IS6100 into the
vector pK18mob2. With a size of 4,516 bp it consists of the mobilizable (RP4mob) cloning
vector  pK18mob2,  a  kanamycin  resistance  marker  (KanR),  an  origin  of  replication  in
Escherichia  coli (ori),  the  IS6100 element  as  well  as  several  restriction  sites  for
transposases. The kanamycin resistance can be used for selection.
Figure 11.  Plasmid  pAT6100  used  for  transposon  mutagenesis,  and  containing  the
mobilizable (RP4mob) cloning vector, the IS6100 transposon element as well as an origin
for replication in E. coli (ori), a kanamycin resistance marker (KanR) and several restriction
sites for transposases (Tauch et al., 2002, modified).
Transposon mutants were generated by conjugation of  Corynebacterium glutamicum and
Escherichia coli S17-1 (donor). The plasmid was transferred to  C. glutamicum by RP4-
mediated high frequency conjugation (Schäfer et al., 1990 and 1994). pAT6100 is unable to
replicate  in  its  new  host,  due  to  a  missing  origin  of  replication  in  this  organism.  A
pat 6100
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kanamycin resistant phenotype of C. glutamicum is only possible when transposition of the
vector into the chromosome took place (Tauch et al., 2002). 
For identification of insertion sites the plasmid rescue technique can be used (Tauch et al.,
1995). Knowledge about the affected gene is necessary to establish a connection between
the loss of a gene function and changes in the phenotype (Bailey et al., 2002). Furthermore,
it enables the identification of novel gene functions.
The genomic DNA is cleaved by restriction enzymes (e.g. EcoRI, XbaI). The cleavage sites
are on the inserted plasmid and in the genome. For example, a cleavage site for EcoRI in
the genome of C. glutamicum can be statistically found every 46 bases. The resulting DNA
fragment contains the part of the plasmid with the kanamycin resistance marker and the
replication of origin for E. coli as well as the part of the genomic DNA which was located
next to the plasmid. This fragment can be ligated using the cleavage sites and augmented in
E. coli. Afterwards, cells containing the circular plasmid can be selected via kanamycin
resistance.  Sequencing  of  the  plasmid  and  a  search  in  the  genome  sequence  of
C. glutamicum leads to the identification of the affected gene. 
1.3 Model organisms
For this comprehensive study in the field of metabolomics three different microorganisms
were  used.  However,  main  focus  was  put  on  the  Gram-positive  prokaryote
Corynebacterium  glutamicum.  This  bacterium  was  the  model  organism  in  the  high-
throughput  and  the  quenching  studies.  Furthermore,  for  a  comprehensive  analysis  of
quenching  of  microorganisms  the  Gram-negative  prokaryote  Escherichia  coli and  the
eukaryote Saccharomyces cerevisiae were investigated as well.
1.3.1 Corynebacterium glutamicum
Corynebacterium glutamicum is a Gram-positive, fast growing, aerobic soil bacterium. It
belongs to the Actinomycetales (Liebl, 2005). The bacterium has a clubbed morphology
(coryne, Greek for club). Furthermore, it forms irregular, non sporulating rods (figure 12).
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Cells  have  a  width  between  0.7 µm  and  1.0 µm  and  a  length  of  1.0 µm  to  3.0 µm.
C. glutamicum is  non  pathogen  but  related  to  several  pathogen  organisms  (e.g.
Corynebacterium diphtheriae, Mycobacterium tuberculosis, Mycobacterium leprae).
Figure 12.  Corynebacterium glutamicum,  cells  viewed by scanning electron microscopy
(Liebl, 2005)
C. glutamicum was first detected in the year 1956 by a Japanese working group during a
research program aiming to obtain glutamic acid producing microorganisms (Abe et al.,
1967, Kinoshita, 2005). Because of its capability to produce amino acids, vitamins and
nucleotides, its industrial relevance became more and more important. The amino acids L-
glutamic acid (flavor enhancer) and L-lysine (feed additive) are the substances with the
highest production yields from fermentations with  C. glutamicum (Eggeling et al., 2001,
Glazer et al., 2007).
In the year 2002, a strategy for genome sequencing of  C. glutamicum ATCC 13032 was
published  (Tauch  et  al.,  2002a).  One  year  later,  two  independent  groups  completely
sequenced the genome of the wild type strain ATCC 13032 (Kalinowski et al., 2003, Ikeda
et al., 2003). Both revealed a total genome size of approximately 3.3 Mb (see figure 13)
with around 3000 protein coding genes as well as a high G+C content of 53.8%. Therewith
they could correct the size which was published some years before by Bathe et al. (Bathe et
al.,  1996).  For  about  83%  of  the  genes  a  function  could  be  assigned,  mostly  from
homology studies  to  known proteins.  Nevertheless,  some of  the functions  can  only be
assumed  rather  than  definitely  proved.  For  8% of  the  genes  similarities  to  conserved
hypothetical proteins in other organisms could be found (Kalinowski et al., 2003).
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Figure 13. Chromosome of the Corynebacterium glutamicum wild type strain ATCC 13032
(Kalinowski et al., 2003)
1.3.2 Escherichia coli
Escherichia coli is  a  motile,  facultative  anaerobe  and  non  sporulating  Gram-negative
bacterium. It's  a rod-like organism with peritrichous flagella (figure 14).  With a size of
0.5 µm  x  1.5 µm  it  is  a  rather  small  microbe.  E. coli is  a  γ-Proteobacteria  from the
Enterobacteriaceae family.  As non pathogen organism its  native habitat  is  the intestinal
tract of humans and animals. Nevertheless, some strains can cause diarrhea because of their
enterotoxins. 
Figure 14. Escherichia coli (http://www3.niaid.nih.gov/.../e_coli.jpg)
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E. coli is able to grow chemo-organotroph. Consequently, it can produce energy through
respiration  but  also  by  mixed  acid  fermentation.  During  this  fermentation  process
significant amounts of  formic acid,  acetic acid,  lactic acid as  well  as succinic acid are
formed as byproducts.
Furthermore,  E. coli is the standard model organism in microbiological research. This is
because  of  its  genetic  accessibility,  the  short  generation  interval  (20  minutes  when
cultivated  aerobically  on  complex  medium) as  well  as  its  ability  to  grow on  minimal
medium.  It  is  industrially  used  especially  for  the  production  of  recombinant  insulin
(Goeddel,  et  al.  1979) and recombinant proteins (e.g.  Derynck, et  al.  1980) as  well  as
amino acids (Ikeda, 2003a).
1.3.3 Saccharomyces cerevisiae
The eukaryote Saccharomyces cerevisiae belongs to the class of the Ascomyceta. Cells are
round or oval with a size between 5 µm and 10 µm (see figure 15). It is an intensively used
microorganism and important for the economy. This is among other things due to its bi-
phaseal metabolism. If it is grown on carbon sources, S. cerevisiae produces large amounts
of ethanol. When this source is consumed the eukaryote can use the produced ethanol for
farther growing (Dickinson et al., 1999).
Figure 15. Saccharomyces cerevisiae (http://www.magma.ca/.../ Yeast-2m.jpg, modified)
Furthermore,  S. cerevisiae is a well established model organism for research. In the year
1996, Goffeau et al. published the first complete sequence of a yeast strain (Goffeau et al.,
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1996). The yeast has 16 chromosomes with approximately 6200 genes. It can exist in stable
form in the diploid as well  as in the haploid state.  Today research is  focused on gene
annotation and the identification of the functions to achieve a complete understanding of
the metabolic network. 
Due to its robustness and its advantageous in genetic manipulation performances yeast is
an often used model organism. For example, a lot of studies in the field of quenching of
microorganisms have been done with S. cerevisiae (e.g. de Koning et al., 1992, Loret et al.,
2007).  Furthermore,  a  lot  of  principle  mechanisms  of  transcriptional  and  translational
control of gene expression, growth control, signal transduction as well as the metabolism
are transferable to higher eukaryotes (Peterson et al., 1992, Tamkun et al., 1992).
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1.4 Thesis aims
A Corynebacterium glutamicum transposon mutant bank had already been in construction
by Chatterjee at the beginning of this work. 
Metabolome analysis of a high number of mutants was not realizable with our standard
performance established by Stelkov et al. (Strelkov et al., 2004). For this reason, the first
part  of  this  thesis  was the development  of a  high-throughput  protocol  for  metabolome
analysis. This included the following sub tasks: The culture size had to be miniaturized and
the cultivation done in parallel. Some pre-analytical parts had to be automated and the time
required for measurement performance with the gas chromatograph/mass spectrometer had
to be shortened.
After the successful development of the high-throughput method, the second part of work
started which is to be considered a pilot project. The aim of this part was to analyze a
representative amount of transposon mutants. Criteria for the identification of interesting
mutants  had  to  be  developed.  The  major  difficulty  was  the  differentiation  between
biological and environmental variations and variations caused by the introduced genetic
perturbation. 
In the third part of this thesis a suitable quenching method for different microorganisms
was  developed.  Whereas  for  a  mutant  screening  with  the  semi-automated,  fast  high-
throughput method the quenching of the organism could be neglected, it is essential to stop
the  organism  in  the  moment  of  harvesting  when  desired  states  and  times  had  to  be
investigated and compared. The interesting genetic modifications would overwhelm other
changes  during  such  a  screening.  But  quenched  samples  are  a  prerequisite  for  a
comparative metabolome analysis, for example of different phases of an organism.
For the evaluation of the developed method it was compared to our unquenched method as
well  as  to  two  published  quenching  protocols.  Furthermore,  the  prokaryotes
Corynebacterium glutamicum,  Escherichia coli as  well  as  the eukaryote  Saccharomyces
cerevisiae were used as model organisms.
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2 Material & Methods
In the following, all used chemicals, machines etc. are listed. Furthermore, the standard
operation protocols for all applied solutions and methods are specified.
1.5 Used chemicals and machines
Table 1. Manufacturer's list of chemicals
Name Purity Manufacturer
α-D(+)-Glucose monohydrate 99.5% Carl Roth, Karlsruhe, D
Adonit/Ribitol ≥ 99.0% Carl Roth, Karlsruhe, D
Agar-Agar Carl Roth, Karlsruhe, D
Agarose NEEO ultra-quality Carl Roth, Karlsruhe, D
Ammonium sulfate ≥ 99.5% Carl Roth, Karlsruhe, D
Biotin > 98.0% Serva, Heidelberg, D
Boric acid Carl Roth, Karlsruhe, D
Brain Heart Infusion Sigma-Aldrich, Steinheim, D
Calcium chloride dihydrate ≥ 99.0% Carl Roth, Karlsruhe, D
Calcium pantothenate Sigma-Aldrich, Steinheim, D
Caseinhydrolysate (Casamino acids) Carl Roth, Karlsruhe, D
Chloroform Fisher Scientific, Schwerte, D
Cobalt(II)-chloride hexahydrate ≥ 99.0% Carl Roth, Karlsruhe, D
Cupric sulfate pentahydrate ≥ 99.5% Carl Roth, Karlsruhe, D
Cyclohexane Fisher Scientific, Schwerte, D
Decane > 98.0% Carl Roth, Karlsruhe, D
Di-Potassium hydrogen phosphate ≥ 99.0% Carl Roth, Karlsruhe, D
DNA Ladder Mix Fermentas St. Leon-Rot, D
Docosane 99.0% Sigma-Aldrich, Steinheim, D
Dodecane Carl Roth, Karlsruhe, D
Dotriacontane 97.0% Sigma-Aldrich, Steinheim, D
EcoRI (100.000 U/ml) NEB, Frankfurt, D
EcoRI buffer NEB, Frankfurt, D
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Name Purity Manufacturer
EDTA Serva, Heidelberg, D
Ethanol HPLC Carl Roth, Karlsruhe, D
Ethidium bromide Carl Roth, Karlsruhe, D
Ferric chloride hexahydrate Fluka Sigma-Aldrich, Steinheim, D
Ferrous sulfate heptahydrate ≥ 99.0% Carl Roth, Karlsruhe, D
Folic acid Sigma-Aldrich, Steinheim, D
Glycerol Zentrales Lager für Chemikalien
TU-Braunschweig, D
Hexatriacontane 98.0% Sigma-Aldrich, Steinheim, D
Hydrochloric acid 37,0 % Honeywell, Seelze, D
(myo-) Inisitol ≥ 99.0% Sigma-Aldrich, Steinheim, D
Kanamycinsulfate Carl Roth, Karlsruhe, D
Loading Dye Solution Fermentas St. Leon-Rot , D
Lysozyme Carl Roth, Karlsruhe, D
Magnesium chloride hexahydrate Carl Roth, Karlsruhe, D
Magnesium sulfate Zentrales Lager für Chemikalien
TU-Braunschweig, D
Magnesium sulfate heptahydrate ≥ 99.0% Carl Roth, Karlsruhe, D
Manganese sulfate monohydrate ≥ 99.0% Carl Roth, Karlsruhe, D
Methanol Fisher Scientific, Schwerte, D
Methoxyamine hydrochloride ≥ 98.0% Sigma-Aldrich, Steinheim, D
MSTFA CS-Chromatographie, Langerwehe, D
Niacine (Nicotinic acid) ≥ 98.0% Sigma-Aldrich, Steinheim, D
Nickel(II)-chloride hexahydrate ≥ 98.0% Carl Roth, Karlsruhe, D
Nonadecane Carl Roth, Karlsruhe, D
Octacosane > 98.0% Carl Roth, Karlsruhe, D
p-Amino-benzoic acid Sigma-Aldrich, Steinheim, D
Pentadecane Carl Roth, Karlsruhe, D
Peptone from Casein Carl Roth, Karlsruhe, D
Phosphor pentoxide ≥ 98.5% Carl Roth, Karlsruhe, D
Potassium aluminum sulfate
dodecahydrate
≥ 98.0% Carl Roth, Karlsruhe, D
Phenol Sigma-Aldrich, Steinheim, D
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Name Purity Manufacturer
Potassium di-hydrogen phoshpate ≥ 99.0% Carl Roth, Karlsruhe, D
Potassium hydroxide Zentrales Lager für Chemikalien
TU-Braunschweig, D
Potassium iodide Merck KGaA, Darmstadt, D
Proteinase K Sigma-Aldrich, Steinheim, D
Pyridine ≥ 99.5% Carl Roth, Karlsruhe, D
Pyridoxine hypochloride Sigma-Aldrich, Steinheim, D
Riboflavin Sigma-Aldrich, Steinheim, D
RNase A Roche, Mannheim, D
Sodium acetate ≥ 99.0% Carl Roth, Karlsruhe, D
Sodium dodecyl sulfate Carl Roth, Karlsruhe, D
Sodium chloride ≥ 99.5% Carl Roth, Karlsruhe, D
Sodium hydroxide ≥ 99.0% Carl Roth, Karlsruhe, D
Sodium molybdate dihydrate ≥ 99.5% Carl Roth, Karlsruhe, D
Sulfuric acid ≥ 96.0% Carl Roth, Karlsruhe, D
T4-DNA-ligase (400.00 U/ml) NEB, Frankfurt, D
Thiamine hypochloride Sigma-Aldrich, Steinheim, D
Tris ≥ 99.0% Carl Roth, Karlsruhe, D
Tryptone from Casein Carl Roth, Karlsruhe, D
Urea ≥ 99.7% Carl Roth, Karlsruhe, D
Yeast extract Serva, Heidelberg, D
Zinc sulfate heptahydrate ≥ 99.5% Carl Roth, Karlsruhe, D
Table 2. List of equipment
Equipment Manufacturer
GC System
6890N Network GC System Agilent Technologies Sales & Services,
Waldbronn, D
Multi Purpose Sampler MPS2-Twister Gerstel, Mülheim an der Ruhr, D
Mass Spectrometer
AccuTOF GC JMS-T100GC Jeol (Deutschland), Eching, D
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Equipment Manufacturer
Shaker for incubation
Certomat BS-1 (orbit: 50 mm) Sartorius Biotech,Göttingen, D
Certomat SII (orbit: 25 mm) Sartorius Biotech,Göttingen, D
TiMix 5, TH15 (orbit: 3 mm) Edmund Bühler, Tübingen, D
Centrifuges
Centrifuge 5810R Eppendorf, Hamburg, D
Centrifuge 5424 Eppendorf, Hamburg, D
Primo R Benchtop Centrifuge Fisher Scientific, Schwerte, D
Mikro 22 R Hettich, Tuttlingen, D
Z 300 K Hermle, Wehingen, D
Others
Electroporater 2510 Eppendorf, Hamburg, D
G:BOX Syngene, Cambridge, UK
Mix Mate Eppendorf, Hamburg, D
Sonorex Digitec UW 2070 Bandelin Electronic, Berlin, D
Sonorex Digitec DT 255H Bandelin Electronic, Berlin, D
Spectral photometer Genesys 6 Sysmex Digitana, Horgen, D
Speed Vac Concentrator 5301 Eppendorf, Hamburg, D
Sunrise-Basic Tecan Deutschland GmbH, Crailsheim, D
Thermo mixer Comfort Eppendorf, Hamburg, D
Table 3. Applied materials
Material Manufacturer
GC column
DB-5MS (30 m * 0.25 mm * 0.25 µm) Agilent (J & W Scientific), Folsom, USA
GC glass liner
71*2 mm glass liner Gerstel, Mülheim an der Ruhr, D
Filter
Fiber glass filter GF/F, 0.7 µm Whatman, Dassel, D
Nitrocellulose filter MCE-MF, 0.22 µm Millipore, Schwalbach, D
Others
Adhesive foil, polyolefin Nunc, Wiesbaden, D
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Material Manufacturer
AeraSealTM, foil Excel  Scientific  Inc.,  Wrightwood,  USA;
Sigma-Aldrich, München D
Bottle R1 s, clear CS-Chromatographie, Langerwehe, D
Bottle 1.1 ml, flange, clear IVA Analysentechnik, Meerbusch, D
BreathEasyTM, foil; T093.1 Diversified Biotech, Boston, USA; Carl Roth,
Karlsruhe, D
Cuvette for electroporation (1 mm) Eppendorf, Hamburg, D
Cuvette from silica glass, 10 mm Carl Roth, Karlsruhe, D
F96 MicroWellTM plate, PS Nunc, Wiesbaden, D
Flanging pliers CS-Chromatographie, Langerwehe, D
Glass wool Restek, Bad Homburg, D
Magnetic flanging cap R11-Silicon,
red/white
CS-Chromatographie, Langerwehe, D
Micro insert G30s CS-Chromatographie, Langerwehe, D
Screw cap 8-SCJ Chromacol, Herts, UK; Kupfer Pfungstadt, D
Septa 8 ST 101 Chromacol, Herts, UK; Kupfer Pfungstadt, D
Silicon mat Nunc, Wiesbaden, D
U96 DeepWellTM plate, PP Nunc, Wiesbaden, D
U96 MicroWellTM plate, PP Nunc, Wiesbaden, D
1.6 Software and libraries
Table 4. Applied software
Software Description
AMDIS 32, Version 2.64
(http://chemdata.nist.gov/mass-spc/amdis/)
Automated  Mass  Spectral  Deconvolution
and  Identification  System,  Analysis  of
GC/MS data 
BLAST, NCBI
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi)
Comparison  of  DNA  sequences  with
genome annotation data
CUMETA Calculation  of  correlation  values  (Pearson
and Spearman correlation)
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Software Description
Excel 2007 Microsoft spreadsheet and data reporting
Gerstel Maestro 1, version 1.1.4.18
(http://www.gerstel.com)
Control  software  for  the  MPS2  twister
autosampler and the PTV injector
LER Auswertung Tool for analysis and comparison of GC/MS
data
Macro3 Macro  (Excel)  for  standardization  of  peak
areas to peak area of the ribitol
Mass Center Main, Version 2.3.0.1 Control software for the GC/MS system
Processing4_3 Processing of results from AMDIS for usage
in XCalibur
Scatter plot beta7 Programmed Excel  sheet  for  generation of
scatter plots for comparison of GC/MS data
XCalibur 1.4 Analysis of GC/MS data
Table 5. Applied libraries
Database Description
NIST Mass Spectral Database
(http://www.nist.gov/)
Library and program for analysis of GC/MS
spectra
Library 3.4.0 Internal mass spectra database with defined
parameters for identification
KEGG Encyclopedia
(http://www.genome.jp/kegg/)
Collection  of  pathways  for  different
organism
PubMed (http://www.ncbi.nlm.nih.gov/pubmed) Literature research
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1.7 Used bacteria strains
Table 6. Bacteria strains
Strain Origin Reference
Corynebacterium glutamicum
ATCC 13032 American Type Culture
Collection, Wesel, D
Kalinowski et al., 2003
Abe et al., 1967
res- 167, ATCC 13032 Delta
(cgllMcgllR-cglllR) (restriction
deficient)
Prof.  Krämer,  Universität zu
Köln, D
Cleas et al., 2002
Transposon mutants Prof. Schomburg, Technische
Universität Braunschweig, D
Chatterjee, unpulished
Mormann et al., 2006
Escherichia coli
DSM 498 DSMZ, Braunschweig, D Castellani et al., 1919
DH5α (mcr) Prof. Waffenschmidt,
Univesität zu Köln, D
Hanahan, 1983
Saccharomyces cerevisiae
CEN.PK 113-7D Dr. Kötter, Universität
Frankfurt (Main), D
Villas-Bôas et al., 2005a
1.8 Applied kits
Table 7. List of applied kits
Name Application Origin
Wizard Plus SV Minipreps
DNA Purification System
Plasmid preparation out of
E. coli
Promega,Mannheim, D
peqGOLD Plasmid Miniprep
Kit I
Plasmid preparation out of
E. coli
Peqlab, Erlangen, D
Phase lock-test tubes Preparation of genomic DNA
out of C. glutamicum
Eppendorf, Hamburg, D
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1.9 Statistic and calculation of errors
The arithmetic average was  calculated from a  series  of  n different  measurements.  The
mean value x (equation 2.1) represents the supposable value of the series.
x=
1
n
∑
i=1
n
x i (2.1)
The standard deviation s (equation 2.2) describes the variation of each single measurement
xi compared to the mean value x . It is the mean error of the single measurement.
s=±
1
n1∑i=1
n
x x i (2.2)
In most cases the accuracy of the mean value is important. The standard error of the mean
value  sx  (equation 2.3) differs from the standard deviation  s by the factor 1/n . It
describes the interval around the mean value, where the true value can be expected.
sx=±
1
nn1∑i=1
n
x xi=
s
n
(2.3)
The important assumptions for these calculations are the independence of all values xi and
there similar accuracy.
The relative error srel (equation 2.4) represents the accuracy of the measurement procedure.
srel=±
sx
x
∗100 % (2.4)
When comparing mean values the error propagation after Gauss was applied. If the ratio
(equation 2.5) of two values x1 and x2, with associated standard errors sx1 and sx2 was
calculated, the error sf had to be calculated according to equation 2.6.
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f x1, x2=
x1
x2
(2.5)
s f=
1
x2
∗s x1 ²
x1
x2 ²
∗s x2 ² (2.6)
If correlations were calculated the Pearson correlation was applied. Values were calculated
using the logarithmic values of the relative concentration vectors.
1.10 Media, buffer and solutions
Brain heart infusion medium (BHI)
Brain Heart Infusion 37 g
BHI has to be filled up to 1 l with double distilled water and autoclaved afterwards.
Luria-Bertani medium (LB)
Peptone from Casein 10 g
Yeast extract   5 g
Sodium chloride 10 g
The compounds were dissolved in double distilled water, filled up to 1 l and autoclaved.
YPD medium
Yeast extract 10 g/l
Peptone from Casein 20 g/l
α-D(+)-Glucose monohydrate 20 g/l
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Components were dissolved in double distilled water, filled up to 1 l and autoclaved.
Stock solution for minimal medium (MM1)
Ammonium sulfate 20.00 g
Urea   5.00 g
Di-Potassium hydrogen phosphate   1.53 g
Potassium di-hydrogen phoshpate   2.00 g
Substances were dissolved in 0.85 l double distilled water and the pH-value was adjusted
with potassium hydroxide (c = 5 M) to 7. Afterwards the solution was filled up to 0.947 l
with double distilled water and autoclaved.
Stock solution for minimal medium with amino acids
Ammonium sulfate 20.00 g
Urea   5.00 g
Di-Potassium hydrogen phosphate   1.53 g
Potassium di-hydrogen phoshpate   2.00 g
Substances were dissolved in 0.85 l double distilled water and the pH-value was adjusted
with potassium hydroxide (c = 5 M) to 7. Afterwards the solution was filled up to 0.947 l
with double distilled water and autoclaved.
Caseinhydrolysate (Casamino acids)   4.00 g
Caseinhydrolysate was dissolved in 20 ml sterile solution prepared before, sterilized by
filtration and combined with the rest of the solution.
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Stock solution of glucose (25 fold)
α-D(+)-Glucose monohydrate 550 g
Glucose had to be dissolved in 0.85 l double distilled water and filled up to 1 l before it
was sterilized by filtration.
Stock solution of magnesium sulfate (100 fold)
Magnesium sulfate heptahydrat 25 g
Compound was dissolved in 0.85 l double distilled water, filled up to 1 l and autoclaved.
Stock solution of calcium chloride (1000 fold)
Calcium chloride dihydrat 10 g
Calcium chloride was dissolved in 0.85 l double distilled water and filled up to 1 l before it
was autoclaved.
Stock solution of trace elements (1000 fold)
Ferrous sulfate heptahydrate 28.500 g
Manganese sulfate monohydrate 16.500 g
Zinc sulfate heptahydrate   6.400 g
Cupric sulfate pentahydrate   0.764 g
Cobalt(II)-chloride hexahydrate   0.128 g
Nickel(II)-chloride hexahydrate   0.044 g
Sodium molybdate dihydrate   0.064 g
Boric acid   0.048 g
Potassium aluminum sulfate dodecahydrate   0.028 g
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Substances were dissolved in 0.85 l double distilled water and the pH-value was adjusted
to 1 with sulfuric acid (c = 3 M). Afterwards the solution was filled up to 1 l with double
distilled water and sterilized by filtration.
Stock solution of biotin (1000 fold)
Biotin 20 g
Sodium hydroxide solution (c = 1 M) 3 drops
Biotin  was  dissolved  in  80 ml  double  distilled  water  via  supplementation  of  sodium
hydroxide  solution.  The  solution  was  filled  up  to  100 ml  with  double  distilled  water,
sterilized by filtration, divided into aliquot parts and stored at -20°C.
Minimal medium (MM1)
Table 8. Composition of different volumes MM1
Component Volume for 100 ml Volume for 20 ml
stock solution for minimal medium 94.7 ml 18.94 ml
stock solution of magnesium sulfate   1.0 ml   0.20 ml
stock solution of calcium chloride   0.1 ml   0.02 ml
stock solution of glucose   4.0 ml   0.80 ml
stock solution of biotin   0.1 ml   0.02 ml
stock solution of trace elements   0.1 ml   0.02 ml
MM1 was always freshly prepared prior to usage.
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Basic medium
Calcium chloride dihydrate 0.132 g
Sodium chloride 0.100 g
Magnesium sulfate 0.500 g
Potassium di-hydrogen phosphate 1.000 g
Ammonium sulfate 5.000 g
Compounds were dissolved in 1 l double distilled water and autoclaved.
Stock solution of vitamins (1000 fold)
Biotin       1 mg
Calcium pantothenate   200 mg
Folic acid       1 mg
Inositol 1000 mg
Niacine   200 mg
p-Amino-benzoic acid   100 mg
Pyridoxine hypochloride   200 mg
Riboflavin   100 mg
Thiamine hypochloride   200 mg
Substances were dissolved in 1 l double distilled water and sterilized by filtration.
Stock solution of trace metals (1000 fold)
Boric acid 500 mg
Cupric sulfate pentahydrate   40 mg
Potassium iodide 100 mg
Ferric chloride hexahydrate 200 mg
Manganese sulfate monohydrate 400 mg
Sodium molybdate dihydrate 200 mg
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Substances were dissolved in 1 l double distilled water and sterilized by filtration.
Minimal medium for yeast
Table 9. Composition of the minimal medium for yeast
Component Volume for 1 l
basic medium 973 ml
stock solution of glucose   25 ml
stock solution of vitamins     1 ml
stock solution of trace metals     1 ml
Nutrient agar plates
For BHI-, LB-, YPD- as well as MM1-agar plates, 15 g agar-agar had to be added to 1 l of
the media and autoclaved. Possibly, a sterile antibiotic was added to the medium before
preparing the agar plates. Plates were stored at 4°C.
Stock solution of ribitol
Ribitol (Adonit) 0.2 g
Ribitol was dissolved in 1 l double distilled water. The solution was sterilized by filtration,
divided into aliquot parts and stored at -20°C. 
Ethanol-ribitol-solution
Ethanol 10.0 ml
Stock solution of ribitol   0.4 ml
Solutions were combined prior to usage.
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SOC medium
Tryptone from casein 20.0 g
Yeast extract   5.0 g
Sodium chloride   0.5 g
Substances were dissolved in 0.98 ml double distilled water.
Potassium chloride solution 250 mM
10 ml  of  the  potassium  chloride  solution  were  added  to  the  dissolved  substances.
Afterwards the pH-value was adjusted to 7 with sodium hydroxide solution (c = 5 M) and
autoclaved. 
Magnesium chloride solution 2 M
α-D(+)-Glucose monohydrate 1 M
A  magnesium  chloride  solution  was  autoclaved  separately.  A  glucose  solution  was
sterilized by filtration. 5 ml of the magnesium chloride solution and 20 ml of the glucose
solution were added to the before prepared solution.
TE-buffer (Tris-EDTA-buffer)
Tris 10 mM
EDTA   1 mM
The prepared solution was filled up to 1 l with double distilled water and the pH-value was
adjusted to 7.5 with a hydrochloric acid solution.
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TAE-buffer (Tris-Acetate-EDTA-buffer, 50 fold)
Tris   2 M
Acetic acid   1 M
EDTA (pH 8) 50 mM
Components were combined and solution was filled up to 1 l with double distilled water.
Stock solutions of antibiotics
Kanamycin I 25 mg/ml
Kanamycin II 50 mg/ml
Stock solutions were prepared with double distilled water.  Solutions were sterilized by
filtration, divided into aliquot parts and stored at -20°C.
B1-solution
Tris/HCl (pH 8) 25 mM
EDTA (pH 8) 10 mM
α-D(+)-Glucose monohydrate 50 mM
Components were combined and a B1-stock solution prepared. As solvent double distilled
water was used. Stock solution was stored at room temperature.
Lysozyme 20 mg/ml
RNase A 100 µg/ml
Both stocks were prepared with double distilled water, sterilized by filtration, divided into
aliquot parts and stored at -20°C. Lysozyme and RNase A were always given to the B1-
stock solution prior to usage.
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Proteinase K
Proteinase K 20mg/ml
Stock solution was prepared with double distilled water,  sterilized by filtration, divided
into aliquot parts and stored at -20°C.
ATP solution
ATP 10 mM
Stock solution was prepared with double distilled water,  sterilized by filtration, divided
into aliquot parts and stored at -20°C.
RNase A
RNase A 10 mg/ml
Sodium acetate solution (pH 5.2) 10 mmol/l
RNase A was dissolved in sodium acetate solution and incubated at 100°C for 15 minutes.
Afterwards the solution cooled down to room temperature. 
Tris/HCl solution (pH 7.5)   1 mol/l
100 µl  of  the  Tris/HCl  solution  were  given  to  1 ml  of  the  before  prepared  solution,
sterilized by filtration, divided into aliquot parts and stored at -20°C.
Sodium chloride solution
Sodium chloride (0.9% w/v) 9.0 g/l
The sodium chloride solution was prepared with double distilled water and stored at 4°C.
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Quenching solutions
Ethanol quenching solution
Ethanol (I...III) 40% v/v
Sodium chloride solution I 0.5% w/v
Sodium chloride solution II 0.8% w/v
Sodium chloride solution III 1.5% w/v
Ethanol quenching solutions I, II and III were prepared with double distilled water, divided
into  aliquot  parts  and  stored  at  -20°C.  Ethanol  was  always  combined  with  a  sodium
chloride solution (I...III) to obtain the end concentration stated earlier.
Methanol quenching solution
Methanol 60% v/v
Methanol quenching solution was prepared with double distilled water, divided into aliquot
parts and stored at -80°C.
Cold glycerol saline quenching solution
Glycerol pure
Sodium chloride solution 13.5 g/l 
Glycerol and the sodium chloride solution were mixed 3:2 v/v, divided into aliquot parts
and stored at -20°C.
Cold glycerol saline washing solution
Glycerol pure
Sodium chloride solution 13.5 g/l 
Glycerol and sodium chloride solution were mixed 1:1 v/v, divided into aliquot parts and
2  Material & Methods 45
stored at -20°C.
Methoxyamine-pyridine-solution (reagent for derivatization)
Methoxyamine hydrochloride 20 mg
Pyridine   1 ml
Solution was freshly prepared prior to usage.
Quality control solution
Pentadecane 0.4 g
Pentadecane was dissolved in 0.85 l cyclohexane and filled up to 1 l  with cyclohexane
afterwards. Solution was stored at 4°C.
Time standard solution
Decane 17.12 µl
Dodecane 16.67 µl
Pentadecane 16.23 µl
Nonadecane 12.50 mg
Docosan 12.50 mg
Octocosane 12.50 mg
Dotriacontane 12.50 mg
Hexatriacontane 12.50 mg
Substances were dissolved in 20 ml cyclohexane and filled up to 25 ml with cyclohexane
afterwards. Solution was stored at room temperature.
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1.11 Standard metabolome analysis 
In the following part all necessary steps for the standard metabolome analysis (Strelkov et
al., 2004) are described in detail.
1.11.1 Cultivation in shaking flasks
Strains were routinely stored as glycerol stocks at -80°C. For metabolome analysis stocks
were taken and streaked out on agar plates containing a complex medium. After incubation
at organism-specific temperatures plates were sealed with parafilm and stored at 4°C.
Cultivation of Corynebacterium glutamicum
C. glutamicum was raised on BHI as complex medium. After incubation on BHI-plates at
30°C for around one day, a single colony was transferred to 5 ml fresh BHI medium in a
test tube. Incubation was done at 30°C, 180 rpm for 7 hours. Afterwards 0.5 ml of this pre-
culture was transferred to 20 ml freshly prepared MM1 medium in a 100 ml-shaking flask
and incubated at 30°C, 180 rpm over night (~16 h). The main culture was prepared in a
500 ml-shaking flask containing fresh MM1. The culture was inoculated with the over
night culture to a starting OD600 of 1. Cells grew for 7 hours, at 30°C and 180 rpm.
If a mutant was raised, kanamycin was added to pre-culture and overnight culture to obtain
a concentration in the medium of 25 µg/ml.
Cultivation of Saccharomyces cerevisiae
S. cerevisiae  was streaked out from glycerol stocks on YPD-agar plates and incubated at
30°C for three days. For the inoculation of the pre-culture several colonies were taken and
transferred to 20 ml YPD in a 100 ml-buffled shaking flask and incubated at 30°C, 200 rpm
for  9  hours.  20 ml  fresh  minimal  medium for  yeast  was  prepared  in  a  100 ml-buffled
shaking flask and inoculated with 2.2 ml of the pre-culture. The over night culture was
incubated at 30°C, 200 rpm for 14...16 hours. For the main culture 50 ml minimal medium
were freshly prepared in a 250 ml-buffled shaking flask and inoculated with the over night
2  Material & Methods 47
culture to a start OD600 of 2.5 and incubated at 30°C and 200 rpm for 5 hours.
Cultivation of Escherichia coli
E. coli was handled differently, compared to both other organisms. Cells were streaked out
from a glycerol stock on MM1-agar plates. After incubation at 37°C for at least one day a
single colony was transferred to 5 ml freshly prepared MM1 medium in a test tube. The
cultures were incubated over night at 37°C and 220 rpm (~16 h). The cultivation of E. coli
was done without pre-culture. 100 ml main culture (MM1) was inoculated with the over
night culture in a 500 ml-shaking flask to a starting OD600 of 0.03...0.05. Again, incubation
was done at 37°C and 220 rpm for 7 hours.
1.11.2 Pre-analytical sample preparation
For  metabolome  analysis  samples  were  prepared  routinely  using  a  standard  protocol
(Strelkov et al., 2004). The workflow is shown in figure 16. The pre-analytical preparation
starts after cultivation with the harvesting of the cells. Time for harvesting is specific for
each organism, but is performed always in the middle of the exponential growth phase. For
reason of comparison the ratio of cell number and volume has to be stable. Consequently,
the volume for harvesting was always calculated according to the optical density of the
main  culture.  Because  of  the  different  morphology  of  the  analyzed  cells,  for  each
microorganism an equation was determined, related to their cell dry mass. 
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Figure 16. Workflow of the standard protocol for metabolome analysis.
Equation 2.7 describes the calculation of the harvesting volume for  C. glutamicum  and
S. cerevisiae and equation 2.8 for E. coli (Jäger, 2007).
V harvesting=
50
OD600
(2.7)
V harvesting=
48
OD600
(2.8)
After  harvesting,  the  cells  were  centrifuged  at  4°C  and  3904 g  for  3 minutes.  The
supernatants were discarded and pellets washed with 20 ml of sodium chloride solution
(0.9% w/v and a temperature of 4°C). Resuspended cells were centrifuged under the same
conditions and the whole washing step was repeated one time. Afterwards, pellets were
resuspended in 1.5 ml of the ethanol-ribitol-solution and cell lysis was performed in the
ultrasonic bath at 70°C for 15 min. Then the samples were cooled on ice for 2 min. 1 ml
double  distilled  water  was  added.  After  intense  mixing  for  around  1 min  0.75 ml
chloroform was added and the mixing was repeated. For phase separation samples were
centrifuged at 4°C and 3904 g for 5 minutes. Afterwards, 1 ml of the upper polar phase
   harvesting
     washing
     cell lysis
1x
phase separation
 derivatization
      drying
 measurement
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could be removed and transferred to a fresh 2 ml-tube and dried over night in the speed
vac. The first  hour was performed with rotation to avoid any delay in boiling and the
remaining time without rotation.
Extract of the samples had to be derivatized before measurement. This was done in two
steps. At first 20 µl methoxyamine-pyridine-solution was added, intensely mixed for 1 min
and incubated in a thermo mixer for 90 min at 30 °C and 600 rpm. Subsequently, 32 µl
MSTFA were added, intensely mixed for 1 min and incubated for 30 min at 37°C and for
further 2 h at 25°C each time at 600 rpm.
Derivatized samples were centrifuged for 3 min and 10,000 g and the clear supernatants
were transferred to glass vials containing micro inserts.
1.11.3 GC/MS analysis and data processing
Measurement was done with a fast GC coupled to a TOF-MS. Analyses were performed
over 60 minutes. Electron impact mode at 70 eV was used for ionization with a source
temperature adjusted to 200°C. The detector voltage was set to 2100 V and the emission
current to 300 µA. Mass spectra were acquired in full scan mode from 40 to 800 m/z with a
scan rate of 2/s and a solvent delay time of 6 min.
Chromatography was performed with a flow rate of 1 ml/min. For measurement 2 µl of the
sample were injected in split mode with a split ratio of 1/25 into the PTV-injector which
had a temperature of 70°C. Injector temperature was increased to 280°C with a rate of
12 K/s for transferring the sample onto the column. The oven temperature had 70°C at the
beginning and was  held  at  70°C for  1 min.  Afterwards  it  was  increased to  76°C with
1 K/min, and further to 325°C with 6 K/min. This temperature was held for 10 min.
At the beginning of each data collection one sample (2 µl, split ratio 1/25) containing the
time standard (mix of 50 µl MSTFA and 4 µl time standard) was injected. Furthermore -
after six samples - pure MSTFA was injected for rinsing the column and after around 12
samples  the  quality  control  was  injected  to  check  the  performance  of  the  mass
spectrometer.
After  measurement  samples  had  to  be  converted  three  times.  Because  acquired  mass
spectra were recorded continuously they had to be made centroid. Furthermore, data were
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converted into net-cdf-files. These net-cdf-files had to be transformed into raw-files and
could be used for standard data processing afterwards.
The first step of the data processing was the identification of the retention times of the
alkane series in AMDIS. Afterwards the information of retention time and corresponding
retention index was used and data were deconvoluted, and peaks identified applying our
internal library. The results were rewritten using Processing4_3 to receive data adaptable
for XCalibur. In XCalibur the in AMDIS identified substances were related to pre-defined
quantification ions and the intensity of these peaks were determined. Afterwards the results
of the data set were exported to Excel where they were rewritten in a result list using the
Macro3. During rewriting process two additional steps were performed: all intensities were
related  to  the  intensity  of  the  internal  standard  ribitol,  and  derivatives  of  the  same
metabolite were combined.
1.12 High-throughput metabolome analysis
In  the  following  part  all  necessary steps  for  the  high-throughput  metabolome analysis
(Börner et al., 2007) are described in detail. Data processing was done according to the
performance in the standard protocol (see part 2.7.3).
1.12.1 Cultivation in micro titer plates
If  only the wild type had to be raised, the first steps till  over night culture were done
according to the standard cultivation in part 2.7.1. For the over night culture 150 µl fresh
MM1 was prepared per well and each well except for two blanks was inoculated with 10 µl
of the pre-culture. Incubation was done at 30°C and 1050 rpm over night (~16 h). 25 µl of
the over  night  culture per  well  were used to  inoculate 400 µl  fresh MM1 of the main
culture. Incubation was done at 30°C and 1050 rpm for 7 h. 
Working in micro titer plates required certain preconditions: the plates had to be closed
using a combination of two foils in order to assure sufficient oxygen supply. Therefore, the
plates were sealed with the AeraSeal foil first and the BreathEasy foil on top.
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Transposon mutants were always stored as glycerol stocks in micro titer plates at -80°C.
For cultivation they had to be streaked out on BHI-kanamycin plates (25 µg/ml) using a
replicator. Incubation was done at 30°C for one day. Pre-cultures contained 150 µl BHI-
kanamycin-solution (25 µg/ml) per well and were inoculated with colonies from the plate.
Colonies were transferred to the wells with the replicator.  Pre-culture was incubated at
30°C and  1050 rpm for  7 h.  150 µl  fresh  MM1 containing  kanamycin  (25 µg/ml)  was
prepared for each well of the over night culture. This culture was inoculated with 10 µl of
the pre-culture and incubated over night (~16 h) at 30°C and 1050 rpm. Starting with the
over night culture, every mutant was “raised three times”. In other words, three consecutive
wells of this plate were inoculated with the same pre-culture. Furthermore, six wells (two
separated triplicates) contained MM1 without kanamycin and were inoculated with 10 µl
of a separately prepared pre-culture of the wild type. Three wells of the plate remained not
inoculated as blanks.
Main culture was raised in 96deepwell plates. 400 µl MM1 were prepared for each well
and inoculated with 25 µl of the over night culture.  Inoculation was done at  30°C and
1050 rpm for 7 hours.
1.12.2 Semi-automatic sample preparation
Sample  preparation  for  the  high-throughput  analysis  was  adapted  from  the  standard
performance (see part 2.7.2) but performed in a micro titer plate. The workflow is shown in
figure 17. For harvesting the whole micro titer plate was centrifuged at 4°C and 3220 g for
3 min. Afterwards cells were washed with 400 µl cold sodium chloride solution (4°C, 0.9%
w/v). For resuspension the plate was sealed with a silicon mat and mixed on a shaker for
micro  titer  plates  (“mix mate”).  Subsequently,  the  plate was  centrifuged again and  the
washing  step  was  repeated  one  time.  Afterwards,  pellets  were  resuspended  in  400 µl
ethanol-ribitol-solution,  and cell  lysis was performed at  70°C in an ultrasonic bath for
15 min. For the lysis micro titer plate had to be covered with a special foil (adhesive foil)
and a metal brace. The plate with the metal brace had to be cooled after lysis for around
10 min on ice. After adding 400 µl double distilled water to each well and mixing for 1 min
on the mix mate, 250 µl chloroform were added, mixed for 1 min again, and then the plate
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was centrifuged to separate the polar and the apolar phase. 
Up to this each step was performed manually. All following steps were done automated
using the MPS2 twister autosampler. Equipped with a 1 ml syringe, around 600 µl of the
upper aqueous phase were transferred from each well into a tapered glass vial (filling speed
40 µl/s and depth of immersion 30 mm). All samples were dried over night in a desiccator
using  phosphor  pentoxide  as  desiccant  under  vacuum.  Glass  vials  were  closed  with
magnetic caps the next day. Afterwards, the dried samples were derivatized automated with
the MPS2 twister autosampler equipped with a 10 µl syringe. Therefore the autosampler
was also filled with vials containing pure MSTFA and methoxyamine-pyridine-solution. 
Derivatization was done in two steps. First  20 µl  methoxyamine-pyridine-solution were
added to the sample. The whole vial was shaken for 2 min at 750 rpm. Incubation was done
for 125 min at around 37°C. Then 32 µl MSTFA were added and the whole vial was shaken
again. Incubation was repeated under same conditions. 
Each sample was freshly prepared before measurement. For the measurement of the time
standard, 4 µl alkane mix was transferred to a tapered glass vial, closed with a magnetic
cap and prepared together with the other samples.
Figure 17. Workflow of the pre-analytical parts of the high-throughput performance.
   harvesting
     washing
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1.12.3 GC/MS analysis and data processing
Measurement was done with a fast GC coupled to a TOF-MS over 18 minutes. Electron
impact mode at 70 eV was use for ionization with a source temperature adjusted to 200°C.
The detector voltage was set to 2100 V and the emission current to 300 µA. Mass spectra
were acquired in full scan mode from 40 to 800 m/z with a scan rate of 5/s and a solvent
delay time of 3.9 min.
Chromatography was performed with a flow rate of 1 ml/min. 2 µl of the sample were
injected  in  split  mode  with  a  split  ratio  of  1/10  into  the  PTV-injector  which  had  a
temperature of 70°C. The temperature was increased to 280°C with 12 K/s transferring the
sample onto the column. The oven temperature had 70°C and was held at 70°C for 1 min.
Afterwards, it was increased to 76°C at 4 K/min, to 325°C with 24 K/min and was held at
this temperature for 6 min.
Retention times were determined and rinsing of the column with pure MSTFA was done as
described before (see part 2.7.3). Data conversion and data processing were performed as
characterized in detail for 60-min-measurements in part 2.7.3.
1.13 Quenching of microorganisms
The  following  part  describes  the  applied  quenching  methods.  In  order  to  provide  a
comparison, our standard method (unquenched method, see part 2.7) was also used. In all
protocols a temperature reduction was applied to achieve a complete stop of metabolism.
Table 10 gives an overview about the tested quenching methods. In all cases the methods
were handled in parallel and the samples (at least triplicates) were strictly derived from the
same  cultivation.  The  way  how  the  different  organisms  were  cultivated  was  already
described in detail in part 2.7.1. Thus, the following part specifies the steps starting from
harvesting.
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Table 10. Quenching methods: unquenched standard method UQ, ethanol quenching EQ,
methanol quenching MQ, cold glycerol saline quenching GSQ
Method Quenching solution Temperature
of quenching
solution
Mixing: parts of
cell suspension
and quenching
solution
Centrifugation
UQ - - -    4°C, 3904 g
EQ 40% ethanol, 
0.8% NaCl (w/v)
-20°C 1+1 -16°C, 3940 g
MQ 60% methanol-solution -60°C 1+2 -9°C, 10,000 g
GSQ 60% glycerol, 
0.54% NaCl (w/v)
-20°C 1+4 -9°C, 18,000 g
For all methods the same extraction protocol was applied. Because the aim of the study
was to examine the quenching step, extraction was performed according to our standard
protocol (see part 2.7.2). Samples were dried over night in the speed vac and derivatization
as well as measurement were done automated according to our high-throughput protocol
(see part 2.8.2).
The  sample  volume  was  calculated  according  to  the  equations  2.7  and  2.8,  with  the
difference that only half of the volume was taken for E. coli and S. cerevisiae. In table 11
the  sample  volume  and  the  corresponding  amounts  of  ethanol-ribitol-solution  for
metabolite extraction and water are summarized.
Table 11.  Used  volumes  during  extraction  for  quenching  experiments  of  the  different
organisms
Organism Sample volume Volume of ethanol-
ribitol-solution
Volume of double
distilled water
C. glutamicum   5 ml 1.50 ml 1.50 ml
E. coli 16 ml 0.75 ml 0.75 ml
S. cerevisiae 10 ml 0.75 ml 0.75 ml
2  Material & Methods 55
1.13.1 Ethanol quenching (EQ)
An ethanol-sodium chloride-solution (40% v/v ethanol and 0.8% w/v sodium chloride) was
parted into aliquots and stored in falcon tubes at -20°C. For each organism the defined
amount  of  quenching  solution  (1+1,  see  table 11  for  the  volume)  was  provided.  The
detailed workflow is shown in figure 18.
Figure 18. Workflow of the ethanol quenching performance
Cooling time and centrifugation time were determined for each organism and are listed in
table 12.
Table 12. Organism specific cooling and centrifugation times.
Organism Cooling time Centrifugation time
C. glutamicum 1.0 min 5 min
E. coli 1.5 min 7 min
S. cerevisiae 1.0 min 5 min
 harvested cell suspension is put   
 into the ethanol quenching           
 solution (1+1)
 cooling down the mix to ~-5...-8°C  
  in a -30°C bath of isopropanol
 centrifugution at 3940 g 
 remove supernatant
 resuspension in ethanol-ribitol-     
 solution and further preparation    
 after standard protocol
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1.13.2 Methanol quenching (MQ)
A 60% methanol solution with double distilled water as solvent was parted into aliquots
and stored in falcon tubes at -80°C. When removing the tubes from the freezer, solution
heats up and thaws immediately and reaches a temperature of around -60°C prior to usage.
For each organism the defined amount of quenching solution (1+2, see table 11 for the
volume) was provided. The detailed workflow is shown in figure 19.
Figure 19. Workflow of the methanol quenching performance
1.13.3 Cold glycerol saline quenching (GSQ)
A 60% glycerol solution was prepared using a 1.35% (w/v) sodium chloride solution. The
obtained quenching solution showed a salt concentration of 0.54%. Solution was parted
into aliquots and stored in falcon tubes at  -20°C. Additionally,  a washing solution was
prepared containing 50% glycerol and 0.675% (w/v) sodium chloride, and stored at -20°C.
For each organism the defined amount of quenching solution (1+4, see table 11 for the
volume) was provided. The detailed workflow is shown in figure 20.
 harvested cell suspension is put   
 into the methanol quenching         
 solution (1+2)
 centrifugution at 10,000 g for 
 5 min 
 remove supernatant
 resuspension in ethanol-ribitol-     
 solution and further preparation    
 after standard protocol
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Figure 20. Workflow of the cold glycerol saline quenching performance
1.14 Plasmid rescue technique
The insertion site of the plasmid in the genome of  Corynebacterium glutamicum mutant
was identified using the plasmid rescue technique (Tauch et al., 1995). Figure 21 gives an
overview over the method which is described in detail afterwards.
 harvested cell suspension is put   
 into the quenching solution (1+4)
 cooling down the mix for 5 min    
 in a -30°C bath of isopropanol
 centrifugution at 18,000 g for       
 20 min
 remove supernatant
 resuspension in ethanol-ribitol-     
 solution and further preparation    
 after standard protocol
 centrifugution at 18,000 g for       
 20 min
 resuspension of the pellet in 2 ml  
 cold washing solution
 remove supernatant
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Figure 21. Overview over the plasmid rescue technique
Genomic preparation
For the genomic preparation a single colony of a  C. glutamicum transposon mutant was
inoculated  in  5 ml  BHI-Kanamycin  (25 µg/ml)  in  a  test  tube  over  night  at  30°C  and
180 rpm. Culture was harvested by centrifugation at 3220 g and 4°C for 15 min the next
day.  After  discarding  of  the  supernatant  the  pellet  was  resuspended  in  500 µl  B1 and
incubated for 1 h at 37°C and 220 rpm. Afterwards, 60 µl of a 10% sodium dodecyl sulfate
solution were added and mixed, 250 µl proteinase K added, again mixed and incubated for
1 h at 37°C and 220 rpm. 
For  the  preparation  of  the  DNA  phase  lock-test  tubes  were  prepared.  Tubes  were
centrifuged for 1 min and 10,000 g to spin down the gel and stored at 4°C until use. 800 µl
of the cell lysat and 800 µl of a phenol-chloroform-solution (25:24, v/v) were transferred
into the phase lock-test tubes. Tubes were intensely mixed for 2 seconds and incubated for
5 minutes  at  room  temperature  before  they were  centrifuged  at  12,000 g  and  4°C  for
5 minutes.  The  clear  supernatant  was  transferred  into  a  fresh  2 ml-tube.  1250 µl  pure
ethanol (~100%) and 50 µl sodium acetate solution (3 M) were added and the tube was
reversed for mixing. After 10 minutes of incubation at room temperature the sample was
centrifuged at 14,000 g and 4°C for 15 minutes. The supernatant was discarded afterwards,
the pellet was washed with 1 ml ethanol solution (70%) and the sample was centrifuged at
 genomic preparation
 restriction digest with EcoRI
 ligation of the fragments
 sequenzing by GATC
 preparation of the plasmid
 transformation applying         
 electroporation
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14,000 g and 4°C for 15 minutes. The washing step was repeated one time. The DNA pellet
was then dried and dissolved in 105 µl sterilized double distilled water.
To remove the RNA 100 µl of the prepared sample were incubated with 5 µl RNase A for
60 minutes in the thermo mixer at 37°C and 400 rpm.
The remaining 5 µl sample was analyzed on an agarose gel.
Restriction digest of genomic DNA
For the restriction digest 90 µl of the genomic DNA, 11 µl  EcoRI buffer (10 fold), 4 µl
EcoRI and 1 µl RNase A were mixed. Incubation was done over night in a thermo mixer at
37°C and 400 rpm.
Ligation of the fragments
After cleavage the samples were heated to 70°C and held at this temperature for 20 min to
denature the restriction enzyme. Samples were cooled to room temperature afterwards and
5 µl were analyzed on an agarose gel.
For ligation 85 µl restricted DNA, 10 µl ATP solution and 5 µl T4-DNA-ligase were mixed
and incubated over night in a thermo mixer at 16°C and 300 rpm.
Transformation by electroporation
For electroporation electro competent E. coli (DH5α mcr) cells had to be prepared. E. coli
was stored as glycerol stock at -80°C. Cells were streaked out on LB-plates and incubated
at 37°C for one day. One colony was picked and transferred to 25 ml LB medium in a
100 ml-shaking flask.  Incubation was performed over  night at  37°C and 220 rpm. One
milliliter  of  the  over  night  culture  was  used  for  inoculation  of  250 ml  fresh  LB in  a
1000 ml-shaking flask.  E. coli was raised to an optical density at 600 nm of 0.5...0.7 at
37°C and 220 rpm. Afterwards, the culture was left on ice for 15 min before centrifugation
at 1000 g and 4°C was done for 15 min. The supernatant was discarded and the pellet
resuspended in 500 ml sterile, cold (4°C) double distilled water and centrifuged under the
same conditions for 20 min. The washing step was repeated one time. After decantation of
the supernatant the pellet was resuspended in 10 ml sterile, ice cold, 10% glycerol solution
and centrifuged for 20 min again. The supernatant had to be carefully decanted one more
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time  and  the  pellet  resuspended  in  1 ml  sterile,  ice  cold,  10%  glycerol  solution.  Cell
suspension was divided into aliquot parts of 40 µl and frozen in liquid nitrogen before it
was stored at -80°C.
For the transformation an aliquot for each sample had to be removed from the freezer and
hold on ice. 20 µl of ligated DNA was dialyzed for 10 minutes against double distilled
water. Additionally, 2 µl of the pure plasmid was prepared this way, too. It was used as
positive  control.  Pure  SOC  medium  was  used  as  negative  control  to  see,  whether
transformation worked properly. 10 µl of the dialyzed DNA as well as 1 µl of the controls
were  transferred  to  an  aliquot  electro  competent  cells.  Mixture  was  transferred  into  a
cuvette for electroporation and placed in a electroporation machine at 1700 V for around
5 ms. Afterwards, the sample was mixed with 1 ml SOC, transferred to a sterile tube and
incubated  for  ~45 min at  37°C and  600 rpm.  Subsequently,  300 µl  and  700 µl  of  each
sample were streaked out on LB-kanamycin-plates (50 µg/ml) and incubated at 37°C over
night. 
Preparation of the plasmid
Colonies of the successfully transformed mutants were transferred to 5 ml LB-kanamycin
(50 µg/ml)  in  a  test  tube  and  incubated  at  37°C  and  220 rpm  over  night.  Cells  were
harvested by centrifugation at 4000 g and 4°C for 10 min. All applied solutions as well as
the  used  protocol  were derived  from the  Wizard  Plus  SV Minipreps  DNA Purification
System from Promega or the peqGOLD Plasmid Miniprep Kit I from Peqlab.
After discarding of the supernatant the pellet was resuspended in 250 µl cell lysis solution
and mixed by reversion. 3 min incubation at room temperature followed. 10 µl alkaline
protease solution were added, mixed and incubated for 5 min again.  Afterwards, 350 µl
neutralization solution was given to the sample and the tube was mixed at 14,000 g for
10 min. The supernatant was transferred to a spin column and centrifuged for 1 min under
the same conditions as before. Spin column was washed with 750 µl column wash solution
followed  by  centrifugation,  washed  again  with  250 µl  column  wash  solution  and
centrifuged one more time. 50 µl nuclease-free water was transferred to the spin column
and incubated for 2 min at room temperature before centrifugation was repeated for 1 min.
During this step the plasmid eluted from the column in the tube. 5 µl of the solution were
analyzed on an agarose gel. The plasmid was stored at -20°C.
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Agarose gel electrophoresis
The agarose gels were prepared with 1% agarose diluted in TAE-buffer (1 fold). 1 fold
TAE-buffer was also used as running buffer during electrophoresis. 5 µl of the sample was
mixed with 1 µl  6x loading dye  solution (purchased from Fermentas  together  with the
DNA ladder mix). One lane of the gel was used for the marker, which was a DNA ladder
mix. 
Electrophoresis  was  performed  at  100 V for  50 minutes.  The  gel  was  incubated  in  an
ethidium bromide bath for 15 min afterwards. Analysis of the gel was performed using a
gel documentation system (G:BOX) where the DNA could be made visible due to trans-
illumination using UV light. 
Photometric determination of the DNA concentration
DNA concentration of the samples was determined photometrically.  2 µl  of  the sample
were diluted in 498 µl double distilled water. Using a cuvette of silica glass the absorption
at  260 nm was  determined.  An absorption of  1  correlates  with 50 µg/ml  double-strand
DNA. 
Additionally, the absorption at 280 nm was measured to identify the protein level (aromatic
amino acids).  The ratio of both absorptions (A260/A280) is  a representative value for the
purity of the sample. The value should be in the range of 1.8 to 2.0.
Sequencing and analysis of the insertion site
Sequencing  was  performed by GATC-Biotech.  DNA concentration of  the  samples  was
diluted to 75 ng/µl and an aliquot of 30 µl was used for sequencing. As primer the “vorIS”-
primer 5'-CTGCACCAATCTCGACTATGCTCAATAC-3' (Feldhaus, 2005) was used.
For further analysis the obtained DNA sequence was converted to the fasta-formate and
could  be  used  for  Blast  analysis  on  the  NCBI  web  page  (http://www.ncbi.nlm.
nih.gov/sutils/genom_table.cgi). Search was done against both annotations (Bielefeld and
Japan) for the Corynebacterium glutamicum wild type strain ATCC 13032 (Kalinowski et
al., 2003, Ikeda et al., 2003).
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3 Results & Discussion
The first part of this thesis deals with the development of a high-throughput method for
metabolome analysis using gas chromatography/mass spectrometry. 
In the second part this method was applied to analyze a high number of transposon mutants
and  also  to  establish  a  screening  performance  in  order  to  find  suitable  criteria  for
comparison and selection.
In  the  third  part  different  quenching  methods  were  compared  whereas  two  of  these
methods base on results of other research groups and the third one was established in this
working group and optimized during this study. Investigations were performed with three
different microorganisms.
3.1 Development of a high-throughput method for metabolome
analysis
If a high number of samples has to be investigate in a suitable time frame a method like our
standard method (Strelkov et al., 2004, see also part 2.7) is not applicable. Therefore, on
the basis of this standard method a high-throughput method had to be developed.
3.1.1 Method development
The standard method from our lab was analyzed in detail to find possible starting points for
designing  a  high-throughput  method.  Figure 22  shows  the  main  parts  of  the  standard
method  and  the  selected  points  for  method  improvement.  The  applied  changes  are
described in detail afterwards. With the parallel processing of 96 samples a time reduction
by a factor larger than 15, compared to the standard method, was achieved. The procedure
is described in detail in chapter 2.8.
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Figure 22. Selected starting points for changes of the standard performance in order  to
establish a high-throughput method.
The change of the cultivation vessel
In order to handle a high number of samples in parallel the cultivation vessel was changed.
Instead of commonly used shaking flasks, cultivation was performed in micro titer plates. 
Experiments  were  performed  with  plates  filled  only  with  wild  type  samples
(Corynebacterium glutamicum ATCC 13032) to establish the method.  And there was a
number of questions that had to be investigated:
● Is enough oxygen supplied in micro titer plates?
● How can cross contamination be avoided?
● Are cells growing similarly in each well of the micro titer plate or are there any
limitations on some places?
● Is enough cell dry mass produced for metabolome analysis?
   harvesting
     washing
     cell lysis
1x
 phase separation
 derivatization of all      
 samples together
 drying in a speed vac
 measurement over      
 60 min
 cultivation in              
 shaking flasks
 cultivation in micro titer plates
 phase separation using a liquid  
 handle robot
 drying in a desiccator
 derivatization of each sample    
 just before measurement
 measurement over 18 min
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Foils as coverage during cultivation
For a good growth of the cells in the 96deepwell plates different foils were tested. The
BreathEasy  foil  which  was  routinely  used  in  our  lab  caused  some  problems.  During
cultivation some of the water of the medium evaporated. Because the foil is  not  water
permeable droplets were formed on the inner surface of the foil and the foil was dragged
into the wells. Consequently, oxygen supply was limited and thus cells showed low growth
rates  (OD595)  of  4.1 ± 0.3  (see  figure 23).  And  furthermore,  problems  occurred  during
sample  transfer.  Because  the  foil  can  not  be  penetrated  by tip,  it  had  to  be  removed.
Because  of  the  droplets  on  the  inner  surface  of  the  foil,  removing of  the  foil  caused
sputtering which led to cross contaminations observable in the blank wells. 
Problems with foils were already mentioned in literature (Zimmermann et al., 2003) and no
single foil was mentioned to overcome all difficulties. Nevertheless, another foil, AeraSeal,
was tested.  This foil  had a completely different structure.  None of the above described
problems occurred. Because the foil was not dragged into the wells it could be removed
easily without causing cross contaminations. But due to the vapor permeability of this foil
after 17 h of cultivation, approximately 12% of the medium were evaporated whereas with
the BreathEasy foil only half the amount was gone. The cell concentration had been higher
after cultivation with this foil because of the loss of water. With the AeraSeal foil cells
grew  to  nearly  two  times  higher  optical  densities  measured  at  595 nm  of  7.8 ± 1.2
compared to the other foil (see figure 23). Nevertheless, the OD595 of the different wells
was quite variant. 
In order to overcome the difficulties of both foils, they were combined. The AeraSeal foil
was  placed  on  the  micro  titer  plate  and  the  BreathEasy  foil  on  top  of  it.  With  this
combination the advantages of both foils could be combined and the disadvantages could
be reduced to almost nothing. Only 5% of the medium were lost after 17 h of cultivation.
Furthermore,  cells  grew  to  high  average  optical  densities  of  around  8.1 ± 0.8  (see
figure 23).  The  variation  between  the  wells  could  also  be  reduced.  Both  foils  can  be
removed together without causing any cross contamination.
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Figure 23. Comparison of the growth of C. glutamicum wild type samples in a 96deepwell
plate covered with different foils or foil combination (Börner et al., 2007).
Evaluation of the growth in micro titer plates
A complete 96deepwell plate was inoculated with wild type colonies, leaving only two
wells not inoculated as blanks. Cultures were always covered with the combination of the
above described foils. The main culture was inoculated with the corresponding well of the
over night  culture (see part  2.8.1 for details).  Each well  of  the over night  culture was
independent from the others and used for inoculation of a main culture. Again, each well
represented an independent main culture. This was a huge contrast to the standard method
where  three  samples  are  taken  from one main  culture  inoculated  from one over  night
culture. Nevertheless, the average starting OD595 in each well was very similar (1.4 ± 0.2)
(figure 24). After 7 h of growth the average optical density was 7.4 ± 0.5 (figure 24). No
limitation could be found, confirming that the bacteria have the same growth conditions in
each well of a 96deepwell plate. Additionally, no change in optical densities of the blank
wells was observed. Thus, cross contamination had not occurred.
66 3  Results & Discussion
Figure 24. Example for an equal growth of wild type samples cultivated in a 96deepwell
plate covered with the two combined foils. No cross contamination occurred (Börner et al.,
2007, modified).
Calculation of the available amount of cell dry weight
It could be demonstrated so far, that wild type cultures grow to high optical densities in all
wells of a plate. In order to find out whether this growth rate is sufficient for a metabolome
analysis  with  GC/MS,  the  OD595 was  correlated  to  the  cell  dry  weight  (CDW).  This
correlation was determined from two experiments shown in figure 25. In the first part the
optical  densities of the photometer (600 nm) and the tecan reader for micro titer plates
(595 nm) were compared (figure 25A). As blank pure minimal medium (MM1) was used.
In contrast to the photometer it was not possible to set a reference value at the tecan reader.
Consequently,  there  is  always  a  shift  of  the  zero-value  along the  ordinate,  which  was
estimated to be constant around 0.032 ± 0.001. 
Additionally, for the OD600 the corresponding cell dry weight was determined (figure 25B).
Using both established correlations an equation for the calculation of the cell dry weight
from OD595 values was established (equation 3.1).
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Figure 25. A Correlation of the optical densities of the photometer (600 nm) and the tecan
reader (595 nm). B Relation of the cell dry weight and the OD600.
CDW [g / l ]=1.272∗OD5950.041 (3.1)
With the equation (3.1) the average amount of cell dry weight was calculated - which was
3.9 mg. The volume in each well was assumed to be 415 µl (400 µl MM1 + 25 µl over
night culture - 2*5 µl sample for OD595 measurement). Compared to the standard method in
which around 22 mg were  harvested,  a  reduction of  cell  mass  by a factor  of  5.6  was
calculated.
It  was necessary to  determine whether  the extracted sample amount  from 3.9 mg cells
would be enough for metabolome analysis, and the results hereto will be described and
discussed in detail in part 3.1.2.
Automated phase separation
Cells were harvested by centrifugation of the whole micro titer plate. Also the washing
steps  were  performed in  the plate.  During these parts,  the  96deepwell  plate  had to  be
covered with a silicon mat. For cell lysis in the ultrasonic bath at 70°C the whole plate had
to be closed with an adhesive foil and a metal brace. This foil was temperature stable as
well as solvent resistant. The metal brace was necessary to assure a tight closure, to avoid
any vapor leakage. Because of the metal brace, the cooling step had to be extended. 
A liquid  handle  robot,  the  MPS2  twister  autosampler,  was  used  to  remove  the  upper
aqueous phase from 94 samples during phase separation. The machine was equipped with a
A B
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1 ml  syringe.  In  order  to  avoid any contamination with the  apolar  phase  the  depth  of
immersion  had to be estimated carefully. It  was adjusted to 30 mm. Additionally,  filling
speed of the syringe had to be optimized. If the syringe is filled too fast, the apolar phase
would be drawn in, too. The filling speed was set to 40 µl/s. After evaluation of these two
parameters they could be used for all experiments. Approximately 580 µl (±20 µl) of the
upper aqueous phase could be removed this way and were transferred into tapered glass
vials.
Drying of the samples
A desiccator with phosphor pentoxide as desiccant and a vacuum pump were used for
drying of up to 150 samples at a time. The normally used speed vac which is only capable
of drying 72 samples at a time was replaced. With this change more than twice the number
of samples could be prepared together. 
The pressure had to be reduced carefully in order to avoid a delay in boiling. This was done
for duration of  one hour.  Afterwards  the samples were hold nearly under vacuum over
night.
Automated sample derivatization
The glass vials with the dried samples were sealed with magnetic caps and placed in the
autosampler of the GC/MS system. Of the high number of so far prepared samples 96
could be placed in the autosampler at  a time. The remaining ones were stored at 4°C.
Before using the stored samples, they had to be placed in the desiccator for at least one
hour again to remove condensed water.
Derivatization was performed automatically from the autosampler (with a 10 µl syringe)
sample by sample after a certain schedule. Because the syringe had to be used both for
derivatization and for sample injection it was not possible to use a bigger one. Otherwise
the reproducibility of injection of 2 µl sample would decrease. 
The detailed workflow is described in chapter 2.8.2. Derivatization reagent is always given
to one sample followed by mixing and incubation. Some minutes later the the next sample
was prepared likewise and so on. This scheduled performance made sure that each sample
was freshly prepared just before injection. The time shifts between sample preparations
were  calculated  by  the  Maestro  software  of  the  autosampler.  With  this  automated
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derivatization  any  chemical  conversions  due  to  differences  in  standing  times  after
completed derivatization till injection could be avoided.
Adapted GC/MS measurement and metabolite detection
The metabolome analysis was performed with a GC/AccuTOF in EI mode equipped with
an  autosampler.  Samples  were  injected  in  a  PTV injector  and  evaporated.  A detailed
comparison of the 60 min standard run and the adapted 18 min run is shown in table 13. In
chapters  2.7.3  and  2.8.3  both  GC/MS  analyses  are  described  in  detail.  The  injector
performance was not needed to be changed. For both run types the same schedule was
used.  To shorten the GC-run temperature rates were increased by a factor of four.  The
holding time at the end of the run was reduced from 10 min to 6 min. Due to the increased
ramps the solvent delay could be reduced to 3.9 min.
Table 13. Parameters of 60 min GC-run and 18 min fast GC-run
Parameter 60 min run 18 min run
Injector
Start temperature 70°C
End temperature 280°C
Rate 12 K/s
GC
Start temperature 70°C
1 min1st holding time
1st rate 1 K/min   4 K/min
Temperature after 1st rate 76°C
2nd rate 6 K/min 24 K/min
End temperature 325°C
2nd holding time 10 min    6 min
Solvent delay   6 min 3.9 min
The settings of the mass spectrometer were the same for both GC-runs except for the scan
rate. The spectrum recording time of course was adapted to the length of the runs. During
18 min of measurement the same information regarding the sample composition had to be
handled as during 60 min runs. A more compact data amount in shorter time was the result
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and the scan rate needed to be increased from 2 scans/s to 5 scans/s. With this higher scan
rate a loss of information could be avoided. 
Furthermore, to use the reduced, available cell dry weight after cultivation in micro titer
plates  (5.6  times  lower  mass  compared  to  standard  cultivations)  for  analyzable
measurement the split ratio was changed from 1/25 to 1/10. This way a 2.5 times higher
amount of sample was transferred to the GC-column and was analyzed. With it the lower
biomass could be compensated. 
After the GC/MS measurement the metabolite detection could be done according to the
standard protocol. Our internal library could still be applied because of the use of retention
indeces instead of retention times. The retention times of the alkane series in a 60 min run
and in a 18 min run are summarized in table 14.
Table 14. Retention times and indices of the alkanes in 60 min runs and 18 min runs
Alkane ~RT in 60 min run ~RT in 18 min run RI
Decane      7 min   4.5 min 1000
Dodecane    13 min      6 min 1200
Pentadecane 20.5 min      8 min 1500
Nonadecane    28 min    10 min 1900
Docosane    33 min    11 min 2200
Octacosane    41 min    13 min 2800
Dotriacontane    46 min 14.5 min 3200
Hexatriacontane    49 min 17.5 min 3600
Nevertheless, RI-values of the identified derivatives after measurements over 18 min were
investigated.  Additionally,  using  the  information  derived  from  the  alkane  test  (“time
standard”), for all substances in our library the retention times could be estimated. This was
done using the Kovàts equation (see part 1.2.1, equation 1.5) in the other direction. The
majority of substances should demonstrate a linear behavior for the changed elution time.
This results  from the fact  that  only the temperature rates were increased, but the same
column  was  used.  The  information  from  over  1000  measurements  was  also  used  to
improve the retention indeces of the identified derivatives. An improved standard library
for the 18 min runs was generated after combining the information from the measurements
and  the  estimated  RI-values.  It  was  applied  for  further  identifications  afterwards.  The
3  Results & Discussion 71
whole list of derivatives and the RIs is shown in table A in the appendix. Table 15 gives a
short  summary  of  the  changes  in  the  retention  time.  As  assumed  over  88%  of  the
substances had changes in their RIs of less than 20 (∆RI=|RI60-RI18|). Less than 3% of the
derivatives had significant changes over 100 (∆RI).
Table 15. Overview to changes in retention index due to a changed temperature profile in
the 18 min run.
Change in RI (∆RI=|RI60-RI18|) Affected derivatives [%]
< 20 88.2
> 20, < 30 4.6 
> 30, < 40 2.2 
> 40, < 50 1.0 
> 50, < 100 1.2 
> 100, < 1000 2.8 
The obtained result confirmed the assumption that most of the substances had only slight
changes  in  their  RI-values  according  to  the  increased  temperature  ramp.  Only  few
derivatives  changed  dramatically  in  their  retention  behavior,  eluting  earlier  or  later
compared  to  the  long  measurements.  A positive  effect  was  the  possible  separation  of
substances coeluting in a 60 min run. On the other hand, it was also possible that some
derivatives, which eluted separately in the long term run, now in the 18 min run appear
unseparated. An example is shown in figure 26. Alanine 3TMS is coeluting with fumaric
acid 2TMS in the long term run. In contrast, it is found clearly separated as single peak in
the short term run. 
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Figure 26.  Example  for  a  substance  (3 alanine  3TMS) which  appeared  separated  in  a
18 min run (A) but coeluting in a 60 min run (B). 1 fumaric acid 2TMS, 2 serine 3TMS, 4
threonine 3TMS (Börner et al., 2007, modified).
The identification  of  a  compound was  not  only done according to  its  retention  index.
Additionally, the mass spectrum was used which is substance specific. Both information
are combined in our internal standard library and had been applied. Mass spectra showed
nearly no effects regarding the GC-run. Maybe some moieties of former or later eluting
substances can be seen as minor mass lane(s). Still, if two substances coelute the single
spectrum needs to be extracted. This could be done with the deconvolution algorithm of
AMDIS.
Furthermore, our internal standard library was developed on a quadrupol MS with an EI-
source.  The mass  spectra are independent  of  any detector  (MS) if  the same ionization
method is used and thus they could be applied to the TOF MS with the EI-source without
any problem.
3.1.2 Method evaluation
In order to evaluate the new high-throughput performance it was compared to the standard
protocol.  The  major  results  are  summarized  in  table 16.  Obviously  the  reduction  of
biomass after cultivation in a 96well format and the measurement over 18 min reduced the
number of detectable peaks (based on AMDIS) as well as the number of observable and
quantifiable compounds. However, the reduction is still within tolerance range as only 15%
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less peaks were detected and 7% less compounds were quantifiable. Applying our internal
library, still 83% of the compounds were identified. Furthermore, with the high-throughput
method  the  relative  standard  error  could  be  highly  reduced  from  25%  (standard
performance) to 13%.
Table 16. Comparison of the developed high-throughput method and the standard method
(Börner et al., 2007, modified).
standard method high-throughput method
Observable peaks ~1200 ~1020
Quantifiable peaks ~700 ~650
Library hits ~180 ~150
Mean relative standard error [%] ~25 ~13
The resulting total ion currents - both for 60 min run of a standard method (A) and 18 min
run of a high-throughput method (B) - are shown in figure 27. They are the result of an
analysis of a C. glutamicum wild type sample. The TICs are quite similar: the 18 min run
represents the compressed profile of the 60 min run. The relative intensities are reduced in
the shortened run by a factor of 100.
Figure 27.  Total  ion  currents  of  a  C.  glutamicum wild  type  sample  from the  standard
performance (A) and the high-throughput performance (B).
Additionally, triplicates from wild type samples raised at different positions on the same
96deepwell  plate were compared and the Pearson correlation coefficient  was calculated
A B
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using the logarithmic values of the relative concentration vectors. An example is shown in
figure 28. The average correlation gave a high value of 0.99 ± 0.01.
Figure 28.  Example  for  a  comparison  of  triplicates  of  wild  type  samples  cultivated  in
different wells of the same micro titer plate (Börner et al., 2007).
The here presented evaluation criteria show clearly that the high-throughput performance
revealed satisfying results and hence this  method can be used for reliable metabolome
analyses.
3  Results & Discussion 75
3.2 Screening of transposon mutants
After  the development of  a  well  performing high-throughput protocol,  the method was
used to start screening of the Corynebacterium glutamicum transposon bank. Because the
analysis of more than 10,000 mutants is still very time consuming, a pilot project started.
More than 300 randomly selected mutants were investigated. The information from this
research were then used to develop suitable screening criteria.
3.2.1 Growth of analyzed transposon mutants
Transposon mutants were always stored in micro titer plates as glycerol stocks. Cultures
had to be transferred in first instance on agar plates (see chapter 2.8.1). This was done
using a cryo replicator. Using this replicator the glycerol stocks remained frozen and only
the surface thawed due to the contact with the warmer replicator. Cells could be transferred
this way. The used device had been built at our institute and could be autoclaved.
In  the  first  instance  the  growth  behavior  of  325  transposon mutants  was  investigated.
Additionally, more than 150 wild type samples were examined and used for comparison
purpose. The wild type samples showed an overall growth of 6.12 ± 0.90 when measuring
the  optical  density  at  595 nm.  The mean value  of  all  mutants  was  slightly  lower  and
calculated with 5.24 ± 1.49. The distribution of the mutants according to their growth is
shown in figure 29.  In  contrast  to  cultures  raised in  a  shaking flask where  the optical
density is calculated as mean of three samples from one culture,  the optical density of
samples  raised in  plates was the mean of  three independent  wells  and cultures  of  one
mutant.  Approximately 9% of the cultivated mutants revealed a growth decrease of more
than  50% when  compared  to  the  mean  optical  density  of  the  wild  type.  Furthermore,
around 5% showed growth rates of only 50% to 75%. In short that means around 14% of
325 examined mutants were growth-deficient.  According to the growth behavior  of the
chosen  mutant  set  it  could  be  assumed  that  these  data  were  a  representative  quantity.
Consequently, all following results could be assumed as representative for C. glutamicum.
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Figure 29. Distribution of 325 analyzed transposon mutants according to their growth after
7 h of inoculation.
For  318  transposon  mutants  a  successful  metabolome  analysis  was  performed  when
applying  our  established  high-throughput  method.  The  metabolites  could  be  identified
using  our  internal  standard  library  and  the  relative  standard  error  for  a  mutant  was
calculated (from triplicates). The relation of the error according to the growth behavior of
the mutants is displayed in figure 30. As expected, growth-deficient mutants often had an
increased  error  due  to  the  reduced  cell  mass  available  for  metabolome  analysis.
Nevertheless, some mutants with reduced growth showed relatively low standard errors as
well. The calculated mean of the relative standard error over all mutants was 17.4 ± 7.7.
Approximately 64.5% of the growth-deficient mutants revealed an increased error. 
Transposon mutants grown to higher optical densities are distributed cloud-like around the
introduced line which represents the rough trend (figure 30).  The increased error of some
mutants with good growth behavior might be an indication for changes in metabolite levels
due to genetic perturbation. Sample treatment and measurement were performed as routine
procedures  in  complex  sets,  thus  changes  in  triplicates  were  more  likely the  result  of
differences in the metabolome, resulting from variations due to transposon integration in
the  analyzed  organism.  The  tested  transposon  mutants  therefore  could  be  used  for
identification of suitable screening criteria. Nevertheless, some mutants might have had
increased errors due to problems during performance, especially after difficulties with the
GC/MS-system (e.g. increased standing times because of system tuning).
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Figure 30.  Spreading  of  the  overall  relative  standard  error  [%]  according  to  the
corresponding optical  density  at  595 nm for  tested  transposon mutants.  The  black  line
describes the rough trend.
3.2.2 Development of suitable screening criteria
For  a  direct  comparison  of  metabolic  profiles,  the  wild  type  samples  (2  independent
triplicates) were always prepared together with the mutants on the same plate. Analysis of
the wild type could therefore reveal systematic problems which possibly had occurred. 
The Pearson correlation coefficient (r) was calculated using the logarithmic values of the
relative concentration vectors of all determined metabolites. The reference was always  the
parallely  handled  wild  type  from  the  same  cultivation.  The  distribution  of  the  318
investigated  mutants  according  to  the  calculated  correlations  is  shown  in  figure 31.
Approximately 78% of all  examined mutants revealed a very good correlation between
0.9...1. Altogether for around 89% a correlation value higher than 0.8 was calculated. Still
around 11% of all tested transposon mutants displayed a low correlation when compared to
the  wild  type  what  is  obviously the  result  of  the  gene  disruption.  In  comparison,  the
correlation coefficient of two triplicates of wild type samples on the same plate revealed
values of 0.96 ± 0.02.
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Figure 31. Distribution of the correlation values (r) of 318 transposon mutants related to
the wild type raised on the same plate.
One reason for a reduced correlation coefficient had been growth-deficiency. In order to
investigate this in detail, correlation and growth were related. The result is displayed in
figure 32. The distribution clearly indicated two groups. The first group of mutants was the
growth-deficient one. These mutants were located in the left part of the plot showing a
linear  behavior  between  correlation  and  optical  density.  For  these  mutants  the  low
correlation to the wild type was the consequence of the reduced growth and the resulting
decrease  in  cell  mass.  An  increase  in  the  amount  of  analyzed  cells  could  possibly
compensate this effect.
The second group was found in the right part of the plot in figure 32. Mutants with good
growth  were  distributed  around  an  average  correlation  of  0.93 ± 0.10.  However,  some
mutants with reduced correlation coefficient  but  good growth values were also visible.
These transposon mutants possess changes in their phenotype and are therefore interesting
for further investigations.
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Figure 32. Interrelation of the calculated correlation values of 318 analyzed mutants and
their growth values.
In order to have a representative wild type data set more than 150 examined wild type
samples were combined and a reference list was created. A comparison to this native state
could reveal important variations, not only of the mutants but also of the wild type samples
raised together with the mutants. The samples used for this reference list were derived from
different and independent cultivations, which had been performed by two operators. The
correlation coefficient  between independent operators calculated from logarithmic mean
values  of  all  identified  metabolites  derived from all  wild type  samples  was 0.94.  This
demonstrates the high reproducibility of the method - not only if the test is performed on
different testing days, but also if it is performed by different users.
All metabolites that had been identified so far in more than 150 wild type samples were
combined  and  summarized  as  a  reference  list  with  currently  216  different  metabolites
(structurally characterized but also structurally unidentified ones - so called “unknowns”).
This  list  comprises  the  mean  of  the  relative  concentrations  normalized  to  ribitol,  the
standard errors and the relative errors as well as the occurrences in the analyzed samples.
This  reference  list  which  is  extended  continually  represents  in  an  excellent  way  the
phenotype of the wild type.
An overview of  the distribution of  the metabolites  according to  their  relative  standard
errors is shown in figure 33. Around 73% of the substances revealed an error lower than
20%. For example most of the phosphorylated compounds, for example, were found to
have  errors  between  20%  and  30%.  The  relative  standard  error  of  most  alcoholic
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compounds was quite high - more than 40%. Besides these compounds, substances with
more than 50% error were often structurally unidentified (“unknowns”).
A critical fact is that the number of identified metabolites varied among analyses. This
happened despite standardized cultivation performance, harvesting, sample preparation and
measurement procedures. Mostly this came from variations of the sensitivity of the used
AccuTOF-MS  due  to  independent  manual  tunings  and  the  high  sample  throughput.
Consequently, average relative standard errors of some metabolites were reduced due to
their  high  occurrence.  Nevertheless,  the  high  reproducibility  of  the  performance  was
obvious. The overall relative standard error was calculated to be 16.2% on average.
Figure 33. Distribution of 216 different reproducible metabolites, combined on a wild type
reference list, according to their relative standard errors.
When applying  this  reference  list  on  mutant  samples,  metabolites  with  higher  relative
standard error occurred more often to have changed than those with smaller errors. But due
to the higher variance of these metabolites changes were not likely to be the result of gene
disruption in every case. To circumvent this difficulty a threshold for each metabolite (TMet)
was considered. Using the information from the derived wild type list a metabolite was
regarded  as  significantly  changed  if  the  absolute  value  of  the  difference  between  the
relative concentration values of this compound on the reference list (Ref) and in the mutant
sample (MT) related to the relative standard error of this metabolite on the reference list
(ErrorRef) exceeded the factor six (equation 3.2). After tests this factor was chosen, because
it  led  to  results  which  were  a  good  compromise  between  sensitivity  and  number  of
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identified differences. A change of the factor led to more (reduced value) or less (increased
value) sensitive thresholds which corresponded to a higher or a lower number of identified
differences. With the application of this equation the metabolites with changed levels due
to  the  genetic  perturbation  were  identified.  The whole  reference  list  is  summarized  in
table B of the appendix.
T Met :∣Ref MT ErrorRef ∣6 (3.2)
A representative overview of the different classes of identified metabolites, their relative
errors and their occurrences in the wild type samples (details from the reference list, see
also table B in the appendix) is summarized in table 17. The above described threshold was
applied on each wild type sample and mutant. The frequency of each metabolite as variant
in these samples is also displayed. Metabolites which were found to be changed very often
- in the wild type samples - had to be regarded as less specific. Variances of that kind might
result  from  biological  and  environmental  changes.  The  metabolites  tryptophan  and
2-hydroxyglutaric acid were identified in changed levels in around 15% of the wild types.
That means, both variated quite much. Consequently, they were also found to be changed
in around 80% of the mutants. These changes surely were only in a few cases the result of
the genetic perturbation, but more often it was the biological or environmental variance of
the compound itself. In the case of tryptophan these observation might be due to the low
solubility in polar solvents. Thus, measurement with the applied protocol is difficult. 
The metabolites AMP, 5-oxoproline, aspartic acid, gamma-glutamylleucine, serine, maltose
and trehalose, 2,6-diaminopimelic acid, hexadecanoic acid, pyrophosphoric acid, pyruvic
acid as well as quinic acid were identified as changed in more than 60% of the analyzed
mutants.  In  wild type samples up to 14% variation was observed for these compounds
which is quite high compared to other metabolites. Identification of these 12 metabolites as
changed in a sample has therefore to be regarded as less specific. For example pyruvic acid
and AMP are both involved in many different pathways.  Consequently,  it  was not very
surprising that these compounds often pertained to changes.
On the other hand, malonic acid and hydroxylamine had been very often identified in the
samples. But the first of them was only found changed in less than one percent of the wild
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type and around 3% of the mutant samples. Therefore, changes might come from genetic
perturbation.  The  compound  itself  did  not  seem  to  be  affected  by  biological  or
environmental variations. Hydroxylamine was identified as varying in only nine percent of
wild type and 24% of mutant samples. But these compound is often an artifact introduced
by the derivatization reagents (Herebian et al., 2007).
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Table 17. Representative overview of identified metabolites, their relative standard errors and occurrences in more than 150 analyzed wild
type samples as well as the number of changed ones in wild type samples and mutants.
Amino acids Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Amino acids Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
2-Aminobutyric acid 4.12 80.1 9 127 Leucine 7.29 84.6 11 134
5-Oxoproline 6.03 100.0 17 195 Lysine 5.15 98.1 8 118
Alanine 6.20 100.0 12 138 Methionine 18.46 69.2 5 52
Aspartic acid 9.19 98.7 17 234 N-Acetyl-L-glutamic acid 5.38 98.1 9 100
beta-Alanine 5.79 99.4 13 144 N-Acetyl-L-glutamine 7.54 88.5 17 176
Cycloleucine 5.26 67.9 7 72 O-Acetyl-serine 11.29 71.2 12 133
gamma-Glutamylleucine 7.71 87.2 15 208 Phenylalanine 5.23 98.1 10 139
gamma-Glutamylvaline 13.63 90.4 13 138 Proline 7.06 96.2 17 183
Glutamic acid 6.28 99.4 15 163 Serine 6.58 99.4 16 197
Glutamine 8.41 91.7 17 170 Threonine 7.46 98.7 16 180
Glycine 12.71 98.1 11 177 Tryptophan 6.85 93.6 23 242
Homoserine 6.02 94.9 13 170 Tyrosine 6.81 98.1 7 133
Isoleucine 6.51 95.5 8 142 Valine 5.42 99.4 10 125
Organic acids Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Organic acids Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
2,6-Diaminopimelic acid 10.50 78.8 16 211 Hexadecanoic acid 6.29 96.8 17 196
2-Hydroxybutanoic acid 10.36 67.9 12 131 Lactic acid 6.02 99.4 8 187
2-Hydroxyglutaric acid 6.86 96.2 24 282 Lactyllactate 6.80 48.1 2 45
2-Phosphoglyceric acid 11.17 50.6 11 135 Malic acid 5.90 98.7 12 145
3 Results & Discussion 84
Organic acids Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Organic acids Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
3-Hydroxy-2-tetradecyl-
octanoic acid 
6.14 64.7 8 86 Malonic acid 17.33 87.8 1 10
3-Phosphoglyceric acid 5.01 98.1 13 137 Nicotinic acid 21.31 66.0 5 51
alpha-Ketoglutaric acid 7.72 98.7 23 186 Oxalic acid 22.24 12.2 1 6
Benzoic acid 19.63 98.1 1 3 Phosphoenolpyruvic acid 6.08 98.1 10 150
Citric acid 7.26 97.4 14 168 Pyrophosphoric acid 6.89 96.2 12 212
Fumaric acid 5.03 98.7 14 184 Pyruvic acid 5.16 98.1 10 192
Glyceric acid 7.33 95.5 15 177 Quinic acid 6.53 98.1 17 212
Glycolic acid 35.13 85.3 2 21 Succinic acid 5.34 99.4 17 116
Phosphorylated compounds Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Phosphorylated compounds Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
2-Deoxyribose-5-phosphate 28.90 35.3 2 30 Glucose-6-phosphate 19.29 84.6 6 62
6-Phosphogluconate 28.02 78.2 5 61 Glycerol-3-phosphate 5.82 98.7 11 180
AMP 6.29 89.1 15 193 Mannose-6-phosphate 24.35 78.8 4 64
Erythrose-4-phosphate 23.89 26.3 3 26 Ribose-5-phosphate 31.28 31.4 3 58
Fructose-1,6-biphosphate 12.60 73.7 8 76 Ribulose-5-phosphate 22.59 75.6 6 64
Fructose-6-phosphate 30.19 33.3 3 40 Uridine-5'-monophosphate 6.92 76.3 10 116
Glucosamine-6-phosphate 24.15 78.8 4 49 Xylulose-5-phosphate 23.73 35.9 2 13
Alcohols Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Alcohols Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
1-Monooleoylglycerol 23.59 53.8 3 39 Glycerol 5.35 99.4 16 124
1-Monopalmitoylglycerol 11.71 71.8 9 117 Hexadecanol 16.22 76.9 3 56
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Alcohols Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Alcohols Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Diethyleneglycol 9.49 54.5 2 21 Mannitol 2.67 75.0 7 100
Erythritol 25.80 34.6 4 45 Tetradecanol 45.68 65.4 0 0
Sugars Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Sugars Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Fructose 18.29 34.0 2 23 Mannose 10.80 89.7 9 132
Glucose 9.90 99.4 17 142 Sucrose 18.62 57.7 4 56
Isomaltose 20.97 72.4 9 86 Trehalose 4.41 98.7 18 252
Lactose 7.14 76.9 13 164 Xylulose 14.35 53.2 3 27
Maltose 5.16 99.4 21 260
Others Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
Others Relative
error [%]
Occurrence
[%]
Number of
changes in
wild type
Number of
changes in
mutants
5-Deoxy-5-
Methylthioadenosine 
6.03 77.6 15 223 Succinic acid
monomethylester 
4.76 78.2 13 153
Adenine 6.89 88.5 12 138 Thymine 6.89 71.2 7 70
Adenosine 6.62 91.7 15 145 Uracil 8.56 91.0 11 152
Cytosin 4.37 55.8 6 74 Urea 22.45 98.1 3 33
Hydroxylamine 13.54 95.5 13 76 Uridine 6.83 98.7 17 184
Nicotinamide 7.25 94.9 9 105
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The wild type reference list, representing a kind of native wild type state, was afterwards
applied on all  mutants. As described before a correlation coefficient  was calculated for
each  mutant.  However,  this  time  mutants  were  correlated  to  this  reference  list.  The
distribution of the calculated correlation values according to the optical density of each
mutant  after  7 h  of  inoculation is  shown in figure 34.  A similar  picture as  before  (see
figure 32, correlation of the mutants to the wild type from the same plate) was revealed.
Again mutants  with growth-deficiencies  revealed  a decreased correlation coefficient.  A
linear interrelation of correlation and optical density was found. Therefore,  the reduced
correlation values were due to the reduced growth and the low corresponding cell mass.
But the picture for mutants grown to higher optical densities looked different from the one
seen in figure 32. The average correlation coefficient of these mutants was 0.75 ± 0.09. The
mutants were spread like a big cloud around the mean value (the trend is indicated as black
line in figure 34). Mutants with high growth values but reduced correlations were the most
interesting ones. They were found below the trend line in the right part of the plot. The
high  number  of  changes  in  the  metabolome  of  these  mutants  resulted  in  decreased
correlation values.  These huge differences  are likely the result  of  an important  genetic
perturbation leading to a changed phenotype.
Figure 34. Distribution of the analyzed transposon mutants. Their correlation coefficients
were calculated to the reference list and the results were related to the growth values of
each mutant after 7 h of inoculation.
The information from the wild type reference list could be used for further procedures.
Additionally the metabolite specific thresholds had been applied and thus changes in the
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metabolome of the 318 analyzed mutants were revealed. The observations are shown in
figure 35. The mutants are plotted against the rate of changed metabolites. Obviously the
majority  of  tested  mutants  (65%)  had  variations  in  25%...50%  of  their  identified
metabolites. Furthermore, 72% of all transposon mutants had changes in less than 50% of
their detected components. In only 28% of the randomly selected samples more than half
of the metabolites were different when compared to the wild type reference list. And only
1.3% of the mutants  revealed dramatic differences in more than 75% of the identified
compounds.  Especially  these  mutants  had  a  rigorously  changed  phenotype.  Again  the
reason for this was limited growth which led to a reduced amount of biomass available for
metabolome analysis. The analysis of the mutants with changes in more than 75% of the
identified  metabolites  proved  that  they all  were  growth-deficient  with optical  densities
below 1.
Figure 35.  Distribution  of  the  analyzed  mutants  according  to  the  rate  of  changed
metabolites  identified  when  applying  the  reference  list  and  the  metabolite  specific
thresholds.
Also the mutants with changes in 50%...75% of the metabolites (see figure 35) were further
investigated. Again, a lot of growth-deficient mutants could be identified, but also some
mutants  which  showed a  normal  growth.  When the  investigation  was  concentrated  on
samples which revealed changes of more than 60% but less than 75%, most of the mutants
also could be specified as growth-deficient. In this analysis it  was very interesting that
besides these growth-deficient ones also mutants with high growth rates were found. These
mutants were from plate 21 (B2P21, one mutant), plate 19 (B2P19, one mutant) and from
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plate 7 (B2P7, eight mutants). The high number of samples (eight mutants) on the same
plate  (B2P7)  was  very  surprising  and  hence  it  was  decided  to  perform  a  further
investigation which is described later on. 
Mutants with changes in 50%...60% could not only be related to reduced growth values:
some mutants with slightly limited growth were found, but also mutants with high growth
values.  For  the  last  mentioned  mutants  a  variant  phenotype  due  to  the  transposon
integration is most likely the reason for the high number of changes.
To gain a better understanding about the necessity of correct wild type reference further
analyses were performed. In the first step the correlation coefficients calculated for each
transposon mutant to the wild type raised together was related to the calculated number of
changed  metabolites  after  application  of  the  reference  list  and  the  metabolite  specific
thresholds. The result is shown in figure 36. The majority of mutants could be found at
very  high  correlations  and  till  around  75  changed  metabolites  (of  the  average  135
quantifiable metabolites). Nevertheless, already in this part some mutants with decreased
correlations could be revealed. These mutants would be chosen for further investigations.
For  values  higher  than  75 changed  metabolites,  the correlation values  decreased in  an
almost linear way with an increasing number of changed metabolites. These were again the
growth-deficient mutants. But additionally, a small group of nine mutants could be seen
with high correlations but also a high number of changes, an occurrence which normally
should not be possible (labeled group in figure 36).
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Figure 36. Relation of the correlation values calculated for each mutant to the wild type
cultivated together to the revealed number of changed metabolites after application of the
reference list and the thresholds for each metabolite. A small group of nine mutants of
outstanding occurrence is labeled. 
In order to understand the reason why some mutants had a high correlation value to the
wild type from the same plate but also a high number of changed metabolites, the same
picture was generated applying the correlations to the reference list. The plot is shown in
figure 37. The distribution looked different.  The whole plot  revealed a linear tendency.
With increasing number of changed metabolites the correlation decreased. Nevertheless,
the majority of mutants again could be found at quite high correlations and changes in less
than 75 metabolites (compare figure 36). The same mutants revealed decreased correlations
and only few variant compounds. The variant metabolites were specific and not identical in
these  mentioned  mutants.  Moreover,  these  variant  compounds  were  from  different
chemical classes.
Also  growth-deficient  mutants  could  be  found  on  the  right  side  of  the  plot  with  low
correlations and high number of changes. But in contrast to figure 36, the group of the nine
mutants (labeled in figure 37) now clearly showed decreased correlation values. Again they
were  found  at  the  right  side  because  of  the  high  number  of  changed  metabolites  at
correlation  values  that  were  a  little  bit  higher  compared  to  the  mutants  with  growth
limitations.
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Figure 37. Relation of the correlation values calculated for each mutant to the wild type
reference list to the revealed number of changed metabolites after application of this list
and the thresholds for each metabolite. The nine mutants which had been of outstanding
occurrence in figure 36 are again labeled.
The different picture for the nine noticeable mutants in figure 37 compared to figure 36 is
only due to the comparison to the wild type reference list instead of using the wild type
grown on the same plate. Therefore, the used wild types raised on the different plates were
further analyzed. All these wild type samples were correlated with the wild type reference
list. Furthermore, the reference list and the threshold specified for each metabolite were
applied and the number of varying metabolites determined. The resulting plot is shown in
figure 38.  The  average  correlation  coefficient  was  0.70 ± 0.08  and  around  55 ± 10
metabolites were mostly varying when applying the above described threshold with the
factor 6 (equation 3.2). A higher factor would of course decrease the number of differing
metabolites but would also reduce the sensitivity of the threshold.
Only one wild type sample was very different.  The correlation value was only slightly
reduced, but the number of changed metabolites was nearly twice the average value.
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Figure 38. Application of the reference list and the metabolite specific thresholds on the
wild type samples that where raised together with mutants on different plates. The revealed
correlation coefficient was related to the number of changed metabolites.
The differing wild type was from plate 7 (B2P7). This wild type had been used to calculate
the correlation of the eight varying mutants found and described before (see figure 35 and
36). The high number of changed metabolites was the same for the mutants as for the wild
type. Consequently, they were very much differing although the correlation to the wild type
of the same plate was quite high. The reason for this was found in the cultivation. Because
of a mistake the medium volume had been twice as much as normal in these wells. The
calculated  optical  density  was  of  course  lower  as  result  of  the  dilution  in  the  higher
medium volume.  A correction  of  the  OD-values  (a  multiplication  by two) during data
processing would compensate this problem. 
This  mistake  was  shown  because  it  is  a  good example  to  demonstrate  why it  is  very
important to have a reliable reference list. The wild type prepared together with the mutants
might be used as first comparison value. But it does not prevent the necessary application
of an independent and reliable reference. Only with the use of the reference list and the
identification of variant metabolites with the metabolite specific thresholds, problems like
the above described one can be revealed easily.
Additionally, the two other mentioned mutants: the one from plate 19 (see figure 35 and
labeled group in figures 36 and 37) and the one from plate 21 (see figure 35) were also
further investigated. For the mutant from plate 19 the reason for the differing behavior was
a  systematic  shift  of  all  metabolites  due  to  a  wrong identified  ribitol  value.  With  the
correction of this value the number of varying compounds was decreased. 
The reason for the distinctive feature of the mutant from plate B2P21 might come from a
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problem during data acquisition. Although the samples were raised to high densities, only a
small  number  of  metabolites  was  identified.  To  further  investigate  this  problem  it  is
probably recommended to repeat cultivation and metabolome analysis for this mutant.
In summary it can be said that mutants which revealed a change in more than 60% of the
detected metabolites (see figure 35) were mostly growth-deficient. The few others revealed
variations  resulting from problems during data acquisition or systematic errors or even
differences  in  cultivation. Thus,  the first  interesting mutants  which had normal  growth
values and hence enough cell mass for metabolome analysis had changes in maximum 60%
of  the  metabolites.  A  differentiation  between  changes  caused  by  biological  or
environmental variations and the desired changes after genetic modification was done. The
latter should be chosen for further investigation.
3.2.3 Hierarchical clustering of the growth-deficient mutants
Cluster analysis is a useful tool for the analysis of large data sets. This data-mining tool is
well  established  for  the  interpretation  of  DNA microarray  data  (Celis  et  al.,  2000).
Furthermore,  Roessner  et  al.  could  demonstrate  the  usefulness  for  metabolic  profiling
studies in plant systems (Roessner et al., 2001). In this study hierarchical cluster analysis
was applied to investigate the growth-deficient mutants. A program which uses emergent
self  organizing  maps  (ESOMs)  for  this  clustering  was  applied  (Hiller,  personal
communication).  This program does not only arrange data in clusters but also can give
further information about the metabolites responsible for the clustering. A test was also
performed to cluster around 250 mutants. Mutants mostly clustered according to the plate
and date of preparation. This was expected because the high-throughput method with its
several automated steps still is affected by changes due to biological and environmental
variations.  On  the  other  hand,  some  differences  caused  by  the  introduced  genetic
perturbation  might  just  lead  to  minor  changes.  Nevertheless,  some  mutants  clustered
separately  (see  figure A in  the  appendix)  and  mutants  from  different  plates  clustered
together.  These are  the interesting ones  because the genetic  perturbation in  such  cases
outweighed changes due to biological or environmental variations.
It  were  the  growth-deficient  mutants  that  appeared  to  be clearly separated.  They were
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found in two clearly separated groups (see appendix figure A) on top and at the bottom of
the dendrogram. Due to this observation only the mutants with growth limitations (optical
densities  below 2,  see  figure 29)  were  again  clustered  (figure 39).  In  this  process  five
clusters  were  formed.  The  metabolites  causing  the  separation  were  identified  as
hydroxylamine and urea for cluster three. Possibly, the reason for deficiencies in growth
might come from problems in nitrogen usage. 
Figure 39. Hierarchical cluster from 23 growth-deficient mutants using ESOMs.
With the use of hierarchical cluster analysis for one separate cluster a hint for the reason
for growth-deficiency of the mutants could possibly be found. The information about the
metabolites  responsible  for  the  other  clusters  did  not  lead  to  further  indication.
Nevertheless,  these  mutants  could  be  separated  in  groups  of  mutants  with  similar
metabolome. Detailed investigation of such small groups might lead to further information.
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3.2.4 Investigation of changes in metabolite levels
The analysis of ten up to twenty most intensive compounds of a sample is a very common
method  to  investigate  changes  in  metabolite  levels.  It  can  give  further  indications  for
interesting  changes  in  the  phenotype  of  a  mutant.  Possibly,  affected  pathways  or
bottlenecks  can  be  found.  In  table 18  the  metabolites  which  were  identified  as  most
intensive  in  over  50%  of  the  tested  mutants  are  shown.  A complete  list,  containing
additional  information,  for  example  about  the  pathways,  is  located  in  the  appendix
(table C).  Ribitol  is  used  as  added  internal  standard.  Beside  the  sugars  trehalose  and
maltose which are very hard to differentiate, because they are isomers, five amino acids
were found mostly in high relative concentrations. Except lysine, all of these amino acids
are  built  directly from intermediates  of  the  central  pathways  or  at  least  close  to  these
pathways. Trehalose is a compatible solute in microorganisms. 
5-oxoproline  is  formed  by cyclization  of  glutamic  acid.  This  reaction  continuous  with
extended  standing  times  of  the  samples  after  derivatization  before  measurement.
Phosphoric acid was detected in nearly all samples in high concentration. Furthermore,
adenosine-5'-monophosphate  and  glycerol-3-phosphate  as  phosphorylated  compounds
were often identified and succinic acid as well as lactic acid from the central pathways.
Table 18. Summary showing the most intensive metabolites in over 50% of the investigated
transposon mutants.
Metabolite Most intensive compound [%]
Phosphoric acid 99.69
Ribitol 95.31
Trehalose 93.13
Glutamic acid 95.94
Lysine 85.63
Maltose 85.00
Alanine 82.81
Lactic acid 81.88
Glycerol-3-phosphate 80.00
Serine 63.13
Succinic acid 63.13
Aspartic acid 61.56
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Metabolite Most intensive compound [%]
Adenosine-5'-monophosphate 55.31
5-Oxoproline 53.75
The information about these most intensive metabolites was analyzed for 318 mutants as
well as for the wild type reference list and a second list which was created after combining
all mutant samples. The reference list revealed all metabolites listed in table 18 (except for
5-oxoproline) as the most intensive compounds. Additionally, the amino acids glutamine,
proline and cycloleucine were found in very high concentrations.  For the wild type  of
C. glutamicum, a bacterium which is often used for amino acid production - a fact that is
not really surprising. For the list of all mutants again the majority of the compounds listed
in table 18 were found as most intensive compounds. Nevertheless, serine, succinic acid
and  5-oxoproline  were  not  among  the  twenty  highest  substances.  The  phosphorylated
compounds glucose-6-phosphate and fructose-1,6-biphosphate as well as cycloleucine and
gamma-glutamylvaline were found in the highest amounts instead. 
Out  of  the  318  analyzed  transposon mutants  19  growth-deficient  mutants  were further
investigated and interesting findings could be revealed. These 19 mutants comprised those
which did not grow higher than an optical density of 2 (compare figure 29). Again, 12 of
the 14 metabolites in table 18 that had been identified as most intensive compounds were
found.  However,  adenosine-5'-monophosphate  and  succinic  acid  were  not  present.
Furthermore, only phosphoric acid, maltose and trehalose, ribitol, alanine and lactic acid
occurred in the majority of the growth-deficient mutants. The others were only found in a
low number of samples. In contrast, some sugars and sugar alcohols, like glucose, mannose
(isomers) as well as mannitol and erythritol, were found in a lot of samples. Most of them
are  metabolites  of  the  sugar  metabolism.  An  assumption  could  be  that  the  mutants
increased their performance in this part of the metabolism to regulate their energy source
but were still not able to compensate the mutation.
Other  metabolites  which  often  occurred  in  the  analyzed  mutants  (see  table 19)  were
hexadecanoic  acid  and  octadecanoic  acid  from  the  fatty  acid  metabolism  as  well  as
glycerol  from  the  glycerolipid  metabolism.  Their  levels  were  increased  compared  to
mutants without growht-deficiencies. Possibly, such mutants had problems in the formation
of membranes which limited their growth.
Urea and hydroxylamine, important for the nitrogen metabolism, were found increased in
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some  mutants  as  well  (compare  results  from  part  3.2.3).  Probably  such  mutants  had
difficulties  in  the nitrogen usage.  Nitrogen is  one of  the  important  compounds  for  the
formation of biomolecules, e.g amino acids, and thus could cause growth-deficiencies.
2-hydroxypyridine  was  also found.  This  was a  residue derived  from the derivatization
compound. It was present in higher concentration in samples derived from growth-deficient
mutants, in which less metabolites were extracted and thus the derivatization reagent is
present in excess. In samples of mutants and wild type which revealed no growth limitation
all of the derivatization reagent is used and 2-hydroxypyridine is not present.
Table 19. Metabolites identified as most intensive compounds in the 19 analyzed mutants
with growth-deficiencies.
Metabolite
Occurrence
[%]
Metabolite
Occurrence
[%]
Hexadecanoic acid 100 Malonic acid 21
Ribitol 100 Lysine 21
Octadecanoic acid 95 Aspartic acid 16
Carbonic acid 95 beta-Alanine 16
Phosphoric acid 95 Glucono lactone 16
Trehalose 95 Valine 16
Glycerol 84 Glycolic acid 16
Maltose 84 Serine 11
Alanine 84 Xylulose 11
Mannose 68 2-Hydroxybutanoic acid 11
Lactic acid 79 2-Hydroxyglutaric acid 11
Glucose 79 Benzoic acid 11
Erythritol 63 Glyceraldehyde 11
Mannitol 53 Norvaline 11
Urea 53 Glycerol-3-phosphate 5
Glutamic acid 42
3-OH-2-tetradecyl-octanoic
acid
5
Hydroxylamine 42 Fructose-1,6-biphosphate 5
5-Oxoproline 37 gamma-Glutamylvaline 5
Dodecanol 32 Glucose-6-phosphate 5
2-Hydroxypyridine 26 Glutamine 5
Cycloleucine 26
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Another important observation regarding table 19 was the presence of compounds from the
glycolysis  -  glucose-6-phosphate  and  fructose-1,6-biphosphate  were  identified.  On  the
other side, the amino acids which were found in high intensities in the majority of mutants
(see table 18)  and which are located near the tricarboxylic  acid cycle were only rarely
found. Normally these phosphorylated compounds from the first steps of glycolysis are not
accumulated, but underlie a quick and ongoing conversion. Possibly, such an accumulation
is a hint that the mutation affects enzymes of the glycolysis itself or the tricarboxylic acid
cycle. The latter is the most important pathway in an organism and mutations inside or near
it surely could lead to severe problems - for example in growth. 
However,  in  addition  to  the  19  analyzed  growth-deficient  transposon  mutants  some
randomly selected mutants with good growth rates were further investigated. An interesting
finding was that very often compounds from the glycolysis, pentose phosphate pathway
and the tricarboxylic acid cycle were found in high levels. For example fumaric acid and
malic  acid  were  detected.  Also  glucose-6-phosphate,  fructose-1,6-biphosphate,  6-
phosphogluconate and 3-phosphoglyceric acid were often found. Although these mutants
had limitations in the central pathways they still grew to high optical densities. It can not
surely be said that the bottlenecks are directly located in these pathways, but due to the
effort of the bacterium to overcome them - in that way it overproduces these important
metabolites which can not be used completely and hence they are found accumulated in the
metabolome.
3.2.5 Identification of the transposon insertion site of some mutants
A complete list of the transposon mutants analyzed in this study is shown in table D in the
appendix. The important characteristics are summarized. The identification of the insertion
site of the transposon was done for ten selected mutants during this study. An overview is
given in table 20. The mutants printed in fat writing had already been described by Reimer
(Reimer, 2008). For half of the mutants only a hypothetical protein could be identified as
affected. One of these was a hypothetical membrane protein and another one was identified
as UDP-N-acetylenolpyruvoylglucosamine reductase hypothetical protein. The analysis of
the metabolic profile did not lead to an indication for affected pathways.
98 3  Results & Discussion
Table 20. Transposon mutants and the identified affected enzyme.
Number Mutant Affected enzyme (gene)
MT63 A2_B2P7 para-aminobenzoat synthase (pabAB, cgl0997)
MT88 C3_B2P7 hypothetical membrane protein (cg0879)
MT91 C6_B2P7 pseudouridine synthase (rluD, cgl2138)
MT92 C7_B2P7 hypothetical protein (cgl0592)
MT107 E1_B2P7 glutamate-ammonia-ligase adenyltransferase (glnE)
MT122 F2_B2P7 hypothetical protein (cg0858)
MT147 H4_B2P7 UDP-N-acetylenolpyruvoylglucosamine reductase  (murB)
MT161 A6_B2P8 hypothetical protein (cgl1708)
MT165 B1_B2P8 aminopeptidase N (pepN, cgl2426)
MT168 B4_B2P8 citrate-transporter/symporter (citP, cgl0067)
The growth behavior of mutant 63 was described in detail by Reimer (Reimer, 2008). This
mutant was growth-deficient. It hardly grew on minimal medium. The additional supply of
amino  acids  in  the  minimal  medium  could  improve  the  growth,  but  a  complete
compensation was not  possible.  The affected gene (cgl0997 annotation Kyowa,  pabAB
annotation Bielefeld) is coding for a subunit of the para-aminobenzoat synthase which is
involved  in  the  tyrosine,  phenylalanine  and  tryptophan  biosynthesis.  However,  the
supplementation of these amino acids alone did not improve the growth behavior.  This
enzyme is responsible for the conversion of chorismate into anthranilate  which is  than
further  converted  to  tryptophan.  Furthermore,  this  enzyme  is  involved  in  the  folate
biosynthesis  where  it  is  responsible  for  the  conversion  of  chorismate  into  4-amino-4-
deoxychorismate. The enzyme is also part of a two-component system responsible for the
regulation of the biosynthesis of tryptophan. 
Mutant 107 was analyzed and the affected gene (glnE annotation Bielefeld) was identified
encoding for a glutamate-ammonia-ligase adenyltransferase.  This gene is  regulating the
glutaminsynthase I, which is involved in the nitrogen metabolism. Glutamine and proline
were found in increased levels in this mutant. Normally the glutaminsynthase I catalyzes
the fixation of nitrogen via glutamine in case of a lack in nitrogen supply. Due to the gene
knock-out  in  this  mutant  the  regulation  of  the  glutaminsynthase  I  by  the  glutamate-
ammonia-ligase adenyltransferase is missing. Therefore, glutamine was found in increased
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levels  because  the  described  path  for  the  nitrogen  fixation  was  active  although  no
limitation  existed.  Furthermore,  in  case  of  nitrogen  abundance,  proline  is  one  of  the
substances synthesized as protectant for osmotic stress. The increased level of this amino
acid could be an indicator for such an abundance of nitrogen, with further influence on
regulations dependent on the nitrogen supply (Reimer, 2008).
In mutant 91 the affected gene (rluD, cgl2138) was identified to code for a pseudouridine
synthase. This enzyme works as catalyst for the reaction of uridine to pseudouridine. In the
metabolic profile of the mutant a reduced amount of uridine was found. Pseudouridine is
not included in our internal library. Therefore, no information about that compound was
available. Additionally, a decrease in the uridine-5'-monophosphate and uracil and most of
the  amino  acids  like  tyrosine,  threonine,  thymine,  isoleucine  and  phenylalanine  were
detected. Uridine is part of the RNA. It is built from the base uracil and the pentose ribose.
The  knock-out  of  the  enzyme  seems  to  have  an  effect  on  the  formation  of  a  lot  of
compounds. The changed uridine level has a direct influence on the uracil level. Because
this base is responsible for the amino acid formation, the value of the base was reduced as
well.
Mutant  147 had  the transposon integration in  the gene (murB)  coding for  an UDP-N-
acetylenolpyruvoylglucosamine reductase. This enzyme is involved in the amino sugars
metabolism. It converts the second part of the reaction of UDP-N-acetyl-D-glucosamine
into UDP-N-acetyl-3-O-(1-carboxyvinyl)-D-glucosamine and further into UDP-N-acetyl-
muramate. In the metabolic profile the phosphorylated compounds glucose-, mannose- and
glucosamine-6-phosphate  were increased in  this  mutant.  Ribose-5-phosphate as  well  as
fructose-6-phosphate were only identified in the mutant but not in the wild type. These
raised levels seemed to be the direct result of the mutation. Because a conversion to UDP-
N-acetylmuramate was not possible, the level of UDP-N-acetyl-D-glucosamine might be
high (not identified because not in our library). Possibly an accumulation of this compound
led  to  an  increased  formation  of  such  phosphorylated  sugars  because  glucosamine-6-
phosphate and fructose-6-phosphate are directly built from UDP-N-acetyl-D-glucosamine. 
The gene (pepN, cgl2426) coding for an aminopeptidase N was identified to be disrupted in
mutant 165. This enzyme is involved in the glutathione metabolism where it converts the
formation of glycine. The metabolic profile did not show many differences. That means,
the mutation did not have much influence on the whole metabolism. The knock-out of this
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specific enzyme rather impacts only the mentioned reaction. Consequently,  glycine was
found in reduced concentration.
Mutant  168  had  the  mutation  in  the  gene  (citP,  cgl0067)  coding  for  a  citrate-
transporter/symporter. The mutant was grown on glucose as carbon source. Consequently,
the mutation in the citrate-transporter did not lead to any changes of the phenotype. The
citric acid concentration was identical to the one of the wild type.
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3.3 Comparison of different quenching methods
In the scientific literature available up to now, different quenching methods exist. Mostly
the methods were developed and optimized especially for one organism. The adaptation of
a protocol from one microorganism to another was often unsatisfactory and could only be
regarded as a compromise.
In this study (together  with Reimer (Reimer,  2008))  different quenching methods were
tested  on  three  different  organisms.  Additionally,  our  standard  protocol  was  used  as
unquenched method for comparison. Two methods from literature were applied: quenching
with methanol and a cold glycerol saline quenching. Furthermore, an ethanol quenching
method was tested. This one had been developed in our working group and was further
improved during this study.
3.3.1 Refinement of the ethanol quenching method
First  experiments  using  an  ethanol  solution  for  quenching  were  done  in  our  lab  by
Buchinger. During this study the method was refined and evaluated, using a 40% ethanol
sodium  chloride  solution  as  basis.  The  whole  method  is  shown  in  chapter  2.9.1.
Background for the development of a quenching method with an alcoholic solution was the
methanol method (see part 2.9.2) which is the quenching performance for microorganism
most  often  used.  Nevertheless,  Wittmann  et  al.  described  so  called  cold-shock
phenomenons during quenching of C. glutamicum (Wittmann et al., 2004). The idea was to
use  a  reduced  alcoholic  solution  and  ethanol  instead  of  methanol  in  order  to  reduce
negative impacts of the high alcohol concentration on the cell membrane. Furthermore, the
temperature of the solution was increased from -50°C to -20°C to reduce stress caused by
the  temperature  drop  but  still  to  be  able  to  stop  the  metabolism.  Additionally,  after
optimization the quenching solution was prepared with a physiological salt concentration
in order to avoid osmotic stress.
In first tests the ethanol quenching solution was made with a 0.5% (w/v) sodium chloride
end concentration. This solution revealed good results for the organisms  C. glutamicum
and S. cerevisiae but for E. coli dramatic losses were found compared to our unquenched
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standard  method.  Probably stress  caused  by the  change  in  osmolarity  and  the  alcohol
caused this effect in the Gram-negative organism. Because of its special morphology with a
relatively thin cell wall E. coli was the only of the tested three organisms responding to this
stress. To optimize the performance different salt concentrations were tested. The sodium
chloride concentration in the ethanol quenching solution was adjusted to a physiological
concentration of 0.8% (w/v) and for comparison to 1.5% (w/v). Tests were prepared with
E. coli. Figure 40 shows the results. The different identified metabolites for each quenching
performance were compared to each other. 
In figure 40A the comparison of the quenching solution with 0.5% (w/v) sodium chloride
to the solution with 0.8% (w/v) is shown. A lot of metabolites were spread around the 45-
degree line but closer shifted to the abscissa. Some of the amino acids were even missing
in the 0.5%-solution but detectable when quenched with the physiological solution (0.8%
w/v). 
The comparison of the quenching solution with 1.5% (w/v) sodium chloride to the solution
containing 0.8% (w/v) is shown in figure 40B.  The result is  very similar to the one in
figure 40A. Again the majority of metabolites is spread around the 45-degree line.  The
tendency was  shifted  to  the  abscissa.  Nevertheless,  a  lot  of  substances  had  only been
detectable  in  the  physiological  solution.  Again  some  amino  acids  were  missing  after
quenching with the 1.5%-solution.
In figure 40C the results for quenching with the 0.5%-solution and the 1.5%-solution are
plotted  against  each  other.  The  identified  metabolites  showed  a  cloud-like  distribution
around the 45-degree line. Some of the substances were only found after quenching with
the 0.5% (w/v) quenching solution and can be seen in the plot on the abscissa whereas
others were only detectable after quenching with the 1.5% (w/v) quenching solution (on the
ordinate). Altogether, the result for these two solutions was quite different. 
Overall,  the physiological  solution  with  0.8% (w/v)  sodium chloride  revealed  the  best
result for E. coli. This solution was used for further experiments with the other organisms,
too. Although, first results with the 0.5%-solution had not revealed such an influence on
these microorganisms, stress caused by the change in osmolarity was avoided this way.
One further result of this study is that one statement from literature could be disapproved -
namely that a salt concentration above the physiological one would be the best and the one
preferred to a physiological concentration (Bolten et al., 2007).
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Figure 40. Comparison of the results after quenching of  E. coli with an ethanol solution
containing different concentrations of sodium chloride.  A 0.5%-solution compared to the
0.8%-solution,  B 1.5%-solution  compared  to  the  0.8%-solution  and  C 1.5%-solution
compared to the 0.5%-solution.
A
B
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Besides the test regarding the quenching solution itself, also the influence of additional
washing steps during quenching was examined. Most important for such an additional step
is the low temperature which has to be hold. Otherwise the metabolism could change again.
Thus, tests were performed using the quenching solution (40% ethanol and 0.8% (w/v)
sodium  chloride)  as  washing  solution,  too.  Different  experiments  were  done:  without
washing, one washing operation and two washing operations. The results are shown in
figure 41.  The  plots  clearly  indicated  a  reduction  of  the  relative  concentrations  of
metabolites after each washing step. Still, some metabolites were only found in the washed
samples  (see  figure 41A  and  B).  These  substances  mostly  were  so  called
“unknowns” (structurally uncharacterized substances) and therefore a reason for the change
could not be discovered.
Figure 41A displays the result after quenching and one washing operation compared to a
performance without washing. It was clearly shown that only after one of these additional
steps the majority of the identified substances could be found in decreased levels. Overall
57% of the relative metabolite concentrations were reduced. 
After two times of washing the before noticed trend could be confirmed. In figure 41B, the
two step washing is  plotted against  quenching without washing.  Even more reductions
were revealed and a lot of the substances were no more detectable in the washed sample
(on  the  abscissa).  Altogether,  60%  of  the  metabolites  were  identified  in  decreased
concentrations. 
To reveal this effect of washing more clearly, in figure 41C the results of two times washed
and one times washed samples is related. The majority of all identified metabolites showed
a reduction after a second additional washing step. Nearly all metabolites are shifted.
Probably the shear stress caused this tremendous effect after washing. The reason is likely
the resuspension of the pellet in the washing solution after centrifugation. During each
washing step the metabolite levels were reduced, affecting over 70% of the compounds.
Most affected are sugars, sugar phosphates but also intermediates of the tricarboxylic acid
cycle.
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Figure 41. Comparison of the ethanol quenching performance with and without washing
steps.  A one washing operation is compared to quenching without washing,  B two step
washing is compared to quenching without washing and  C quenching with one and two
washing steps is compared to each other.
A
B
C
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Because of this huge effect of washing of  E. coli cells, the washing was not performed
routinely in  our  ethanol  quenching  method.  Since  the  aim was  to  evaluate  a  protocol
suitable for quenching of different organisms, the washing was not applied on the two other
microorganisms, too. Nevertheless, in the literature such a negative effect of a methanol
method containing a washing step on C. glutamicum had been already described (Wittmann
et al., 2004). 
3.3.2 Difficulties in the cold glycerol saline quenching performance
The cold glycerol saline quenching method was recently described in the literature (Villas-
Bôas et  al.,  2007).  A detailed workflow of  the method is  shown in chapter  2.9.2.  The
quenching solution used consisted of 60% glycerol and 0.54% (w/v) sodium chloride. Due
to the high viscosity of this solution the centrifugation speed and time had to be very high.
The speed was over 4.5times higher than the performance in our unquenched protocol and
the time was increased by a factor of nearly 7. 
During this quenching method the pellet  had to be resuspended in a 50% glycerol and
0.675% (w/v) sodium chloride washing solution. This solution again was very viscous.
Consequently,  the  resuspension  took  quite  long  and  another  big  problem  occurred.
Although the washing solution had been precooled to -20°C the whole mixture of cells and
this solution could not be held at this low temperature. 
A similar  temperature  problem  occurred  with  the  centrifuge  itself.  The  machine  was
precooled to -9°C. But  during quite long centrifugation steps at  a  very high speed the
centrifuge could not hold this low temperature and warmed, reaching temperatures higher
than 0°C.
Nevertheless, the protocol was applied and after cell lysis the polar phase was extracted
and dried. But due to the high amount of glycerol in the solutions a quite high amount of
this compound sticked to the sample. With this moiety a derivatization with MSTFA was
not possible. Glycerol is very hygroscopic and this silylation step has to be performed in
the absence of water. Villas-Bôas et al. already described this findings (Villas-Bôas et al.,
2007), but in their opinion this amount of glycerol, which they quantified with less than
150 µl,  was  not  distracting.  They  applied  another  derivatization  compound  (methyl
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chloroformate) which is also working in the presence of water. In this study the moiety of
glycerol on the samples could not be neglected because it was distracting. Furthermore,
due to comparison purpose a change of the derivatization performance was not possible.
Additionally,  applying  methyl  chloroformate  would  reduce  the  number  of  different
detectable  substances.  A  silylation  with  MSTFA can  be  used  for  a  broad  range  of
substances  (e.g.  sugars  and  sugar  derivatives,  amino  acids,  organic  acids,  fatty  acids,
amines)  whereas  others  are  mostly  suitable  for  a  smaller  number  of  compounds.
Chloroformate can be used for the derivatization of e.g. amino acids, keto acids, fatty acids
and aliphatic amines (Villas-Bôas et al., 2005).
In  order  to  overcome  this  difficulty  an  additional  washing  step  with  ice  cold  sodium
chloride solution (0.9% w/v) was tested. A reduction of the glycerol moiety was achieved.
But because of the high viscosity of this compound it could not be completely removed.
The amount sticking to the sample was still too high for further investigation. 
Finally,  because of the here mentioned problems this method had to be discarded. The
produced results after measuring the samples with GC/MS were not analyzable.
3.3.3 Quenching of Escherichia coli
For quenching experiments with E. coli cells were cultivated as described in chapter 2.7.1.
In order to compare the different applied protocols correctly, samples were always taken
together and at least in triplicates for each method. As direct comparison our unquenched
standard method (UQ) was also exerted.
In figure 42 the results of the ethanol quenching (EQ) are plotted in a scatterplot against the
unquenched method. Displayed are the normalized peak areas which correspond to the
relative intensities of the identified metabolites. A relatively high number of substances
could only be detected in the ethanol quenched samples. This metabolites which can be
seen on the ordinate were mostly sugars and phosphorylated compounds. The majority of
substances was distributed cloud-like around the 45-degree line. In contrast, among others
some of the amino acids were only detected in the unquenched samples and can be seen in
figure 42 on the abscissa. Altogether, quite a high number of obvious differences can be
found when analyzing the scatterplot. This might indicate that in the unquenched samples
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the metabolism was not stopped but ongoing during sample preparation, whereas in the
ethanol quenched samples a stopped metabolism was achieved.
Figure 42. Scatterplot of ethanol quenched (EQ) and unquenched samples (UQ) of E. coli.
In order to confirm the hypothesis that the changes between the samples quenched with
ethanol and the unquenched ones were due to the ongoing metabolism in the not quenched
samples,  an  additional  experiment  was  performed.  Again  E.  coli was  cultivated  and
harvested.  Sample triplicates were handled according to the unquenched method or the
ethanol  quenching.  But  additionally,  one  triplicate  was  harvested  together  with  the
unquenched samples but was kept on ice for 30 min before further applying this method.
Another group was harvested and quenched but was hold at -5°C for 30 min before further
sample preparation according to the quenching protocol was done. The result of this test is
shown  in  figure 43.  Obviously  the  metabolism  was  not  quenched  when  applying  the
standard  performance (see figure 43A).  The scatterplot  revealed  quite  a  lot  differences
when keeping the samples on ice for 30 min. The average calculated correlation coefficient
using  the  logarithmic  values  of  the  relative  concentration  vectors  was  calculated  with
0.83 ± 0.02 which confirmed the high number of changes. 
Glucose  and  mannose  were  identified  in  higher  relative  concentrations  in  the  samples
directly  prepared.  This  approved  the  hypothesis.  Because  they  are  isomers,  these  two
compounds are hard to distinguish and hence are mostly identified together. If they were in
higher values in the first prepared samples but reduced in the samples after 30 min standing
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time, the carbon source glucose might have been consumed in the ongoing metabolism.
Methionine had only been found in the unquenched samples in figure 42. But in figure 43A
it  even  seems  to  be  further  synthesized  during  the  30 min  standing  time.  A similar
observation  could  be  made  for  glutamic  acid,  being  reduced  in  the  ethanol  quenched
samples  (figure 42),  but  even  more  increased  in  the  unquenched  samples  after  30 min
(figure 43A). Furthermore,  some metabolites could only be detected in the unquenched
samples kept on ice for 30 min.
In contrast, there are only few differences between samples quenched with ethanol and
those  stored  for  30 min  before  further  applying  the  quenching  protocol  (figure 43B).
2-aminobutyric  acid  was  only  detectable  in  the  quenched  samples  without  additional
standing time but in quite low concentration. Two amino acids were slightly decreased
after 30 min. Nicotinic acid was identified in increased value after additional standing time.
Overall,  the correlation coefficient  was significant higher (0.94 ± 0.04) compared to the
result of the unquenched performance. 
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Figure 43.  Scatterplots  of  unquenched  (UQ)  and  ethanol  quenched  (EQ)  samples.
A unquenched samples compared to unquenched ones additionally held on ice for 30 min
and B ethanol quenched samples compared to those stored for 30 min at -5°C.
This  analysis  could  approve  the  hypothesis  to  receive  good  quenched  samples  when
applying the ethanol quenching. On the other hand, when applying our standard protocol
the  metabolism was  not  stopped.  The cooling step  seems to  be  the  most  critical  one.
Cooling from 37°C to a lower temperature just by placing the cells on ice seemed not
sufficient and additionally rather uncontrolled, whereas the fast cooling in a -30°C-cold
isopropanol bath worked very well.
The comparison of the results from the methanol quenching and the unquenched method is
shown in figure 44. A high number of differences could be found. A lot of amino acids
A
B
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could only be detected in unquenched samples and can be seen on the abscissa, whereas
some  sugars  and  phosphorylated  compounds  could  only  be  identified  in  methanol
quenched  samples.  The  majority  of  metabolites  was  spread  around  the  45-degree  line
revealing  quite  a  lot  reduced  substances  when  applying  the  methanol  quenching
performance.
Figure 44.  Scatterplot  of  methanol  quenched  (MQ)  and  unquenched  samples  (UQ)  of
E. coli.
For  a  direct  comparison  of  both  quenching  methods  their  results  are  shown  in  direct
relation in figure 45. Only one substance identified as “unknown” was found to be present
in  the  methanol  quenched  but  not  in  the  ethanol  quenched  samples  (on  the  ordinate).
Substances that are described as “unknown” in our library are structurally not identified
compounds which can be found repeatedly in the samples. They are not labeled in the
scatterplots. The majority of detected compounds was found in higher concentrations in
samples quenched with ethanol. A lot of phosphorylated compounds clearly showed this
trend. Phosphorylated intermediary metabolites have very low time constants and thus are
consumed in an ongoing metabolism.
Some amino acids could only be detected in ethanol quenched samples and can be found
on the abscissa in figure 45. This comparison clearly demonstrated an improved result for
samples after ethanol quenching.
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Figure 45. Scatterplot of methanol quenched (MQ) and ethanol quenched (EQ) samples of
E. coli.
A direct overview about relative concentration ratios of some identified metabolites for all
three methods is shown in table 21. Some of the best reproducible substances are outlined.
As  already  seen  in  figure 44  and  45  a  lot  of  substances  were  identified  in  lower
concentrations in the methanol quenched samples. Especially the amino acids and several
phosphorylated compounds showed this  decrease in the direct  comparison of  methanol
quenching  to  ethanol  quenching.  Uridine-5'-monophosphate  and  adenosine-5'-mono-
phosphate were not detected in unquenched samples but were found after applying both
quenching  methods.  In  samples  quenched  with  ethanol  both  substances  were  found in
highest concentration. In summary, more than 80% of all identified metabolites showed
lower concentrations after methanol quenching.
The results of figure 43 for the relation of ethanol quenched and unquenched samples were
confirmed  by  the  results  in  table 21.  While  phosphorylated  compounds  were  most
abundant in ethanol quenched samples, some amino acids revealed lower concentrations.
Additionally,  pyruvic  acid  was  even  2fold  increased  in  ethanol  quenched  samples.
Moreover, pyruvic acid is a metabolite of the central metabolism which is involved in the
important pathways and thus is consumed quite fast. All the given facts confirm the good
results and make the use of an ethanol quenching method preferable. 
Lactic acid was detected in over 10fold higher relative concentrations in the unquenched
samples. However, succinic acid was only identified in moieties in quenched samples but
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in quantifiable amounts in the unquenched samples. This compound was 6fold (EQ) or
even  8fold  (MQ)  increased  when  applying  our  standard  method  without  quenching
(table 21). Possibly these two substances were accumulated due to continuous changes in
the metabolism of the unquenched samples. In figure 43A was shown that the metabolism
was not stopped during the standard performance, whereas a stopped organism was found
after quenching with ethanol (figure 43B). An additional indication for this might be the
increased values for malic acid and fumaric acid, intermediates of the tricarboxylic acid
cycle, in ethanol quenched samples compared to the unquenched ones.
Table 21.  Comparison  of  the  relative  concentrations  of  some  identified  amino  acids,
phosphorylated  compounds  and  other  metabolites  in  E. coli applying  the  different
procedures. 
Metabolite Ratio EQ to UQ Ratio MQ to UQ Ratio MQ to EQ
amino acids
Tyrosine 0.014 ± 12.2% 0.008 ± 16.3% 0.595 ± 16.9%
Threonine 0.105 ± 33.0% not detected in MQ not detected in MQ
Glutamic acid 0.075 ± 13.9% 0.001 ± 13.8% 0.114 ± 24.9%
Valine 0.536 ± 65.5% 0.014 ± 18.5% 0.035 ± 23.8%
Glycine 0.547 ± 8.2% 0.048 ± 54.7% 0.088 ± 48.7%
Alanine 3.336 ± 21.9% 0.197 ± 27.5% 0.063 ± 19.7%
Phenylalanine 5.556 ± 13.5% 0.141 ± 25.3% 0.024 ± 25.1%
Aspartic acid 35.437 ± 60.0% not detected in MQ not detected in MQ
phosphorylated compounds
Glycerol-3-phosphate 0.989 ± 10.4% 0.216 ± 22.4% 0.218 ± 20.4%
Xylulose-5-phosphate 1.316 ± 10.0% 0.202 ± 22.3% 0.154 ± 19.9%
Erythrose-4-phosphate 1.114 ± 7.6% 0.022 ± 7.9% 0.017 ± 2.8%
6-Phosphogluconate 1.317 ± 9.9% 0.009 ± 50.4% 0.007 ± 50.0%
3-Phosphoglyceric acid 1.238 ± 17.0% not detected in MQ not detected in MQ
Glucose-6-phosphate 1.930 ± 5.9% 0.462 ± 29.1% 0.231 ± 27.8%
Ribulose-5-phosphate 3.415 ± 24.8% 0.109 ± 28.7% 0.063 ± 29.2%
Uridine-5'-
monophosphate 
not detected in UQ not detected in UQ 0.025 ± 15.1%
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Metabolite Ratio EQ to UQ Ratio MQ to UQ Ratio MQ to EQ
Fructose-1,6-
biphosphate 
not detected in UQ not detected in UQ 0.001 ± 33.5%
Adenosine-5'-
monophosphate 
not detected in UQ not detected in UQ 0.055 ± 38.1%
others
Lactic acid 0.086 ± 20.1% 0.079 ± 21.2% 0.916 ± 24.5%
α-Ketoglutaric acid 0.105 ± 19.4% not detected in MQ not detected in MQ
Succinic acid 0.161 ± 7.1% 0.017 ± 50.6% 0.121 ± 51.4%
Citric acid 0.601 ± 12.5% 0.053 ± 7.2% 0.097 ± 20.0%
Fumaric acid 2.369 ± 10.5% 0.170 ± 27.1% 0.073 ± 24.9%
Pyruvic acid 2.156 ± 11.2% 0.678 ± 11.6% 0.338 ± 9.6%
Malic acid 2.762 ± 6.4% 0.015 ± 18.5% 0.005 ± 21.1%
Another important  result  of the method comparison was the difference in the achieved
standard errors. The ethanol method had the lowest error of 16% corresponding to the best
reproducibility. The unquenched method revealed a slightly higher error of 17% whereas
the methanol method had a standard error of 32% which is double the error rate of ethanol
quenching, assuming a high variance in the samples. Furthermore, the number of identified
metabolites  was  the  highest  in  samples  quenched  with  ethanol  and  the  lowest  when
quenched with methanol. Altogether, 124 different metabolites were found when applying
our internal library. The distribution and the number of identified metabolites are shown in
a venn diagram in figure 46. 36% more metabolites could be detected in samples quenched
with ethanol than after methanol quenching.
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Figure 46. Division of 124 identified metabolites from three applied methods for E. coli.
First analysis of the supernatants was also done. A big problem during such analysis with
GC/MS  had  been  the  high  glucose  concentration  in  the  medium.  Because  cells  were
harvested in the middle of the exponential growth phase to show a stable phenotype, a
quite  high  amount  of  the  sugar  was  still  present  in  the  medium.  To  circumvent  an
overloading of the GC-column as well as the MS-detector, samples had to be analyzed in
small amounts. But due to the high dilution of possibly leaked metabolites, concentrations
of  these  substances  might  be  below detection limit.  Nevertheless,  some analyses  were
done. In samples quenched with methanol, pyruvic acid was found in 1.5fold enhanced
concentration in the supernatant when compared to unquenched ones. 
Because of the results shown in figure 42 and table 21 the supernatant of ethanol quenched
samples was analyzed in order to seek amino acids. Some had been only found in the
extracts of unquenched samples. However, no high amounts of amino acids derived from
cell leakage could be identified. Only aspartate was found in a high concentration. But this
substance  can  be  secreted  from  E.  coli and  furthermore,  it  was  even  found  in  high
concentration in the corresponding quenched extracts. Additionally, 10fold higher amounts
were determined in the supernatant of unquenched samples. Thus, a clear indication for cell
leakage could not be found.
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3.3.4 Quenching of Corynebacterium glutamicum
For  quenching  experiments  with  C.  glutamicum cells  were  cultivated  as  described  in
chapter 2.7.1. To compare the different applied protocols correctly, samples were always
taken together and at least in triplicates for each method (ethanol quenching, methanol
quenching and standard method without quenching).
In figure 47 the results of the ethanol quenching are plotted in a scatterplot against  the
unquenched method. Displayed are the normalized peak areas which correspond to the
relative intensities of the identified metabolites. Some metabolites could only be detected
in  samples  quenched  with  ethanol  and  were  found  in  the  scatterplot  on  the  ordinate.
Furthermore,  a  lot  of  substances,  for  example  some  sugars  and  organic  acids,  were
identified  in  higher  relative  concentrations  in  the  quenched  samples.  The  majority  of
compounds is located around the 45-degree line showing only small differences. Still some
metabolites, like threonine and gamma-glutamylleucine, were higher concentrated in the
unquenched samples. Altogether, the scatterplot indicated a better result after quenching
because of the high number of increased substances.
Figure 47.  Scatterplot  of  ethanol  quenched  (EQ)  and  unquenched  (UQ)  samples  of
C. glutamicum.
In order to find out whether the metabolism really was completely stopped after quenching
with ethanol and if any changes appeared during the standard, unquenched performance, an
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experiment with additional standing times over 30 min was prepared. The results for both
methods are displayed in figure 48. Hardly any changes were visible when comparing the
standard method with routinely preparation with those additionally hold on ice for 30 min
and  similarly  handled  afterwards  (see  figure 48A).  Just  two sugars  were  detectable  in
samples  without  standing  time  but  not  in  30 min-samples.  The  calculated  correlation
coefficient of the logarithmic values of the concentration vectors revealed very good values
of  0.94 ± 0.03, confirming only few changes - a fact  that  could already be seen in the
scatterplot.
The result for the comparison of the ethanol quenching in figure 48B showed a similar
picture as for the unquenched method. Some substances could only be detected in samples
directly  prepared  (on  the  abscissa)  and  some only in  samples  stored  over  30 min  and
handled afterwards by applying the same method (on the ordinate). But the majority of
samples  did  not  show  any  changes.  Some  amino  acids  were  slightly  varying.  The
correlation coefficient  revealed a very good value of  0.94 ± 0.01,  confirming only few
changes and a nearly completely stopped metabolism. 
Overall the results for the unquenched and ethanol quenched method were almost identical.
Most of the enzymes seemed to be already stopped when reducing the temperature from
30°C  for  cultivation  to  4°C  in  the  unquenched  method.  Nevertheless,  for  temperature
decrease the material was kept on ice which made it hard to control the process running
inside. Consequently, it can not clearly be said that all enzymes were stopped, whereas in
the quenching performance this cooling step was done controlled and due to the higher
drop of temperature surely all enzymes were affected.
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Figure 48.  Scatterplots  of  unquenched  (UQ)  and  ethanol  quenched  (EQ)  samples.
A unquenched samples compared to unquenched ones that were additionally held on ice for
30 min and B ethanol quenched samples compared to those stored for 30 min at -8°C.
The  comparison  of  samples  quenched  with  methanol  and  unquenched  ones  showed  a
completely different picture. In figure 49 the scatterplot is displayed. Nearly all metabolites
were distributed cloud-like. Only some were located on the 45-degree line. The metabolites
galactosamine,  erythritol,  succinic  acid  monomethylester  and  leucine  could  only  be
identified in methanol quenched samples, whereas 2,6-diaminopimelic acid, nicotinamide,
glutamine and adenine were only detected in the unquenched ones. Furthermore, a lot of
amino acids were found in higher concentrations in unquenched samples. This observation
had already been described in the literature for  the methanol  method (Wittmann et  al.,
2004).  But,  for example, some sugars and other metabolites were detected in increased
A
B
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levels  in  the  methanol  quenched  samples.  Altogether  both  methods  led  to  completely
different results.
Figure 49.  Scatterplot  of  methanol  quenched  (MQ)  and  unquenched  (UQ)  samples  of
C. glutamicum.
In order to allow a better evaluation of the results  coming from the comparison of the
methanol method and the unquenched method, a comparison of both quenching methods
was done. The scatterplot is shown in figure 50. The metabolites were distributed like a
cloud around the 45-degree line with a trend in direction of the ethanol method. Especially
some amino acids were detected in increased amounts in samples quenched with ethanol.
Furthermore,  2,6-diaminopimelic  acid,  nicotinamide,  adenine  and  glutamine  were  not
identifiable  in  methanol  quenched  samples  but  in  ethanol  quenched  ones.  These  four
compounds on the abscissa had already been detected as missing when compared to the
unquenched method (see figure 49). 
Other  metabolites,  for  example,  lactylactate  and  succinic  acid  monomethylester,  were
detected in higher concentrations in the methanol quenched samples. Just to remind, the
latter one even had been missing and the first had occurred in a lower value in unquenched
samples (see figure 49). 
120 3  Results & Discussion
Figure 50. Scatterplot of methanol quenched (MQ) and ethanol quenched (EQ) samples of
C. glutamicum.
A direct overview regarding the relative concentration ratios of some identified metabolites
for all three methods is given in table 22. Some of the best reproducible substances are
outlined.  As  already  presented  in  figure 49  the  methanol  quenching  compared  to  the
unquenched method showed a loss in the relative concentrations of more than 50% of the
identified metabolites. The comparison of the applied methods revealed the best result for
the ethanol quenched samples. Around 64% of all identified metabolites were found in
higher concentrations in these samples compared to unquenched ones. Additionally, when
related to the methanol quenched samples, even more than 70% of the compounds had
larger values in samples quenched with ethanol.
Table 22.  Comparison  of  the  relative  concentrations  of  some  identified  amino  acids,
phosphorylated compounds and other metabolites in C. glutamicum applying the different
procedures. 
Metabolite Ratio EQ to UQ Ratio MQ to UQ Ratio MQ to EQ
amino acids
Aspartic acid 0.469 ± 8.1% 0.183 ± 25.8% 0.376 ± 27.4%
Glycine 0.630 ± 33.0% 0.101 ± 19.8% 0.159 ± 33.0%
Glutamic acid 0.728 ± 6.3% 0.260 ± 8.4% 0.344 ± 13.9%
Alanine 1.264 ± 15.3% 0.659 ± 4.9% 0.536 ± 20.4%
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Metabolite Ratio EQ to UQ Ratio MQ to UQ Ratio MQ to EQ
Tyrosine 1.269 ± 14.7% 0.613 ± 15.0% 0.443 ± 22.9%
Phenylalanine 2.072 ± 6.0% 0.736 ± 33.2% 0.375 ± 25.9%
phosphorylated compounds
Glycerol-3-phosphate 0.282 ± 4.9% 0.093 ± 24.3% 1.320 ± 24.5%
Fructose-1,6-biphosphate 0.583 ± 9.0% 0.224 ± 20.0% 0.416 ± 31.5%
Phosphoenolpyruvic acid 0.934 ± 9.8% 0.685 ± 11.2% 0.733 ± 13.3%
Glucosamine-6-phosphate 0.943 ± 21.1% 0.642 ± 17.6% 0.738 ± 22.9%
2-Phosphoglyceric acid 0.965 ± 4.5% 0.334 ± 6.7% 0.344 ± 6.8%
3-Phosphoglyceric acid 1.152 ± 3.6% 0.454 ± 11.1% 0.394 ± 11-0%
Glucose-6-phosphate 1.233 ± 9.5% 1.453 ± 13.2% 1.152 ± 9.4%
Mannose-6-phosphate 1.470 ± 12.4% 2.708 ± 12.2% 1.897 ± 13.9%
Uridine-5'-monophosphate 1.514 ± 3.0% 0.984 ± 5.9% 0.638 ± 6.0%
Adenosine-5'-monophosphate 1.595 ± 7.2% 0.834 ± 9.1% 0.517 ± 9.4%
others
Trehalose 0.916 ± 2.9% 0.658 ± 3.2% 0.723 ± 2.2%
Fumaric acid 1.092 ± 14.4% 1.743 ± 24.7% 1.553 ± 28.4%
N-acetyl-L-glutamic acid 1.455 ± 2.1% 0.909 ± 5.7% 0.631 ± 5.2%
Malic acid 1.554 ± 11.1% 1.587 ± 5.8% 1.030 ± 11.8%
α-Ketoglutaric acid 2.607 ± 11.3% 3.335 ± 7.8% 1.251 ± 14.1%
Succinic acid 2.744 ± 13.0% 2.159 ± 19.4% 0.787 ± 19.3%
Pyruvic acid 5.988 ± 8.2% 9.646 ± 10.1% 1.521 ± 11.1%
Citric acid 21.904 ± 7.9% 2.806 ± 26.5% 0.129 ± 26.8%
Lactic acid 29.550 ± 24.7% 22.900 ± 24.9% 0.775 ± 14.3%
The average relative standard error of all tested methods was estimated to evaluate the
reproducibility.  The  error  of  the  unquenched  method,  which  had  been  established  for
C. glutamicum (Strelkov et al.,  2004, Börner et al.,  2007), revealed the lowest value of
14%. Nevertheless, the standard error of the ethanol quenching was only 18% whereas the
methanol quenching showed an error of 23%. This outcome indicated the best results for
ethanol quenching and the standard method. Due to the identified increased amounts of
metabolites in samples quenched with ethanol, this method obtained the best results.
Overall, 160 different metabolites were identified applying our internal library for analysis
of divers methods. Figure 51 shows the venn diagram of the distribution of the compounds
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according  to  the  methods.  Again,  the  best  result  was  achieved  for  ethanol  quenching
leading to the highest number of 151 detected metabolites. Over 80% of all metabolites
were found in all three methods.
Figure 51.  Distribution  of  the  identified  metabolites  to  the  corresponding  methods  for
C. glutamicum.
To  find  an  indication  why some metabolites  were  reduced  in  a  defined  method,  first
experiments to analyze the supernatants were performed. One problem, already mentioned
in chapter  3.3.3  for  E.  coli,  was the high amount  of  glucose in  the medium. Possibly
glucose  was  even  sticking  to  the  pellets  and  therefore  was  found  in  increased  levels
(glucose and mannose) in both quenching methods (see figure 47 and 49).  Due to two
washing steps in the unquenched standard performance, such moieties on the cells might be
removed. Nevertheless, additional washing steps caused shear stress, as could be shown in
chapter 3.3.3 for  E. coli,  and thus were omitted in the quenching performances.  In the
literature the methanol quenching of C. glutamicum was described applying an additional
washing step. Dramatic losses in the levels of amino acids and phosphorylated compounds
were the result (Wittmann et al., 2004).
However,  in  these  experiments  it  was  not  possible  to  find  such  a  high  amount  of
metabolites in the supernatant of methanol quenched samples. The lower values of 50% of
the metabolites (compared to unquenched samples) could thus not be ascribed to leakage
during quenching. Even if some metabolite concentrations might be below the detection
limit,  a lot of substances (see table 22) were reduced to such values that  detection still
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should have been possible. Nevertheless, some metabolites of the tricarboxylic acid cycle,
like fumaric acid, malic acid and succinic acid were found in the supernatant of methanol
quenched samples. Also lactic acid, pyruvic acid as well as the amino acids alanine and
glycine  were  detected.  However,  a  direct  correlation  between  the  compounds  in  the
supernatant and a possible decrease of their levels in the extracts could not be found. Some
substances  might  simply be  secreted  from the  cells,  others  might  have  been  in  higher
concentrations because of cell lysis of several cells during growth. This might be especially
the reason for metabolites of the central metabolism. They are not likely to be secreted.
Furthermore, because of their occurrence in the supernatant a clear separation of cells and
medium  during  harvesting  should  be  always  done  to  be  able  to  quantify  metabolite
amounts correctly. Newer methods using the whole broth (Canelas et al., 2008) could lead
to overestimations of the internal metabolite amounts (Bolten et al., 2007).
Glycine was detected in increased amounts in cell extracts of unquenched samples (see
table 22). Though, it was also found in four times higher amounts in the supernatant of the
corresponding samples than in ethanol quenched ones. Possibly this amino acid had been
built in high concentrations and was excreted during growth of the bacterium.
3.3.5 Quenching of Saccharomyces cerevisiae
For quenching experiments S. cerevisiae cells were cultivated as described in chapter 2.7.1.
A comparison of the different applied protocols was done. Therefore samples were always
taken together and at least in triplicates for each method (ethanol quenching, methanol
quenching and standard method without quenching).
In figure 52 the results of the ethanol quenching are shown in a scatterplot compared to the
unquenched method. Displayed are the normalized peak areas which correspond to the
relative intensities of the identified metabolites. The majority of detected metabolites had
the same values in both methods. Only few substances, for example fructose, were only
identified in ethanol quenched samples. Some compounds were found in increased levels
in quenched samples. Uracil,  3-phosphoglyceric acid and phosphoenolpyruvic acid, had
higher  concentrations  in  unquenched samples.  Overall,  ethanol  quenching worked  very
satisfying for yeast cells leading to even higher values and hardly any reduced ones. 
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Figure 52.  Scatterplot  of  ethanol  quenched  (EQ)  and  unquenched  (UQ)  samples  of
S. cerevisiae.
Additional experiments were performed to analyze whether the metabolism was stopped
after  harvesting  the  samples  for  ethanol  quenching  and  standard  method  without
quenching. Therefore, representative samples were hold on ice for 30 min before applying
the unquenched method, respectively at -8°C for 30 min before handling them according to
the ethanol quenching protocol. The result for both methods is shown in figure 53. The
comparison  of  directly  treated  unquenched  samples  and  those  stored  before  further
processing  revealed  an  ongoing  metabolism (figure 53A).  Some  metabolites  had  been
detectable in the directly prepared samples but were not identified in the samples with the
additional standing time (on the abscissa). Furthermore, histidine was only found in stored
samples (on the ordinate). Most of the metabolites were located around the 45-degree line
but the tendency showed higher concentrations of some substances in the directly handled
samples. Possibly, these substances, for example some phosphorylated compounds, were
further  converted  during  standing  time  and  thus  detected  in  lower  values  in  the  other
samples.  This  would hint  to  a  not  completely stopped  metabolism when applying  our
standard, unquenched method. Nevertheless, the calculated correlation coefficient using the
logarithmic relative concentration vectors was 0.95 ± 0.01, indicating only few changes
and confirming the before described findings.
Ethanol  quenched samples  and  those  stored  for  30 min before  further  processing were
compared and are shown in figure 53B. Nearly all metabolites were located around the 45-
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degree line. Some phosphorylated compounds were found in slightly higher concentrations
in directly prepared samples. 2-aminobutyric acid was detected in stored samples only and
was found on the ordinate.  The calculated correlation coefficient  revealed a very good
value of 0.96 ± 0.01, confirming the determination of a stopped metabolism when applying
ethanol quenching.
Figure 53.  Scatterplots  of  unquenched  (UQ)  and  ethanol  quenched  (EQ)  samples.
A unquenched samples compared to unquenched ones additionally held on ice for 30 min
and B ethanol quenched samples compared to those stored for 30 min at -8°C.
The comparison of the methanol quenching and the unquenched method revealed a similar
picture as the relation of ethanol quenching and unquenched protocol (see figure 52) had
done. The scatterplot is shown in figure 54. Most of the metabolites were spread around the
A
B
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45-degree  line.  Some compounds  like  3-phosphoglyceric  acid  and  phosphoenolpyruvic
acid were slightly increased in samples of the unquenched method. A lot of phosphorylated
compounds were identified in higher values in methanol quenched samples. Fructose and
hydroxylamine were only found in the quenched samples. The methanol method seemed to
work very efficient and produced satisfying results for this organism. Only few substances
were reduced whereas a lot of metabolites could be identified in increased levels.
Figure 54.  Scatterplot  of  methanol  quenched  (MQ)  and  unquenched  (UQ)  samples  of
S. cerevisiae.
In order to estimate which of the both tested quenching methods worked best, they were
directly compared (figure 55). Most of the metabolites showed the same concentration in
both methods. Hydroxylamine was only identified in methanol quenched samples. Some
substances,  for  example  some  phosphorylated  compounds,  were  slightly  increased  in
samples quenched with methanol. Other compounds like cysteine and pyruvic acid were
slightly higher concentrated after ethanol quenching. The scatterplot confirmed a similar
result  after  quenching  for  both  methods  which  was  only  slightly  differing  for  a  few
metabolites.
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Figure 55. Scatterplot of methanol quenched (MQ) and ethanol quenched (EQ) samples of
S. cerevisiae.
A direct  overview  regarding  the  relative  concentration  ratios  of  some  representative
compounds of  the identified metabolites  for  all  three methods is  shown in table 23. In
contrast to the other tested organisms, the results for all performances did not so much
differ for yeast. About 64% of all identified metabolites showed increased concentrations
in samples quenched with ethanol when compared to the unquenched ones.  In  samples
quenched with methanol still 58% of the detected metabolites revealed higher values than
in  unquenched  samples.  The  direct  comparison  of  both  quenching  methods  gave  an
increased  level  for  60%  of  the  metabolites  in  ethanol  quenched  samples.  This  again
indicated a very similar performance of both quenching methods, but also a slightly better
result for samples quenched with the performance that was improved in this study.
Table 23.  Comparison  of  the  relative  concentrations  of  some  identified  amino  acids,
phosphorylated compounds and other metabolites in  S. cerevisiae applying the different
procedures.
Metabolite Ratio EQ to UQ Ratio MQ to UQ Ratio MQ to EQ
amino acids
Leucine 0.715 ± 6.3% 0.612 ± 7.9% 0.832 ± 14.3%
Proline 0.767 ± 3.0% 0.661 ± 5.9% 0.874 ± 6.9%
Valine 0.874 ± 2.0% 0.825 ± 5.1% 0.946 ± 5.3%
Phenylalanine 0.878 ± 6.5% 0.94  ± 8.3% 1.070 ± 5.4%
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Metabolite Ratio EQ to UQ Ratio MQ to UQ Ratio MQ to EQ
Tyrosine 0.999 ± 4.5% 0.952 ± 4.9% 0.950 ± 3.5%
Alanine 1.035 ± 4.4% 0.916 ± 6.3% 0.889 ± 5.0%
Threonine 1.083 ± 1.9% 1.016 ± 4.7% 0.936 ± 4.3%
Lysine 1.132 ± 8.7% 1.060 ± 9.6% 0.925 ± 4.9%
Glutamic acid 1.148 ± 5.8% 1.089 ± 6.2% 0.930 ± 3.8%
Glutamine 1.238 ± 14.9% 0.846 ± 19.9% 0.683 ± 15.8%
Aspartic acid 1.455 ± 15.2% 1.147 ± 9.7% 0.817 ± 3.3%
Serine 1.517 ± 6.7% 1.483 ± 18.6% 0.960 ± 10.9%
Tryptophan 1.585 ± 25.3% 1.511 ± 25.7% 0.937 ± 4.0%
phosphorylated compounds
3-Phosphoglyceric acid 0.078 ± 1.3% 0.111 ± 1.6% 1.414 ± 30.5%
Erythrose-4-phosphate 0.905 ± 5.2% 0.956 ± 7.0% 1.068 ± 10.4%
Glycerol-3-phosphate 0.922 ± 3.2% 1.116 ± 14.5% 1.261 ± 19.4%
Xylulose-5-phosphate 0.984 ± 5.0% 1.380 ± 15.9% 1.445 ± 19.7%
Ribulose-5-phosphate 1.010 ± 4.9% 1.508 ± 15.8% 1.562 ± 18.3%
others
Succinic acid 0.619 ± 2.5% 0.585 ± 4.4% 0.966 ± 6.3%
Fumaric acid 0.758 ± 3.0% 1.023 ± 7.1% 1.351 ± 8.1%
Malic acid 0.847 ± 1.4% 0.626 ± 3.3% 0.740 ± 3.7%
Lactic acid 1.026 ± 4.4% 0.862 ± 6.4% 0.847 ± 5.4%
Citric acid 1.399 ± 7.8% 1.322 ± 14.6% 0.922 ± 8.1%
Pyruvic acid 2.047 ± 32.4% 0.695 ± 28.5% 0.458 ± 11.4%
Applying  our  internal  standard  library,  altogether  152  metabolites  were  identified  for
S. cerevisiae when testing the different quenching methods. The distribution is shown in a
venn diagram in figure 56. Only slightly differing numbers of metabolites were detected in
the different samples.  Nearly 97% of all found metabolites were detectable in all three
methods. For the ethanol quenching performance the lowest average standard error of 10%
was obtained.  The methanol  method led  to  an  error  of  17%,  whereas  the unquenched
performance reached a standard error of 16%. 
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Figure 56.  Distribution  of  the  identified  metabolites  to  the  corresponding  methods  for
S. cerevisiae.
Some experiments to analyze the supernatants were performed. Again, the difficulty was
the high amount of glucose in the medium. Increased levels of identified glucose in both
quenching methods (see figure 52 and 54) already indicated this issue. Only metabolites
from the central metabolism, for example pyruvic acid, lactic acid and oxalic acid, were in
the supernatants. But these compounds additionally showed increased concentrations in the
corresponding cell  extracts.  Therefore,  they were  likely derived  from cell  lysis  during
growth rather than from cell leakage during quenching. Increased levels of amino acids or
phosphorylated compounds could not be detected. In fact, higher values of the latter ones
found in the extracts of the quenched samples (see figure 52 and 54) indicated a proper
quenching of the metabolism, whereas these compounds were further converted and thus
reduced in the unquenched ones.
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4 Summary
For a comprehensive metabolome analysis of microorganisms, a high-throughput method
for metabolome analysis using gas chromatography coupled to mass spectrometry had been
developed. As model organism the fast growing bacterium Corynebacterium glutamicum
was used. The established method combined multiparallel growth in micro titer plates and
a semi-automated pre-analytical  sample preparation. Despite  the significantly decreased
culture  volume,  metabolome  analysis  was  successfully  performed.  Due  to  the  semi-
automation a time efficiency for the pre-analytical steps by a factor of 15 could be achieved
in the high-throughput method compared to the standard method. Additionally, the standard
error  of  the  analysis  was  reduced  as  well.  It  decreased  from  25%  in  the  standard
performance to 13%. Furthermore, with the shortened GC/MS run and an adapted library it
was possible to measure around 72 single samples per day and machine - which was four
times more than with standard runs - and still identify a high number of metabolites. The
high reproducibility of this established method was proven with a very high correlation
coefficient of independent wild type samples of 0.99 ± 0.01.
The development of such a reliable high-throughput method was the prerequisite for the
screening of a large transposon mutant collection for the identification of mutants with an
altered metabolome. For the identification of suitable screening criteria a pilot project with
around 320 randomly selected and representative transposon mutants was performed. In
first  instance  mutant  samples  were  compared  to  the  wild  type  raised  under  the  same
conditions together with the mutant on the same plate. This led to the identification of first
differences.  Nevertheless,  it  was  not  possible  to  distinguish  between  changes  directly
caused by the genetic perturbation and those resulting from biological and environmental
variance. Thus, a reference list was generated combining all the information from wild type
samples of different cultivations and operators. The list represented the native wild type
state.  Comparison  of  the  single  wild  type  samples  and  this  reference  list  revealed
significant  differences  due  to  biological  and  environmental  changes  but  also  from
performance variations  (especially the GC/MS machine).  Moreover,  directly comparing
this reference list against the mutants changes due to the genetic modification were found
and interesting phenotypes identified.  With the calculated threshold for each metabolite
significant  changes in  compound levels  were  revealed.  The investigation  of  the ten  to
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twenty most abundant substances of a sample and the method of hierarchical clustering
gave further indications of possibly affected pathways. Further information was obtained
after identification of the insertion site of the transposon. A correlation of the disrupted
gene and the derived phenotype could be performed. 
In  parallel  to  the  development  and the  evaluation of  the  high-throughput  screening  of
transposon mutants from Corynebacterium glutamicum research was done on the field of
quenching  of  microorganism.  To stop the  metabolome in  the  moment  of  harvesting is
especially important, if, for example, different growth conditions have to be investigated.
The  differences  might  be  very  small  and  any  changes  could  be  overwhelmed  by  an
unquenched metabolism. Thus, a quenching performance that was established in our group
which  used a  cold ethanol  solution was  optimized  and  evaluated  using three  different
microorganisms:  Corynebacterium  glutamicum,  Escherichia  coli  and Saccharomyces
cerevisiae. For comparison, our standard method was used as unquenched control method,
and also two published quenching methods were applied whereof only one revealed useful
results.  With  the  new  developed  method  improved  results  could  be  achieved  for  all
organisms.  The  number  of  identified  metabolites  as  well  as  the  detected  relative
concentrations were mostly the highest combined with a low standard error. Furthermore,
the completely stopped metabolism could be confirmed when applying ethanol quenching.
The correlation coefficients of samples stored for 30 minutes under quenched conditions
and those directly handled after quenching reached high values of 0.94...0.96 depending on
the organism. The most striking results in this test were revealed for  E. coli. As Gram-
negative organism it is at high risk for cell leakage. Nevertheless, applying our quenching
performance, no leakage was found.
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5 Outlook
The developed high-throughput metabolome analysis and the established screening criteria
can be used for an investigation of the whole transposon mutant bank of Corynebacterium
glutamicum. It can also be applied on other microorganisms. The prerequisite is a growth
of  the  organism  to  high  optical  densities  and  a  well  established  standard  library  for
identification of the metabolites.
The information from such a screening combined with those of the identified disrupted
gene will provide a deeper understanding of the gene function. Furthermore, novel gene
functions might be obtained. Therefore, this protocol can be applied to close existing gaps
in pathways and can in the end create a complete overview about all enzymes present in the
organism. 
Using  all  the  information  about  the  different  phenotypes,  accumulations  in  desired
pathways  can  easily  be  found.  The  relation  to  the  disrupted  gene  can  lead  to  new
conclusions and interesting observations in regulations.
The developed ethanol quenching protocol can be used for the investigation of different
growth conditions of microorganisms. Especially interesting might be the differentiation of
the growth phases. Variations after cultivation on different carbon and nitrogen sources can
also be investigated. 
A refinement  of  the  quenching method could  possibly be the variation of  the ratio  of
culture and quenching solution. The high amount of sugar detected in quenched extracts
might be from medium moieties and could possibly be removed this way.
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7 Appendix
Table A. Library 3.4.0, comparison of the retention times for a 60 min run and a 18 min run
Derivative RI in 60 min run RI in 18 min run Abs. differenz 
!1-Cyclohexenol_1TMS 1051.0 1057.8 6.8 
!2-Hydroxypyridine_TMS 1032.4 1041.1 8.7 
!Carbonic_acid_
1MeOX_2TMS
1144.3 1138.9 5.4 
!Cyclohexanol_TMS 1003.1 1011.4 8.3
!Decane 1000.0 1000.0 -
!Decanol_TMS 1388.4 1388.7 0.3
!Dicyclohexyl 1313.1 1314.6 1.5
!Docosane 2200.0 2200.0 -
!Docosanol_1TMS 2565.8 2568.2 2.4
!Dodecane 1200.0 1200.0 -
!Dodecanol_1TMS 1573.6 1558.2 15.4
!Dotriacontane 3200.0 3200.0 -
!Nonadecane 1900.0 1900.0 -
!Nonanol_1TMS 1293.9 1295.7 1.8
!Octacosane 2800.0 2800.0 -
!Pentadecane 1500.0 1500.0 -
!Pentadecanol_TMS 1867.3 1871.7 4.4
!Phosphate_3TMS 1278.2 1263.5 14.7
!Phosphate_mono-
methylester_2TMS
1177.5 1180.6 3.1
!Ribitol_5TMS 1727.1 1708.5 18.6
#!Octamethyltrisiloxane 1072.4 977.9 94.5
#1,2,3-Benzenetriol_3TMS 1600.1 1591.6 8.5
#2,4,5,6-
Tetrahydroxypyrimidine 
1752.3 1754.8 2.5
#2-Deoxyarabinose_3TMS 1488.8 1487.5 1.3
#3-Hydroxy-
decanoic_acid_2TMS 
1659.8 1660.7 0.9
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
#5-Chlorouracil_2TMS 1457.0 1456.2 0.8
#Alloxanic_acid_4TMS 1677.2 1689.7 12.5
#Aminomalonic_acid_3TMS 1466.2 1468.7 2.5
#Dodecanoic_acid_1TMS 1660.5 1647.9 12.6
#N-Carboxyhydroxyl-
amine_2TMS 
1188.6 1191.3 2.7
#Octadecanoic_acid_1TMS 2236.6 2236.5 0.1
#Pantothenic_acid_(deriv)_3T
MS
1982.5 1967.4 15.1
#trans-9-
Hexadecenoic_acid_1TMS
2021.1 2028.4 7.3
1,3-Diphosphoglyceric_acid 2674.0 2674.1 0.1
1,6-Anhydro-beta-D-
glucose_3TMS 
1705.1 1691.8 13.3
1-Monooleoyl-glycerol_2TMS 2757.9 2734.0 23.9
1-Monopalmitoyl-
glycerol_2TMS
2600.6 2574.9 25.7
1-Monostearoyl- glycerol_2T
MS
2780.5 2773.1 7.4
2,6-Diaminopimelic_
acid_4TMS
1990.8 1962.3 28.5
 2-Aminobenzoic_ acid_1TMS 1483.9 1482.7 1.2
2-Aminobenzoic_ acid_2TMS 1617.9 1618.1 0.2
2-Aminobutyric_
acid_1_2TMS
1174.2 1166.3 7.9
2-Aminobutyric_
acid_2_2TMS
1430.8 1430.4 0.4
2-Deoxy-D-
glucose_1_1MeOX_4TMS
1794.6 1797.8 3.2
2-Deoxy-D-
glucose_2_1MeOX_4TMS 
1797.8 1801.0 3.2
2-Deoxyribose_1 1582.9 1582.4 0.5
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
2-Deoxyribose_2 1586.5 1586.1 0.4
2-Hydroxybutanoic_
acid_2TMS
1130.4 1130.7 0.3
2-Hydroxyglutaric_
acid_3TMS
1574.7 1556.1 18.6
2-Ketoglutaric_
acid_1MeOX_2TMS 
1581.2 1558.2 23.0
2-Monooleoyl-glycerol_2TMS 2725.0 2739.8 14.8
2-Phosphoglyceric_
acid_4TMS
1793.2 1756.4 36.8
3,4-Dihydroxy-benzoic_acid 1821.5 1825.2 3.7
3-Amino-2-piperidone_2TMS 1459.0 1458.2 0.8
3-Dehydroshikimate_
3TMS_1MeOX 
1800.6 1803.9 3.3 
3-Hydroxybutyric_
acid_2TMS
1163.2 1161.1 2.1
3-Indoleacetonitrile_
(TRP)_1TMS
1868.0 1872.5 4.5
3-OH-2-tetradecyl-
octanoate_2TMS
3478.5 3441.0 37.5
3-Phosphoglyceraldehyde_1 1719.1 1721.0 1.9
3-Phosphoglyceraldehyde_2 1734.3 1736.5 2.2
3-Phosphoglyceric_
acid_4TMS
1811.0 1785.7 25.3
4-Aminobenzoic_ acid_1TMS 1651.7 1652.5 0.7
4-Aminobenzoic_ acid_2TMS 1833.7 1837.6 3.9
4-OH-phenyl-
pyruvate_1MeOX_2TMS
1904.0 1910.2 6.2
5-Aminolevulinate_
1_1MeOX_3TMS 
1766.1 1768.8 2.7
5-Aminolevulinate_
2_1MeOX_3TMS
1788.7 1791.8 3.1
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
5'-Methylthio-
adenosine_2TMS
2731.2 2736.9 5.7
5'-Methylthio-
adenosine_3TMS
2782.6 2777.4 5.2
5-Oxoproline_1TMS 1499.6 1494.9 4.7
5-Oxoproline_2TMS 1518.1 1510.2 7.9
9-Octadecenal_(Z) 1999.8 2006.9 7.1
Adenine_2TMS 1869.1 1860.8 8.3
Adenosine_3TMS 2594.7 2592.3 2.4
Adenosine_4TMS 2639.7 2621.2 18.5
Adenosine-mono-
phosphate_1_4TMS 
3047.9 3081.3 33.4
Adenosine-mono-
phosphate_2_5TMS
3061.8 3023.0 38.8
Adipic_acid_2TMS 1506.3 1504.5 1.8
Alanine_2TMS 1106.8 1104.3 2.5
Alanine_3TMS 1362.9 1357.1 5.8
Arabinose_1_1MeOX_ 4TMS 1669.6 1670.4 0.8
Arabinose_2_1MeOX_ 4TMS 1671.7 1661.4 10.3
Asparagine_3TMS 1681.0 1682.2 1.2
Asparagine_4TMS 1634.1 1634.5 0.4
Asparagine_xTMS 1588.3 1587.9 0.4
Aspartic_acid_2TMS 1431.9 1416.1 15.8
Aspartic_acid_3TMS 1520.9 1499.8 21.1
Aspartic_acid_4TMS 1602.4 1602.3 0.1
Benzoic_acid_1TMS 1249.7 1248.7 1.0
beta-Alanine_1TMS 1008.7 1016.8 8.1
beta-Alanine_2TMS 1191.2 1185.3 5.9
beta-Alanine_3TMS 1431.3 1421.1 10.2
Cadaverine_2TMS 1444.2 1443.6 0.6
Cadaverine_4TMS 1833.1 1837.0 3.9
Chorismic_acid_(assumed)_
TMS
1887.9 1892.7 4.8
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
cis-Aconitat_3TMS 1756.7 1759.2 2.5
Citric_acid_4TMS 1825.5 1798.2 27.3
Creatinine_3TMS 1552.9 1551.9 1.0
Cycloleucine_2TMS 1191.5 1194.1 2.6 
Cycloleucine_3TMS 1373.7 1512.3 138.6
Cystathionine_4TMS 2206.2 2216.2 10.0
Cysteine_1_xMeOX_xTMS 1316.0 1317.4 1.4
Cysteine_2_xMeOX_xTMS 1606.5 1606.5 0.0
Cysteine_3_xMeOX_xTMS 1881.9 1886.6 4.7
Cysteine_3TMS 1563.0 1562.2 0.8
Cysteine_4TMS 1421.7 1421.5 0.2
Cytosin_2TMS 1523.1 1524.2 1.1
Diethylenglycol_2TMS 1248.0 1242.3 5.7
Dihydroorotic_acid_3TMS 1770.9 1773.7 2.8
Dihydroxyacetone_2TMS 1227.3 1230.1 2.8
Eicosanol_TMS 2365.8 2372.4 6.6
Erythritol_4TMS 1509.2 1873.3 364.1
Erythrose-4-phos_
1_1MeOX_4TMS
1903.2 1905.7 2.5
Erythrose-4-phos_
2_1MeOX_4TMS
1918.7 1908.2 10.5
Fructose_1_1MeOX_5TMS 1869.2 1858.0 11.2
Fructose_2_1MeOX_5TMS 1878.8 1867.6 11.2
Fructose_3-TMS_5TMS 1804.3 1800.3 4.0
Fructose_4-TMS_5TMS 1816.6 1848.3 31.7
Fructose-1,6-bisP_
1_1MeOX_7TMS
2677.9 2682.0 4.1
Fructose-1,6-bisP_
2_1MeOX_7TMS
2724.3 2705.0 19.3
Fructose-1,6-bis-
phosphate_7TMS
2677.9 2644.4 33.5
Fructose-6-phosphate_
1MeOX_5TMS
2310.3 2294.3 16.0
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Fucose_1_1MeOX_4TMS 1731.5 1733.6 2.1
Fucose_2_1MeOX_4TMS 1743.1 1745.4 2.3
Fumaric_acid_2TMS 1362.4 1343.9 18.5
Galactosamine_5TMS 1938.5 1945.0 6.5
Galactosamine_6TMS 1875.1 1879.7 4.6
Galactosamine_ MeOX_6TMS 1954.1 1960.8 6.7
Galactosamine_ MeOX_7TMS 1930.5 1937.0 6.5
Galacturonic_acid_1_
1MeOX_5TMS
1938.4 1944.9 6.5
Galacturonic_acid_2_
1MeOX_5TMS
1956.0 1962.7 6.7
gamma-Glutamyl-
leucine_2TMS
2183.9 2178.4 5.5
gamma-Glutamyl-
leucine_3TMS
2220.5 2210.4 10.1
gamma-Glutamyl-
leucine_4TMS
2112.3 2120.5 8.2
gamma-Glutamyl-
valine_2TMS
2135.2 2126.9 8.3
gamma-Glutamyl-
valine_3TMS
2174.7 2165.5 9.2
gamma-Glutamyl-
valine_4TMS
2076.2 2052.3 23.9
Glucono_lactone_4TMS 1886.2 1875.0 11.2
Glucono_lactone_xTMS 1892.6 1881.3 11.3
Glucono-1,4-lactone_
1MeOX_3TMS
1894.2 1899.1 4.9
Glucosamine_1 1913.5 1919.8 6.3
Glucosamine_2 1937.8 1944.3 6.5
Glucosamine_3 1950.1 1956.7 6.6
Glucosamine-6-phos_
1_1MeOX_6TMS
2359.7 2355.1 4.6
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Glucosamine-6-phos_
2_1MeOX_6TMS
2366.7 2352.2 14.5
Glucose_1_1MeOX_5TMS 1891.8 1869.1 22.7
Glucose_1-TMS_5TMS 1889.4 1878.2 11.2
Glucose_2_1MeOX_5TMS 1910.0 1885.8 24.2
Glucose_2-TMS_5TMS 1981.6 1959.7 21.9
Glucose-6-phosphate1
_1MeOX_6TMS 
2323.4 2300.1 23.3
Glucose-6-phosphate2
_1MeOX_6TMS 
2340.2 2323.2 17.0
Glucose-6-phosphate3 _6TMS 2396.4 2404.2 7.8
Glutamic_acid_2TMS 1532.7 1518.6 14.1
Glutamic_acid_3TMS 1628.5 1610.4 18.1
Glutamic_acid_methyl-
ester_2TMS 
1510.2 1508.5 1.7
Glutamine_3TMS 1778.4 1762.7 15.7
Glutamine_4TMS 1738.4 1721.0 17.4
Glutaric_acid_2TMS 1413.7 1406.5 7.2
Glyceraldehyde_1 1207.0 1210.2 3.2
Glyceraldehyde_2 1224.5 1227.4 2.9
Glyceric_acid_3TMS 1343.4 1321.0 22.4
Glycerol_3TMS 1282.1 1261.9 20.2
Glycerol-2-phosphate_4TMS 1732.4 1727.2 5.2
Glycerol-3-phosphate_4TMS 1767.8 1741.8 26.0
Glycerone_phosphate1_
1MeOX_3TMS 
1753.9 1756.4 2.5
Glycerone_phosphate2_
1MeOX_3TMS 
1764.8 1767.5 2.7
Glycine_2TMS 1126.6 1123.4 3.2
Glycine_3TMS 1313.8 1302.9 10.9
Glycolic_acid_2TMS 1083.0 1076.9 6.1
Guanidine_4TMS 1233.5 1236.3 2.8
Guanine_3TMS 2135.0 2143.4 8.4
7  Appendix 149
Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Heneicosanol_1TMS 2468.6 2473.0 4.4
Heptadecanol_TMS 2062.9 2070.6 7.7
Hexadec-9-enal 1958.0 1964.7 6.7 
Hexadecanal 1876.4 1881.0 4.6
Hexadecanoic_acid_1TMS 2047.1 2036.9 10.2
Hexadecanol_1TMS 1964.0 2407.1 443.1
Hexanoic_acid_1MeOX 1296.4 1298.2 1.8
Histidine_3TMS 1915.6 1921.9 6.3
Homocysteine_3TMS 1669.3 1668.8 0.5
Homoserine_2TMS 1368.7 1352.1 16.6
Homoserine_3TMS 1453.0 1435.8 17.2
Hydroxylamine_3TMS 1114.8 1116.2 1.4
Hypoxanthine_2TMS 1811.5 1862.9 51.4
Indolepyruvic_acid_1_
1MeOX_2TMS 
2135.9 2144.2 8.4
Indolepyruvic_acid_2_
1MeOX_2TMS 
2200.6 2210.7 10.1
Inosine_4TMS 2582.4 2584.4 2.0
Inositol_6TMS 2086.3 2094.2 7.9
Isocitric_acid_4TMS 1831.0 1834.8 3.8
Isoleucine_2TMS 1296.3 1288.1 8.2
Isoleucine_xTMS 1176.0 1175.8 0.2
Isomaltose_1_1MeOX_ 8TMS 2870.5 2878.2 7.7
Isomaltose_2_1MeOX_ 8TMS 2900.7 2848.2 52.5
Lactic_acid_2TMS 1 062.9 1061.4 1.5
Lactose_1_1MeOX_8TMS 2692.8 2684.9 7.9
Lactose_2_1MeOX_8TMS 2706.9 2693.5 13.4
Lactyllactat_2TMS 1396.1 1391.6 4.5
Leucine_2TMS 1274.1 1265.2 8.9 
Lysine_3TMS 1849.9 1844.1 5.8 
Lysine_4TMS 1918.1 1898.3 19.8
Lyxose_1_1MeOX_4TMS 1654.7 1655.5 0.8
Lyxose_2_1MeOX_4TMS 1668.7 1658.4 10.3
150 7  Appendix
Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Maleic_acid_2TMS 1312.4 1313.9 1.5
Malic_acid_3TMS 1488.3 1468.7 19.6
Malic_acid-1-
methylester_2TMS 
1396.1 1396.3 0.2 
Malic_acid-4-
methylester_2TMS 
1375.5 1376.0 0.5
Malonic_acid_2TMS 1202.5 1205.9 3.4
Maltose_1_1MeOX_8TMS 2736.3 2710.9 25.4
Maltose_2_1MeOX_8TMS 2760.2 2713.8 46.4
Maltotriose_1_1MeOX_
11TMS 
 3541.2 0.4
Maltotriose_2_1MeOX_
11TMS 
3570.3 3570.2 0.1
Mannitol_6TMS 1925.5 1944.3 18.8
Mannose_1_1MeOX_5TMS 1883.1 1869.1 14.0
Mannose_2_1MeOX_5TMS 1894.6 1890.0 4.6
Mannose-6-phosphate1
_1MeOX_6TMS 
2324.5 2300.1 24.4
Mannose-6-phosphate2
_1MeOX_6TMS 
2333.6 2346.4 12.8
Methionine_2TMS 1520.2 1517.6 2.6
Methionine_xTMS 1413.7 1412.9 0.8
Myristic_acid_amide 1974.2 1981.1 6.9
Myristic_acid_amide_1TMS 2043.5 2051.0 7.5
N-Acetylalanine_1TMS 1268.5 1270.7 2.2
N-Acetylglucosamine1_
1MeOX_4TMS 
2069.0 2065.2 3.8
N-Acetylglucos-amine2_
1MeOX_4TMS 
2077.0 2084.8 7.8
N-Acetyl-L-glutamic _acid_
2TMS 
1788.4 1771.0 17.4
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
N-Acetyl-L-glutamic_acid_
3TMS
1766.1 1755.7 10.4
N-Acetyl-L-glutamine_ 2TMS 1931.7 1916.0 15.7 
N-Acetyl-L-glutamine _3TMS 1910.1 1916.4 6.3
N-Acetyl-L-glutamine _4TMS 1862.4 1866.8 4.4
N-Acetylmannos-amine1
_1MeOX_4TMS 
2074.8 2082.7 7.8
N-Acetylmannos-amine2
_1MeOX_4TMS 
2087.4 2095.4 7.9
N-Acetylneuraminic_acid_1 2628.7 2629.7 1.0 
N-Acetylneuraminic_acid_2 2666.1 2666.3 0.2
N-Ac-glucosamine-6-P
_1MeOX_5TMS 
1990.6 1997.6 7.0
n-Butylamine_2TMS 1106.5 1111.7 5.2
Nicotinamide_1TMS 1482.3 1480.1 2.2
Nicotinamide_xTMS 1472.1 1471.1 1.0
Nicotinic_acid_1TMS 1300.3 1302.9 2.6
Norleucine_2TMS 1329.0 1284.8 44.2
Norleucine_3TMS 1548.5 1547.5 1.0
Norvaline_1TMS 1116.7 1121.6 4.9
Norvaline_2TMS 1244.0 1201.1 42.9
Norvaline_3TMS 1478.5 1477.4 1.1
O-Acetyl-serine_2TMS 1402.1 1385.0 17.1
Octadecanal 2025.1 2032.5 7.4
Octadecanol_TMS 2161.5 2163.9 2.4
Octanol_TMS 1186.8 1189.6 2.8 
Oleic_acid_amide 2370.1 2376.6 6.5
Ornithine_1_4TMS 1817.5 1816.5 1.0
Ornithine_2_4TMS 1761.0 1763.6 2.6
Ornithine_3_5TMS 2039.5 2047.0 7.5
Ornithine_4_3TMS 8 1621. 1622.0 0.2
Orotic_acid_3TMS 1751.4 1753.8 2.4
Oxalic_acid_2TMS 1139.3 1137.7 1.6
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Oxaloacetic_acid_1MeOX
_2TMS 
1475.7 1474.6 1.1
Palmitic_acid_amide 2177.0 2185.8 8.8
Palmitic_acid_amide_1TMS 2240.1 2249.4 9.3
Phenylalanine_1TMS 1545.8 1545.7 0.1
Phenylalanine_2TMS 1629.4 1625.0 4.4
Phenylpyruvic_acid_1 1522.6 1521.1 1.5
Phenylpyruvic_acid_2 1591.0 1590.7 0.3
Phosphoenolpyruvic_acid
_3TMS 
1599.2 1583.3 15.9
Phosphoethanolamine _4TMS 1787.0 1790.1 3.1
Prephenic_acid_3TMS_
1MeOX 
2083.4 2091.3 7.9
Proline_1TMS 1172.7 1175.8 3.1
Proline_2TMS 1302.3 1296.3 6.0
Pyridoxine_3TMS 1888.3 1893.1 4.8 
Pyrophosphoric_acid_4TMS 1669.4 1645.9 23.5
Pyrrole-2-carboxylic
_acid_2TMS 
1356.6 1357.4 0.8
Pyruvic_acid_1MeOX_ 1TMS 1055.7 1070.9 15.2
Pyruvic_acid_2TMS 1091.9 1625.0 533.1
Quebrachitol_5TMS 1859.1 1863.4 4.3
Quinic_acid_5TMS 1855.7 1835.7 20.0
Rhamnose_1 1723.7 1725.7 2.0
Rhamnose_2 1729.4 1731.5 2.1
Ribose_1MeOX_4TMS 1685.7 1675.4 10.3
Ribose-5-
phosphate_1MeOX_5TMS 
2112.0 2297.2 185.2
Ribulose-5-phos_1_
1MeOX_5TMS 
2101.7 2109.0 7.3
Ribulose-5-phos_2_
1MeOX_5TMS 
 2118.6 1746.0 372.6
Ribulose-5-phos_5TMS 2116.0 2317.5 201.5
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Sarcosine_2TMS 1140.0 1106.7 33.3
Sarcosine_xTMS 1387.0 1379.9 7.1
Serine_2TMS 1258.2 1248.7 9.5
Serine_3TMS 1368.7 1350.5 18.2
Serine_4TMS 1570.9 1570.2 0.7
Shikimic_acid_4TMS 1815.3 1818.8 3.5
Sorbitol_6TMS 1932.1 1938.6 6.5 
Spermidine_4TMS 2187.4 2196.3 8.9
Spermine_5TMS 2747.9 2746.4 1.5
Succinic_acid_2TMS 1325.4 1309.5 15.9
Succinic_acid_methylester_
1TMS 
1179.3 1173.4 5.9
Succinyllactate_2TMS 1649.9 1650.6 0.7
Sucrose_8TMS 2643.6 2648.5 4.9
Tartaric_acid_4TMS 1648.0 1648.7 0.7
Tetradecanol_1TMS 1773.8 1758.5 15.3
Threonine_2TMS 1297.4 1289.8 7.6
Threonine_3TMS 1392.6 1375.1 17.5
Thymidine-mono-
phosphate_3TMS 
2824.9 2882.6 57.7
Thymine_2TMS 1408.4 1396.4 12.0
Trehalose_8TMS 2741.2 2736.9 4.3
Trehalose_phosphate_9TMS 3192.8 3201.6 8.8
Tricarballylic_acid_3TMS 1740.3 1742.6 2.3
Tridecanol_TMS 1677.2 1678.4 1.2
Triethanolamin_3TMS 1637.1 1637.6 0.5
Tryptophane_1_1TMS 2157.9 2166.5 8.6
Tryptophane_2_2TMS 2181.8 2190.6 8.8
Tryptophane_3_(1xRing)_
2TMS 
2189.8 2210.4 20.6
Tryptophane_4_3TMS 2203.1 2216.2 13.1
Tyrosine_2TMS 1882.5 1877.5 5.0
Tyrosine_3TMS 1939.8 1921.1 18.7
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Unknown#bth_pae_002 1655.5 1656.3 0.8
Unknown#bth_pae_003 2056.2 2063.8 7.6
Unknown#bth_pae_004 1156.5 1160.2 3.7
Unknown#bth_pae_005 2183.1 2191.9 8.8
Unknown#bth_pae_007 1017.3 1025.1 7.8
Unknown#bth_pae_008 1031.8 1184.1 152.3
Unknown#bth_pae_009 1067.1 1063.8 3.3
Unknown#bth_pae_010 1131.8 1136.2 4.4
Unknown#bth_pae_011 1158.5 1162.1 3.6
Unknown#bth_pae_012 1161.8 1158.7 3.1
Unknown#bth_pae_013 1169.8 1157.9 11.9
Unknown#bth_pae_014 1178.4 1181.4 3.0
Unknown#bth_pae_015 1194.7 1190.3 4.4
Unknown#bth_pae_016 1241.6 1235.0 6.6
Unknown#bth_pae_017 1246.4 1232.3 14.1
Unknown#bth_pae_018 1268.2 1270.4 2.2
Unknown#bth_pae_019 1282.2 1284.2 2.0
Unknown#bth_pae_020 1329.3 1330.5 1.2
Unknown#bth_pae_021 1333.9 1330.8 3.1
Unknown#bth_pae_022 1371.4 1396.4 25.0
Unknown#bth_pae_023 1375.4 1365.3 10.1
Unknown#bth_pae_024 1385.3 1375.1 10.2
Unknown#bth_pae_025 1411.4 1411.3 0.1
Unknown#bth_pae_026 1412.7 1398.1 14.6
Unknown#bth_pae_027 1414.0 1413.9 0.1
Unknown#bth_pae_028 1422.0 1421.8 0.2
Unknown#bth_pae_029 1424.5 1424.2 0.3
Unknown#bth_pae_030 1454.4 1453.6 0.8
Unknown#bth_pae_031 1472.5 1471.5 1.0
Unknown#bth_pae_032 1505.1 1493.3 11.8
Unknown#bth_pae_033 1515.8 1499.8 16.0
Unknown#bth_pae_034 1524.1 1522.6 1.5
Unknown#bth_pae_035 1530.4 1529.0 1.4
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Unknown#bth_pae_036 1549.1 1548.1 1.0
Unknown#bth_pae_037 1554.3 1553.4 0.9
Unknown#bth_pae_038 1567.3 1562.4 4.9
Unknown#bth_pae_039 1586.9 1748.1 161.2 
Unknown#bth_pae_040 1593.5 1593.7 0.2
Unknown#bth_pae_041 1596.1 1595.9 0.2
Unknown#bth_pae_042 1630.4 1630.8 0.4
Unknown#bth_pae_043 1641.9 1642.5 0.6
Unknown#bth_pae_044 1643.0 1581.2 61.8
Unknown#bth_pae_045 1647.7 1648.4 0.7
Unknown#bth_pae_046 1649.4 1650.1 0.7
Unknown#bth_pae_047 1667.9 1668.9 1.0
Unknown#bth_pae_048 1681.6 1682.8 1.2
Unknown#bth_pae_049 1702.4 1704.0 1.6
Unknown#bth_pae_050 1703.1 1704.7 1.6
Unknown#bth_pae_051 1707.3 1709.0 1.7
Unknown#bth_pae_052 1735.4 1737.6 2.2
Unknown#bth_pae_053 1736.3 1725.7 10.6
Unknown#bth_pae_054 1740.7 1743.0 2.3
Unknown#bth_pae_055 1754.4 1756.9 2.5
Unknown#bth_pae_056 1768.1 1752.3 15.8
Unknown#bth_pae_057 1777.8 1762.7 15.1
Unknown#bth_pae_058 1991.9 1998.9 7.0
Unknown#sst_cgl_002 1116.2 1121.1 4.9 
Unknown#sst_cgl_003 1150.5 1154.4 3.9
Unknown#sst_cgl_004 1193.1 1195.7 2.6
Unknown#sst_cgl_006 1231.2 1785.7 554.5
Unknown#sst_cgl_008 1248.7 1230.7 18.0
Unknown#sst_cgl_009 1250.2 1245.5 4.7
Unknown#sst_cgl_010a 1254.8 1248.2 6.6
Unknown#sst_cgl_011 1259.5 1249.6 9.9
Unknown#sst_cgl_012 1264.8 1197.7 67.1
Unknown#sst_cgl_014 1285.9 1287.8 1.9
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Unknown#sst_cgl_015 1291.6 1284.8 6.8
Unknown#sst_cgl_020 1401.8 1401.9 0.1
Unknown#sst_cgl_022 1410.5 1388.2 22.3
Unknown#sst_cgl_023 1411.8 1411.7 0.1
Unknown#sst_cgl_024 1438.6 1431.3 7.3
Unknown#sst_cgl_026 1460.2 1459.4 0.8
Unknown#sst_cgl_027 1470.1 1457.2 12.9
Unknown#sst_cgl_028 1478.9 1477.8 1.1
Unknown#sst_cgl_029 1482.3 1481.1 1.2
Unknown#sst_cgl_030 1493.1 1476.9 16.2
Unknown#sst_cgl_033 1551.1 1533.2 17.9
Unknown#sst_cgl_035 1587.3 1574.9 12.4
Unknown#sst_cgl_036 1590.9 1595.1 4.2 
Unknown#sst_cgl_037 1601.4 1601.3 0.1
Unknown#sst_cgl_038 1605.0 1591.6 13.4
Unknown#sst_cgl_039 1621.0 1621.2 0.2
Unknown#sst_cgl_040 1636.9 1637.4 0.5
Unknown#sst_cgl_041 1638.3 1638.8 0.5
Unknown#sst_cgl_042 1649.9 1650.6 0.7
Unknown#sst_cgl_043 1654.8 1655.6 0.8
Unknown#sst_cgl_044 1657.2 1658.0 0.8
Unknown#sst_cgl_045 1660.9 1661.8 0.9
Unknown#sst_cgl_046 1661.5 1662.4 0.9
Unknown#sst_cgl_048 1676.9 1678.1 1.2
Unknown#sst_cgl_049 1696.3 1697.9 1.6
Unknown#sst_cgl_050 1705.4 1707.1 1.7
Unknown#sst_cgl_052 1715.4 1704.9 10.5
Unknown#sst_cgl_053 1708.7 1706.4 2.3
Unknown#sst_cgl_054 1730.0 1732.1 2.1
Unknown#sst_cgl_055 1733.4 1725.1 8.3
Unknown#sst_cgl_056 1735.3 1737.5 2.2
Unknown#sst_cgl_058 1746.5 1748.9 2.4
Unknown#sst_cgl_060 1758.1 1760.7 2.6
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Unknown#sst_cgl_062 1772.1 1771.9 0.2
Unknown#sst_cgl_064 1786.2 1789.2 3.0 
Unknown#sst_cgl_065 1798.4 1801.7 3.3
Unknown#sst_cgl_068 1811.6 1815.1 3.5
Unknown#sst_cgl_072 1830.0 1833.8 3.8
Unknown#sst_cgl_073 1833.8 1837.7 3.9
Unknown#sst_cgl_074 1834.1 1838.0 3.9
Unknown#sst_cgl_075 1840.9 1825.3 15.6
Unknown#sst_cgl_076 1843.5 1827.4 16.1
Unknown#sst_cgl_077 1845.5 1849.6 4.1
Unknown#sst_cgl_078 1847.3 1842.0 5.3
Unknown#sst_cgl_081 1894.9 1944.3 49.4
Unknown#sst_cgl_082 1902.3 1908.5 6.2
Unknown#sst_cgl_083 1938.6 1945.1 6.5
Unknown#sst_cgl_084 1957.3 1936.5 20.8
Unknown#sst_cgl_085 1969.6 1976.4 6.8
Unknown#sst_cgl_087 1989.4 1996.4 7.0
Unknown#sst_cgl_087a 1989.4 1996.4 7.0
Unknown#sst_cgl_088 1995.0 2004.5 9.5
Unknown#sst_cgl_089 2008.5 1990.6 17.9
Unknown#sst_cgl_090 2019.3 2000.9 18.4
Unknown#sst_cgl_091 2028.0 2028.0 0.0
Unknown#sst_cgl_092 2052.4 2060.0 7.6
Unknown#sst_cgl_093 2061.7 2069.4 7.7
Unknown#sst_cgl_094 2097.4 2080.6 16.8
Unknown#sst_cgl_095 2101.5 2647.3 545.8 
Unknown#sst_cgl_096 2129.7 2132.1 2.4
Unknown#sst_cgl_098 2152.8 2161.4 8.6
Unknown#sst_cgl_100 2190.4 2199.3 8.9
Unknown#sst_cgl_101 2195.7 2175.8 19.9
Unknown#sst_cgl_102 2207.0 2217.0 10.0
Unknown#sst_cgl_104 2223.7 2224.9 1.2
Unknown#sst_cgl_105 2238.6 2230.7 7.9
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Unknown#sst_cgl_106 2244.1 2246.8 2.7
Unknown#sst_cgl_107 2249.1 2233.6 15.5
Unknown#sst_cgl_108 2252.9 2261.9 9.0
Unknown#sst_cgl_109 2257.8 2245.1 12.7
Unknown#sst_cgl_110 2275.7 2288.5 12.8
Unknown#sst_cgl_111 2282.3 2274.1 8.2
Unknown#sst_cgl_112 2283.6 2292.0 8.4
Unknown#sst_cgl_113 2292.4 2304.0 11.6
Unknown#sst_cgl_114 2295.6 3137.0 841.4
Unknown#sst_cgl_115 2331.8 2339.1 7.3
Unknown#sst_cgl_116 2331.8 2320.3 11.5
Unknown#sst_cgl_117 2365.8 2366.6 0.8
Unknown#sst_cgl_120 2615.1 2606.6 8.5
Unknown#sst_cgl_121 2635.0 2601.0 34.0
Unknown#sst_cgl_122 2666.0 2644.4 21.6
Unknown#sst_cgl_123 2673.7 2673.8 0.1
Unknown#sst_cgl_124 2681.9 2681.8 0.1 
Unknown#sst_cgl_125 2696.7 2696.3 0.4
Unknown#sst_cgl_126 2858.9 2848.2 10.7
Unknown#sst_cgl_128 2878.8 2842.9 35.9
Unknown#sst_cgl_129 3413.2 3377.1 36.1
Unknown#sst_cgl_130 3464.4 3466.0 1.6
Unknown#sst_cgl_131 3493.1 3494.2 1.1
Unknown#sst_cgl_132 3515.6 3556.9 41.3
Unknown#sst_cgl_133 3522.7 3523.3 0.6
Unknown#sst_cgl_A03 1689.5 1690.9 1.4
Unknown#sst_cgl_A04 1723.6 1712.6 11.0
Unknown#sst_cgl_A08 2358.8 2352.2 6.6
Unknown#sst_cgl_A09 2381.3 2367.3 14.0
Unknown#sst_cgl_A10 2731.9 2716.5 15.4
Unknown#sst_cgl_A11 1746.7 1733.5 13.2
Unknown#sst_cgl_A12 1876.8 1869.9 6.9
Unknown#sst_cgl_A13 1797.9 1801.2 3.3
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Derivative RI in 60 min run RI in 18 min run Abs. differenz 
Unknown#sst_cgl_A14 1797.1 1800.3 3.2
Unknown#sst_cgl_A15 2051.8 2042.0 9.8
Unknown#sst_cgl_A16 2260.0 2253.8 6.2
Unknown#sst_cgl_A17 2276.4 2256.7 19.7
Unknown#sst_cgl_A18 2294.0 2288.5 5.5 
Unknown#sst_cgl_D03 1088.9 1094.6 5.7
Unknown#sst_cgl_D04 1129.0 1133.5 4.5
Unknown#sst_cgl_D05 1143.4 1147.5 4.1
Unknown#sst_cgl_D07 1149.1 1153.0 3.9
Unknown#sst_cgl_D08 1149.9 1153.8 3.9
Unknown#sst_cgl_D09 1155.4 1156.7 1.3
Unknown#sst_cgl_D11 1116.6 1115.3 1.3
Uracil_2TMS 1346.9 1335.7 11.2
Urea_2TMS 1261.9 1243.8 18.1
Uridine_3TMS 2459.1 2453.4 5.7
Uridine-5'-mono-
phosphate_5TMS 
2872.1 2903.8 31.7
Valine_1TMS 1093.7 1093.6 0.1
Valine_2TMS 1214.5 1202.8 11.7
Xanthine_3TMS 2027.0 2034.4 7.4
Xylose_1_1MeOX_4TMS 1653.4 1654.2 0.8
Xylose_2_1MeOX_4TMS 1664.3 1665.3 1.0
Xylulose_1MeOX_4TMS 1685.1 1668.7 16.4
Xylulose_4TMS 1697.6 1687.2 10.4
Xylulose-5-phos_
1_1MeOX_5TMS 
2099.9 2288.5 188.6
Xylulose-5-phos_
2_1MeOX_5TMS 
2117.3 1743.9 373.4 
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Table B. Reference list derived from more than 150 wild type samples.
Metabolite
Relative
intensity
Standard
error
Relative
error
Occurrence
[%]
!2-Hydroxypyridine 2435.85 210.31 0.09 70.5
!Carbonic acid 15149.27 1290.32 0.09 99.4
!Docosanol 288.88 253.60 0.88 1.3
!Dodecanol 2752.17 1634.70 0.59 29.5
!Phosphoric acid 1252671.21 65554.72 0.05 99.4
!Ribitol 274174.13 7972.93 0.03 100.0
#!Octamethyltrisiloxane 6602.83 857.32 0.13 19.2
#1,2,3-Benzenetriol 14435.80 14279.78 0.99 14.1
#Alloxanic acid 55.73 10.78 0.19 1.3
#Aminomalonic acid 755.74 45.98 0.06 55.1
#Boric acid 491.68 92.99 0.19 10.3
#Carbodiimide 7201.30 1739.34 0.24 12.8
#Dodecanoic acid 935.59 193.22 0.21 66.7
#Octadecanoic acid 40254.45 2489.45 0.06 99.4
#Pantothenic acid (deriv) 569.74 116.27 0.20 1.9
1,6-Anhydro-beta-D-
glucose
4332.28 2570.24 0.59 91.7
1-Monooleoylglycerol 806.80 190.31 0.24 53.8
1-Monopalmitoylglycerol 474.15 55.54 0.12 71.8
1-Monostearoylglycerol 405.67 296.27 0.73 3.2
2,6-Diaminopimelic acid 8250.63 866.51 0.11 78.8
2-Aminobutyric acid 3636.05 149.83 0.04 80.1
2-Deoxyribose-5-phosphate1385.91 400.53 0.29 35.3
2-Hydroxybutanoic acid 286.75 29.71 0.10 67.9
2-Hydroxyglutaric acid 14112.38 967.71 0.07 96.2
2-Monooleoylglycerol 322.04 74.57 0.23 1.3
2-Phosphoglyceric acid 9604.27 1072.40 0.11 50.6
3,4-Dihydroxy-benzoic
acid
37.79 17.02 0.45 1.3
3-Hydroxy-2-tetradecyl-
octanoic acid
14228.57 873.70 0.06 64.7
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Metabolite
Relative
intensity
Standard
error
Relative
error
Occurrence
[%]
3-Hydroxybutyric acid 15455.33 6583.49 0.43 59.0
3-Phosphoglyceric acid 48014.11 2403.83 0.05 98.1
5-Deoxy-5-
Methylthioadenosine
3094.07 186.66 0.06 77.6
5-Oxoproline 72190.42 4351.51 0.06 100.0
6-Phosphogluconate 16023.55 4489.46 0.28 78.2
Adenine 19593.11 1349.46 0.07 88.5
Adenosine 5834.98 386.53 0.07 91.7
Adenosine-5'-
monophosphate
159524.63 10027.94 0.06 89.1
Alanine 199516.43 12361.10 0.06 100.0
alpha-Ketoglutaric acid 25658.96 1981.61 0.08 98.7
Arabinose 29.82 9.96 0.33 4.5
Aspartic acid 234366.03 21545.59 0.09 98.7
Benzoic acid 42557.81 8353.91 0.20 98.1
beta-Alanine 30070.10 1741.39 0.06 99.4
Citric acid 61369.68 4457.95 0.07 97.4
Cycloleucine 422776.53 22234.30 0.05 67.9
Cytosin 455.13 19.88 0.04 55.8
Diethyleneglycol 693.89 65.86 0.09 54.5
Dihydroxyacetone 755.03 136.80 0.18 3.2
Erythritol 77401.46 19971.35 0.26 34.6
Erythrose-4-phosphate 17643.90 4215.33 0.24 26.3
Fructose 6279.84 1148.30 0.18 34.0
Fructose-1,6-bisphosphate 87215.71 10986.46 0.13 73.7
Fructose-6-phosphate 371.42 112.12 0.30 33.3
Fumaric acid 59113.95 2972.63 0.05 98.7
gamma-Glutamylleucine 5876.95 453.08 0.08 87.2
gamma-Glutamylvaline 96431.11 13144.57 0.14 90.4
Glucono lactone 5798.52 656.51 0.11 10.3
Glucosamine-6-phosphate 9458.00 2283.89 0.24 78.8
162 7  Appendix
Metabolite
Relative
intensity
Standard
error
Relative
error
Occurrence
[%]
Glucose 19859.54 1965.41 0.10 99.4
Glucose-6-phosphate 53411.33 10301.17 0.19 84.6
Glutamic acid 2441393.78 153198.06 0.06 99.4
Glutamine 125686.69 10569.10 0.08 91.7
Glyceraldehyde 64421.87 9471.10 0.15 3.8
Glyceric acid 3396.18 249.10 0.07 95.5
Glycerol 11218.20 600.07 0.05 99.4
Glycerol-2-phosphate 267.57 66.32 0.25 5.8
Glycerol-3-phosphate 110402.89 6423.03 0.06 98.7
Glycerone phosphate 8980.64 688.90 0.08 1.9
Glycine 14909.37 1894.88 0.13 98.1
Glycolic acid 4028.23 1415.27 0.35 85.3
Hexadecanoic acid 36940.36 2323.03 0.06 96.8
Hexadecanol 1635.10 265.28 0.16 76.9
Homocysteine 98.30 6.48 0.07 41.7
Homoserine 2263.01 136.15 0.06 94.9
Hydroxylamine 864.52 117.04 0.14 95.5
Hypoxanthine 7325.67 415.27 0.06 14.7
Isoleucine 5814.27 378.63 0.07 95.5
Isomaltose 23305.64 4886.10 0.21 72.4
Lactic acid 190774.66 11493.32 0.06 99.4
Lactose 8663.13 618.48 0.07 76.9
Lactyllactate 66.97 4.55 0.07 48.1
Leucine 5290.23 385.42 0.07 84.6
Lysine 390974.75 20153.38 0.05 98.1
Malic acid 59626.98 3517.51 0.06 98.7
Malonic acid 3677.79 637.38 0.17 87.8
Maltose 978513.02 50457.25 0.05 99.4
Mannitol 70215.31 1874.65 0.03 75.0
Mannose 19602.76 2116.21 0.11 89.7
Mannose-6-phosphate 22770.72 5544.96 0.24 78.8
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Methionine 7689.80 1419.71 0.18 69.2
N-Acetylglucosamine 975.45 457.03 0.47 1.9
N-Acetyl-L-glutamic acid 26229.31 1411.65 0.05 98.1
N-Acetyl-L-glutamine 7139.73 538.01 0.08 88.5
Nicotinamide 5754.91 417.48 0.07 94.9
Nicotinic acid 677.81 144.41 0.21 66.0
Norleucine 6051.60 705.64 0.12 5.8
Norvaline 52247.33 7961.22 0.15 16.0
O-Acetyl-serine 2699.09 304.77 0.11 71.2
Octadecanol 356.55 193.47 0.54 55.1
Ornithine 1222.36 235.26 0.19 60.9
Oxalic acid 1550.10 344.73 0.22 12.2
Phenylalanine 4720.46 246.96 0.05 98.1
Phosphoenolpyruvic acid 8388.03 509.77 0.06 98.1
Proline 111191.89 7851.08 0.07 96.2
Pyrophosphoric acid 157201.55 10830.68 0.07 96.2
Pyruvic acid 3241.00 167.39 0.05 98.1
Quebrachitol 1868.04 843.88 0.45 7.7
Quinic acid 16179.20 1056.99 0.07 98.1
Ribose-5-phosphate 265.48 83.05 0.31 31.4
Ribulose-5-phosphate 14161.04 3199.53 0.23 75.6
Sarcosine 20171.68 4982.86 0.25 18.6
Serine 175540.49 11555.24 0.07 99.4
Succinic acid 117805.67 6287.84 0.05 99.4
Succinic acid
monomethylester
515.43 24.53 0.05 78.2
Sucrose 879.04 163.68 0.19 57.7
Tetradecanol 969.97 443.09 0.46 65.4
Threonine 11566.91 863.05 0.07 98.7
Thymine 1165.04 80.25 0.07 71.2
Trehalose 832327.93 36735.82 0.04 98.7
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Tridecanol 113.64 16.20 0.14 1.9
Tryptophan 45358.59 3105.14 0.07 93.6
Tyrosine 17709.60 1205.45 0.07 98.1
Unknown#bth_pae_001 2380.16 498.81 0.21 19.2
Unknown#bth_pae_008 24090.42 6061.03 0.25 21.8
Unknown#bth_pae_009 18351.06 2616.53 0.14 33.3
Unknown#bth_pae_012 14936.55 1214.10 0.08 3.8
Unknown#bth_pae_013 1756.56 89.96 0.05 99.4
Unknown#bth_pae_015 1386.50 80.52 0.06 3.2
Unknown#bth_pae_017 36399.32 2016.21 0.06 92.3
Unknown#bth_pae_021 293.71 59.83 0.20 89.7
Unknown#bth_pae_022 177.23 23.56 0.13 22.4
Unknown#bth_pae_023 2415.91 315.92 0.13 94.2
Unknown#bth_pae_024 114.49 13.73 0.12 55.1
Unknown#bth_pae_026 2520.29 1373.57 0.55 6.4
Unknown#bth_pae_030 107.59 61.75 0.57 1.3
Unknown#bth_pae_032 11750.84 1781.92 0.15 10.3
Unknown#bth_pae_033 2003.92 250.81 0.13 78.8
Unknown#bth_pae_034 570.00 31.66 0.06 3.8
Unknown#bth_pae_038 753.25 270.83 0.36 63.5
Unknown#bth_pae_039 19192.66 1736.34 0.09 37.8
Unknown#bth_pae_040 2231.14 363.30 0.16 78.2
Unknown#bth_pae_044 10286.59 759.67 0.07 3.8
Unknown#bth_pae_056 15955.15 758.14 0.05 89.7
Unknown#bth_pae_057 2457.57 154.99 0.06 82.7
Unknown#sst_cgl_006 85958.63 10144.47 0.12 36.5
Unknown#sst_cgl_008 105362.39 5503.49 0.05 98.7
Unknown#sst_cgl_009 1453.09 109.83 0.08 93.6
Unknown#sst_cgl_010a 6336.09 5303.17 0.84 1.9
Unknown#sst_cgl_010b 1164.65 222.69 0.19 60.3
Unknown#sst_cgl_011 612.76 150.90 0.25 55.8
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Unknown#sst_cgl_012 591.88 23.64 0.04 53.8
Unknown#sst_cgl_015 803.12 157.10 0.20 30.1
Unknown#sst_cgl_022 974.78 570.14 0.58 8.3
Unknown#sst_cgl_024 298.92 150.37 0.50 1.9
Unknown#sst_cgl_027 2256.45 210.79 0.09 92.3
Unknown#sst_cgl_030 10061.76 630.65 0.06 90.4
Unknown#sst_cgl_033 1563.26 288.09 0.18 28.2
Unknown#sst_cgl_035 2966.32 204.30 0.07 73.7
Unknown#sst_cgl_036 79.84 12.34 0.15 22.4
Unknown#sst_cgl_038 32207.71 5454.31 0.17 94.9
Unknown#sst_cgl_046 545.61 237.30 0.43 2.6
Unknown#sst_cgl_049 59.70 5.47 0.09 30.8
Unknown#sst_cgl_052 422.73 26.28 0.06 1.9
Unknown#sst_cgl_053 13250.95 4579.26 0.35 63.5
Unknown#sst_cgl_055 11508.30 616.68 0.05 98.7
Unknown#sst_cgl_062 26320.28 1197.01 0.05 59.0
Unknown#sst_cgl_075 219.07 10.02 0.05 56.4
Unknown#sst_cgl_076 1775.49 521.93 0.29 7.1
Unknown#sst_cgl_078 551.70 110.69 0.20 10.3
Unknown#sst_cgl_081 19802.29 1738.43 0.09 85.3
Unknown#sst_cgl_084 22601.98 1462.62 0.06 91.0
Unknown#sst_cgl_088 1539.97 143.06 0.09 48.1
Unknown#sst_cgl_089 7304.82 526.78 0.07 90.4
Unknown#sst_cgl_090 7600.26 393.38 0.05 97.4
Unknown#sst_cgl_091 1302.06 153.01 0.12 79.5
Unknown#sst_cgl_094 2069.73 658.80 0.32 3.8
Unknown#sst_cgl_095 845.63 239.62 0.28 7.1
Unknown#sst_cgl_096 169.81 31.12 0.18 15.4
Unknown#sst_cgl_101 37009.21 3586.77 0.10 91.7
Unknown#sst_cgl_103 344.21 14.28 0.04 47.4
Unknown#sst_cgl_104 48407.90 3418.05 0.07 81.4
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Unknown#sst_cgl_105 464.54 94.76 0.20 8.3
Unknown#sst_cgl_106 2667.15 152.35 0.06 76.3
Unknown#sst_cgl_107 3284.83 943.11 0.29 16.0
Unknown#sst_cgl_109 2896.07 329.61 0.11 79.5
Unknown#sst_cgl_110 1316.76 200.58 0.15 34.6
Unknown#sst_cgl_111 123347.19 9859.37 0.08 73.7
Unknown#sst_cgl_113 14756.09 3362.95 0.23 76.9
Unknown#sst_cgl_116 98479.45 10930.54 0.11 51.3
Unknown#sst_cgl_117 957.84 90.79 0.09 1.9
Unknown#sst_cgl_119 5611.39 843.48 0.15 25.6
Unknown#sst_cgl_120 12476.03 2592.69 0.21 78.2
Unknown#sst_cgl_121 41810.95 2797.02 0.07 80.8
Unknown#sst_cgl_122 10093.63 552.75 0.05 71.2
Unknown#sst_cgl_126 36072.62 4868.42 0.13 76.9
Unknown#sst_cgl_128 34896.52 3292.44 0.09 75.0
Unknown#sst_cgl_129 4282.36 351.25 0.08 75.0
Unknown#sst_cgl_132 4977.88 262.49 0.05 3.2
Unknown#sst_cgl_134 3094.29 837.04 0.27 8.3
Unknown#sst_cgl_A04 173608.06 10740.51 0.06 96.8
Unknown#sst_cgl_A08 8702.87 2223.62 0.26 76.3
Unknown#sst_cgl_A09 13404.75 653.49 0.05 64.1
Unknown#sst_cgl_A10 5719.48 717.15 0.13 51.9
Unknown#sst_cgl_A11 283.82 18.37 0.06 91.7
Unknown#sst_cgl_A12 100.69 15.25 0.15 36.5
Unknown#sst_cgl_A15 185.45 34.34 0.19 41.7
Unknown#sst_cgl_A16 897.01 89.29 0.10 76.3
Unknown#sst_cgl_A17 928.59 50.12 0.05 68.6
Unknown#sst_cgl_A18 54.19 12.34 0.23 3.2
Unknown#sst_cgl_D09 618.07 159.28 0.26 23.7
Uracil 2443.61 209.28 0.09 91.0
Urea 2216.69 497.65 0.22 89.1
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Uridine 30813.36 2104.58 0.07 98.7
Uridine-5'-monophosphate 59262.43 4098.11 0.07 76.3
Valine 64258.67 3481.45 0.05 99.4
Xylulose 684.51 98.22 0.14 53.2
Xylulose-5-phosphate
27678.53 6569.23 0.24 35.9
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Figure A. Dendrogram of 255 samples (mutants and wild type). Splitted for a better
overview.
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Table C. List of the 10...20 most intensive metabolites (without “unknowns”) in 318 analyzed transposon mutants. Information about the
occurrence as most intensive compound as well as their pathways and additional information are combined.
Metabolite Most intensive
compound [%]
Pathway Other name Additional information
Phosphoric acid 99.69 oxidative phosphorylation,
peptidoglycane biosynthese
phosphate,
orthophosphate
Ribitol 95.31 internal standard
Trehalose 93.13 starch and sucrose metabolism differentiation trehalose and
maltose difficult (isomers)
Glutamic acid 95.94 glutamate metabolism, urea cycle and
metabolism of amino groups, argininge
and proline metabolism, D-glutamine
and D-glutamate metabolism,
glutathione metabolism, nitrogen
metabolism, aminoacyl-tRNA
biosynthese, ABC-transporter for
glutamate (secretion)
Lysine 85.63 lysine biosynthese, aminoacyl-tRNA
biosynthese
2,6-diamino-
hexanoic acid
Maltose 85.00 starch and sucrose metabolism differentiation trehalose and
maltose difficult (isomers)
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Metabolite Most intensive
compound [%]
Pathway Other name Additional information
Alanine 82.81 alanine and aspartate metabolism, D-
alanine metabolism, selenoaminoacid
metabolism, aminoacyl-tRNA
biosynthese
Lactic acid 81.88 glycolysis, pyruvate metabolism
Glycerol-3-phosphate 80.00 glycerophospholipid metabolism,
glycerolipidmetabolism, ABC
transporter evailable
glycerophosphoric
acid
Serine 63.13 glycin, serine and threonine metabolism,
cysteine metabolism, aminoacyl-tRNA
biosynthese
Succinic acid 63.13 citrate cycle, oxidative phosphorylation,
glyoxylate and dicarboxylate
metabolism
Aspartic acid 61.56 urea cycle and metabolism of amino
groups, alanine and aspartate
metabolism, glycine, serine and
threonine metabolism, lysine
biosynthese, beta-alanine metabolism,
2-aminosuccinic
acid
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Metabolite Most intensive
compound [%]
Pathway Other name Additional information
nitrogen metabolism, aminoacyl-tRNA
biosynthese
Adenosine-5'-
monophosphate
55.31 purine metabolism AMP formation after usage of
adenosine-5'-diphospate and
-triphosphate
5-Oxoproline 53.75 glutathione metabolism pyroglutamic acid,
pyroglutamate
formation due to cyclization of
glutamate and glutamine
Pyrophosphoric acid 49.06 oxidative Phosphorylierung 
gamma-Glutamylvaline 40.31 - dipeptide
Fumaric acid 35.31 citrate cycle, oxidative phosphorylation,
urea cycle and metabolism of amino
groups
fumarate, trans-
butenedioic acid
Proline 31.56 arginine and proline metabolism,
aminoacyl-tRNA biosynthesis
2-
pyrrolidinecarboxyli
c acid
Malic acid 31.25 citrate cycle 
Cycloleucine 30.94 valine, leucine, isoleucine biosynthese,
aminoacyl-tRNA biosynthese
leucine only leucine in KEGG
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Metabolite Most intensive
compound [%]
Pathway Other name Additional information
Mannitol 26.25 fructose and mannose metabolism
Glucose-6-phosphate 22.81 glycolysis,pentose phosphate pathway,
aminoacyl-tRNA biosynthesis
alpha-D-glucose 6-
phosphate
Fructose-1,6-
bisphosphate
25.31 glycolysis, pentose phosphate pathway,
fructose and mannose metabolism
beta-D-fructose 1,6-
bisphosphate
Valine 20.31 valine, leucine and isoleucine
biosynthese/degradation, aminoacyl-
tRNA biosynthese
2-amino-3-
methylbutyric acid
Octadecanoic acid 19.38 Fatty acid biosynthese no enzyme for this reaction in C.
glutamicum in KEGG
Tryptophan 19.06 phenylalanine, tyrosine and tryptophan
biosynthesis, aminoacyl-tRNA
biosynthesis
(S)-alpha-amino-
beta-(3-indolyl)-
propionic acid
hardly any enzymes for the
tryptophan metabolism in C.
glutamicum in KEGG
Citric acid 18.75 tryptophan metabolism, phenylalanine,
tyrosine and tryptophan biosynthesis,
aminoacyl-tRNA biosynthesis
Isomaltose 18.75 starch and sucrose metabolism
Glutamine 18.44 D-glutamine and D-glutamate
metabolism, purine metabolism,
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Metabolite Most intensive
compound [%]
Pathway Other name Additional information
pyrimidine metabolism, glutamate
metabolism, nitrogen metabolism
6-Phosphogluconate 17.81 pentose phosphate pathway 6-phospho-D-
gluconate
Erythritol 17.81 - in no pathway in KEGG
Mannose-6-phosphate 18.13 fructose and mannose metabolism
Glucosamine-6-
phosphate
10.94 glutamate metabolism, aminosugars
metabolism
D-glucosamine
phosphate
Hexadecanoic acid 10.94 fatty acid biosynthese/metabolism
3-Hydroxybutyric acid 8.75 synthesis and degradation of ketone
bodies
enzyme not annotated,
formation of acetoacetate from
this compound
Uridine 8.75 pyrimidine metabolism
Carbonic acid 7.50 nitrogen metabolism
Erythrose-4-phosphate 7.19 pentose phosphate pathway
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Metabolite Most intensive
compound [%]
Pathway Other name Additional information
Glucose 5.94 glycolysis, starch and sucrose
metabolism
differentiation glucose and
mannose difficult (isomers)
Glycerol 6.25 glycerolipid metabolism glycerin, 1,2,3-
propanetriol
Mannose 6.25 fructose and mannose metabolism differentiation glucose and
mannose difficult (isomers)
Uridine-5'-
monophosphate
6.25 pyrimidine metabolism,peptidoglycan
biosynthesis
UMP formation after usage of
uridine-5'-diphospate and
-triphosphate
Glycolic acid 5.00 glyoxylate and dicarboxylate
metabolism
glycolate
Urea 4.38 arginine and proline metabolism, ABC-
transporter available (for branched-chain
amino acids), urea cycle and metabolism
of amino groups
carbamide enzyme for formation of urea
directly from arginine not
annotated in C. glutamicum, but
due to instabilities arginine
dissociates to ornithine and urea
Hydroxylamine 3.75 nitrogen metabolism enzyme not annotated 
Ribulose-5-phosphate 2.81 pentose phosphate pathway hard to distinguish from
xylulose-5-phosphate, both
7 Appendix 179
Metabolite Most intensive
compound [%]
Pathway Other name Additional information
compounds can directly be
converted to each other
2-Hydroxypyridine 2.50 - residues from derivatization
compound
Dodecanol 2.19 - not in KEGG
Xylulose-5-phosphate 2.19 pentose phosphate pathway hard to distinguish from
ribulose-5-phosphate, both
compounds can directly be
converted to each other
Malonic acid 1.88 beta-alanine metabolism --> fatty acid
biosynthesis
enzyme not annotated for C.
glutamicum
Benzoic acid 1.56 benzoate degredation via
hydroxylation/via CoA ligation, side
product in phenylalanine metabolism
benzoate
beta-Alanine 1.56 alanine and aspartate metabolism, beta-
alanine metabolism
3-aminopropionate
Nicotinamide 1.56 nicotinate and nicotinamide metabolism nicotinic acid
amide, niacinamide,
vitamine PP
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Metabolite Most intensive
compound [%]
Pathway Other name Additional information
Methionine 1.25 methionine metabolism, aminoacyl-
tRNA biosynthesis
L-2-amino-4-
methylthiobutyric
acid
2-Hydroxyglutaric acid 0.94 butanoate metabolism 2-hydroxyglutarate enzyme not annotated for C.
glutamicum
Glucono lactone 0.94 Pentose Phosphate Pathway D-glucono-1,5-
lactone
enzyme not annotated for C.
glutamicum
Glyceraldehyde 0.94 fructose and mannose metabolism,
glycolipid metabolism
D-glyceraldehyde
Norvaline 0.94 - L-2-aminopentanoic
acid
no pathway in KEGG, relate to
valine
2-Hydroxybutanoic acid 0.63 propanoate metabolism 2-hydroxybutyrate
3-Phosphoglyceric acid 0.63 glycolysis 3-phosphoglycerate,
glycerate 3-
phosphate
Xylulose 0.63 pentose and glucuronate
interconversions
3-Hydroxy-2-tetradecyl-
octanoic acid
0.31 - not pathway in KEGG
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Metabolite Most intensive
compound [%]
Pathway Other name Additional information
Ornithine 0.31 urea cycle and metabolism of amino
groups, arginine and proline metabolism
not possible to be differentiated
from arginine, see arginine
Table D. List of analyzed transposon mutants and summary of the important characteristics.
Number Mutant OD Standard
deviation
of the OD
r to wild
type on
same plate
Error
[%]
Number of
increased
metabolites
Number of
reduced
metabolites
Number of
varying
metabolites
r to
reference
list
Affected enzyme
(gene name)
MT1 A1_B2P6 6.58 0.64 0.818 - 11 48 59 0.503
MT2 A2_B2P6 6.62 0.24 0.872 16.95 17 44 61 0.533
MT3 A3_B2P6 6.70 0.37 0.878 23.93 23 46 69 0.527
MT4 A4_B2P6 7.23 0.78 0.967 12.52 16 33 49 0.809
MT5 A5_B2P6 6.13 0.11 0.986 12.28 9 29 38 0.776
MT6 A6_B2P6 6.34 0.11 0.895 14.15 18 41 59 0.791
MT7 B1_B2P6 6.31 0.59 0.848 14.68 16 44 60 0.507
MT8 B2_B2P6 6.19 0.89 0.843 16.16 13 46 59 0.510
MT9 B3_B2P6 5.27 0.66 0.819 13.86 17 41 58 0.475
MT10 B4_B2P6 5.83 0.36 0.939 16.82 14 38 52 0.633
7 Appendix 182
Number Mutant OD Standard
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of the OD
r to wild
type on
same plate
Error
[%]
Number of
increased
metabolites
Number of
reduced
metabolites
Number of
varying
metabolites
r to
reference
list
Affected enzyme
(gene name)
MT11 B5_B2P6 6.43 0.74 0.975 13.71 10 29 39 0.850
MT12 B6_B2P6 5.55 0.60 0.951 13.38 8 37 45 0.813
MT13 B7_B2P6 4.98 0.17 0.965 16.86 22 24 46 0.831
MT14 B8_B2P6 5.60 0.52 0.969 13.92 17 26 43 0.847
MT15 C1_B2P6 6.19 1.03 0.948 16.45 10 43 53 0.627
MT16 C2_B2P6 5.42 0.62 0.937 13.50 9 50 59 0.621
MT17 C3_B2P6 5.28 0.51 0.944 16.11 11 42 53 0.617
MT18 C4_B2P6 5.85 0.47 0.967 13.97 13 40 53 0.659
MT19 C5_B2P6 5.77 0.81 0.964 13.51 12 35 47 0.797
MT20 C6_B2P6 4.82 0.17 0.928 17.42 10 33 43 0.811
MT21 C7_B2P6 4.09 0.35 0.926 - 10 32 42 0.837
MT22 C8_B2P6 5.31 0.75 0.968 13.10 13 28 41 0.853
MT23 D1_B2P6 6.38 0.31 0.938 13.72 9 47 56 0.618
MT24 D2_B2P6 5.44 0.97 0.921 22.91 13 40 53 0.717
MT25 D3_B2P6 4.85 0.52 0.926 14.03 16 41 57 0.644
MT26 D4_B2P6 5.86 0.90 0.969 13.76 12 41 53 0.662
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Number Mutant OD Standard
deviation
of the OD
r to wild
type on
same plate
Error
[%]
Number of
increased
metabolites
Number of
reduced
metabolites
Number of
varying
metabolites
r to
reference
list
Affected enzyme
(gene name)
MT27 D5_B2P6 5.66 0.70 0.977 13.18 8 36 44 0.818
MT28 D6_B2P6 4.45 0.33 0.918 14.92 9 34 43 0.805
MT29 D7_B2P6 4.17 0.53 0.918 12.03 8 29 37 0.791
MT30 D8_B2P6 4.93 0.67 0.959 14.86 10 29 39 0.824
MT31 E1_B2P6 5.73 0.66 0.942 15.22 8 48 56 0.606
MT32 E2_B2P6 3.73 0.47 0.915 13.82 22 42 64 0.585
MT33 E3_B2P6 4.29 1.12 0.875 30.38 22 32 54 0.810
MT34 E4_B2P6 5.73 0.44 0.973 14.00 12 41 53 0.653
MT35 E5_B2P6 5.67 0.91 0.97 16.82 12 32 44 0.826
MT36 E6_B2P6 4.89 0.39 0.852 15.65 22 30 52 0.676
MT37 E7_B2P6 4.36 0.19 0.909 18.42 20 30 50 0.783
MT38 E8_B2P6 5.03 1.14 0.948 16.39 15 34 49 0.813
MT39 F1_B2P6 6.13 1.05 0.971 15.90 10 44 54 0.639
MT40 F2_B2P6 6.14 0.85 0.932 15.36 9 48 57 0.615
MT41 F3_B2P6 5.38 1.07 0.98 18.89 12 41 53 0.686
MT42 F4_B2P6 5.81 0.29 0.97 17.17 15 37 52 0.714
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Number Mutant OD Standard
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of the OD
r to wild
type on
same plate
Error
[%]
Number of
increased
metabolites
Number of
reduced
metabolites
Number of
varying
metabolites
r to
reference
list
Affected enzyme
(gene name)
MT43 F5_B2P6 0.97 0.05 0.465 41.81 3 65 68 0.389
MT44 F6_B2P6 4.88 0.29 0.936 15.03 7 37 44 0.782
MT45 F7_B2P6 0.86 0.00 0.312 23.42 2 66 68 0.246
MT46 F8_B2P6 5.49 0.92 0.982 12.00 21 23 44 0.850
MT47 G1_B2P6 6.75 0.71 0.967 16.39 11 43 54 0.645
MT48 G2_B2P6 7.03 0.70 0.963 16.93 7 46 53 0.663
MT49 G3_B2P6 6.31 0.36 0.993 12.44 11 48 59 0.671
MT50 G5_B2P6 5.84 0.46 0.982 22.15 6 36 42 0.870
MT51 G6_B2P6 4.84 0.25 0.888 19.02 5 45 50 0.711
MT52 G7_B2P6 0.81 0.03 0.342 23.23 1 67 68 0.263
MT53 H1_B2P6 7.99 0.60 0.895 23.47 13 42 55 0.562
MT54 H2_B2P6 7.85 1.20 0.953 17.71 8 51 59 0.609
MT55 H3_B2P6 7.83 0.17 0.94 19.96 10 49 59 0.723
MT56 H5_B2P6 5.56 0.64 0.934 16.55 6 44 50 0.854
MT57 H6_B2P6 4.67 1.14 0.976 20.46 5 54 59 0.827
MT58 H7_B2P6 5.70 0.91 0.937 18.11 5 51 56 0.805
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MT59 A1_B2P7 5.85 0.68 0.937 14.07 31 34 65 0.726
MT60 A10_B2P7 5.75 0.24 0.944 15.11 23 41 64 0.714
MT61 A11_B2P7 5.71 0.43 0.919 14.40 28 53 81 0.673
MT62 A12_B2P7 5.91 0.35 0.963 22.44 23 52 75 0.776
MT63 A2_B2P7 1.68 0.03 0.652 24.13 30 59 89 0.461 para-aminobenzoat
synthase (cgl0997,
pabAB)
MT64 A3_B2P7 5.33 0.35 0.881 15.15 33 29 62 0.773
MT65 A4_B2P7 5.80 0.39 0.863 20.80 38 36 74 0.718
MT66 A5_B2P7 7.28 0.45 0.949 7.11 92 9 101 0.686
MT67 A6_B2P7 6.75 0.64 0.987 13.31 100 8 108 0.654
MT68 A7_B2P7 7.02 0.74 0.957 8.06 98 9 107 0.663
MT69 A8_B2P7 6.75 0.85 0.955 11.26 98 8 106 0.670
MT70 A9_B2P7 6.61 0.46 0.93 11.31 21 57 78 0.714
MT71 B1_B2P7 5.88 0.35 0.925 11.80 27 31 58 0.752
MT72 B10_B2P7 5.11 0.23 0.955 30.26 25 51 76 0.715
MT73 B11_B2P7 5.31 0.32 0.917 10.38 23 55 78 0.700
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MT74 B12_B2P7 5.87 0.37 0.964 23.42 22 48 70 0.837
MT75 B2_B2P7 5.24 0.51 0.936 12.35 36 26 62 0.744
MT76 B3_B2P7 4.94 0.11 0.95 21.60 38 16 54 0.743
MT77 B4_B2P7 5.19 0.26 0.933 12.48 36 26 62 0.713
MT78 B5_B2P7 6.89 0.89 0.959 7.94 97 9 106 0.684
MT79 B6_B2P7 5.94 0.71 0.953 8.68 99 8 107 0.692
MT80 B7_B2P7 6.19 0.05 0.966 7.98 95 7 102 0.686
MT81 B8_B2P7 6.47 0.72 0.964 10.47 92 9 101 0.684
MT82 B9_B2P7 6.45 0.42 0.898 12.73 19 63 82 0.675
MT83 C1_B2P7 5.40 0.28 0.955 25.02 36 17 53 0.706
MT84 C10_B2P7 2.52 0.34 0.808 18.86 14 69 83 0.699
MT85 C11_B2P7 5.25 0.30 0.921 12.42 21 52 73 0.737
MT86 C12_B2P7 5.97 0.41 0.95 24.58 20 55 75 0.797
MT87 C2_B2P7 4.90 0.38 0.942 7.79 26 14 40 0.746
MT88 C3_B2P7 4.58 0.10 0.951 18.72 37 13 50 0.732 hypothetical membrane
protein (cg0879)
7 Appendix 187
Number Mutant OD Standard
deviation
of the OD
r to wild
type on
same plate
Error
[%]
Number of
increased
metabolites
Number of
reduced
metabolites
Number of
varying
metabolites
r to
reference
list
Affected enzyme
(gene name)
MT89 C4_B2P7 5.23 0.11 0.946 16.37 36 18 54 0.724
MT90 C5_B2P7 5.81 0.91 - - - - - -
MT91 C6_B2P7 3.63 0.37 0.907 9.65 46 22 68 0.726 pseudouridine synthase
(cgl2138, rluD)
MT92 C7_B2P7 5.01 0.31 0.918 16.06 41 12 53 0.717 hypothetical protein
(cgl0592)
MT93 C8_B2P7 5.48 0.62 - - - - - -
MT94 C9_B2P7 5.88 0.64 0.939 14.13 19 53 72 0.770
MT95 D1_B2P7 5.78 0.65 0.967 21.92 30 22 52 0.735
MT96 D10_B2P7 4.68 0.52 0.795 19.53 21 48 69 0.623
MT97 D11_B2P7 4.70 0.28 0.955 21.43 27 37 64 0.805
MT98 D12_B2P7 5.29 0.79 0.947 26.51 21 50 71 0.768
MT99 D2_B2P7 4.71 0.26 0.953 9.32 39 11 50 0.766
MT100 D3_B2P7 3.45 0.60 0.932 12.61 35 19 54 0.732
MT101 D4_B2P7 2.88 0.09 0.931 16.53 45 25 70 0.759
MT102 D5_B2P7 0.89 0.03 0.331 17.40 16 97 113 0.210
MT103 D6_B2P7 4.90 0.49 - - - - - -
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MT104 D7_B2P7 3.52 0.07 - - - - - -
MT105 D8_B2P7 5.33 0.26 - - - - - -
MT106 D9_B2P7 6.09 0.55 0.958 21.97 20 53 73 0.773
MT107 E1_B2P7 6.41 0.50 0.926 15.87 29 37 66 0.745 glutamate-ammonia-
ligase adenyl-
transferase (glnE)
MT108 E10_B2P7 4.47 0.50 0.916 13.82 15 43 58 0.782
MT109 E11_B2P7 4.83 0.56 0.919 14.67 15 43 58 0.760
MT110 E12_B2P7 5.23 1.04 0.963 27.39 23 49 72 0.775
MT111 E2_B2P7 5.69 0.53 0.959 9.13 17 19 36 0.787
MT112 E3_B2P7 4.47 0.33 0.947 10.36 33 14 47 0.739
MT113 E4_B2P7 5.07 0.25 0.961 19.71 40 18 58 0.775
MT114 E5_B2P7 6.35 0.44 0.84 18.39 36 46 82 0.646
MT115 E6_B2P7 5.36 0.45 0.791 27.14 25 64 89 0.493
MT116 E8_B2P7 5.43 0.48 0.882 23.53 38 47 85 0.581
MT117 E9_B2P7 6.25 0.54 0.926 14.52 20 62 82 0.755
MT118 F1_B2P7 6.27 0.34 0.965 18.49 23 24 47 0.764
7 Appendix 189
Number Mutant OD Standard
deviation
of the OD
r to wild
type on
same plate
Error
[%]
Number of
increased
metabolites
Number of
reduced
metabolites
Number of
varying
metabolites
r to
reference
list
Affected enzyme
(gene name)
MT119 F10_B2P7 5.09 0.29 0.929 24.34 20 50 70 0.733
MT120 F11_B2P7 3.19 0.11 0.88 12.29 16 56 72 0.727
MT121 F12_B2P7 5.22 0.99 0.954 24.32 24 52 76 0.763
MT122 F2_B2P7 5.36 0.23 0.904 7.19 30 36 66 0.743 hypothetical protein
(cg0858)
MT123 F3_B2P7 4.77 0.53 0.948 12.59 23 17 40 0.754
MT124 F4_B2P7 5.19 0.33 0.97 19.12 40 21 61 0.778
MT125 F5_B2P7 2.09 0.31 0.755 22.37 34 60 94 0.629
MT126 F6_B2P7 5.66 0.76 0.854 13.42 27 42 69 0.682
MT127 F7_B2P7 5.19 0.05 0.832 12.79 24 41 65 0.701
MT128 F8_B2P7 5.73 0.61 0.844 28.27 26 34 60 0.656
MT129 F9_B2P7 5.90 0.55 0.957 21.71 20 56 76 0.743
MT130 G1_B2P7 6.71 0.51 0.947 11.59 36 29 65 0.784
MT131 G10_B2P7 4.95 0.86 0.945 15.94 13 45 58 0.781
MT132 G11_B2P7 4.78 0.28 0.919 9.77 28 54 82 0.669
MT133 G12_B2P7 1.43 0.12 0.533 30.86 20 61 81 0.374
MT134 G2_B2P7 6.55 0.50 0.953 15.00 28 30 58 0.781
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MT135 G3_B2P7 4.69 0.42 0.957 24.15 48 15 63 0.771
MT136 G4_B2P7 5.93 0.85 0.963 19.11 15 43 58 0.815
MT137 G5_B2P7 6.07 0.87 0.837 24.46 35 54 89 0.635
MT138 G6_B2P7 5.24 0.34 0.816 10.09 31 50 81 0.670
MT139 G7_B2P7 0.91 0.08 0.31 17.41 14 98 112 0.206
MT140 G8_B2P7 5.74 0.57 0.85 26.59 28 50 78 0.645
MT141 G9_B2P7 6.10 0.38 0.94 15.80 24 57 81 0.734
MT142 H1_B2P7 6.39 0.48 0.927 23.79 21 41 62 0.738
MT143 H10_B2P7 5.67 0.27 0.955 20.43 22 57 79 0.711
MT144 H11_B2P7 6.04 0.18 0.905 - 25 58 83 0.721
MT145 H2_B2P7 6.56 0.94 0.948 14.43 29 29 58 0.775
MT146 H3_B2P7 5.55 0.11 0.973 18.48 45 23 68 0.776
MT147 H4_B2P7 6.99 1.49 0.739 28.34 16 42 58 0.579 UDP-N-
acetylenolpyruvoylgluc
osamine reductase
(murB)
MT148 H5_B2P7 6.06 0.07 0.887 13.64 24 45 69 0.699
7 Appendix 191
Number Mutant OD Standard
deviation
of the OD
r to wild
type on
same plate
Error
[%]
Number of
increased
metabolites
Number of
reduced
metabolites
Number of
varying
metabolites
r to
reference
list
Affected enzyme
(gene name)
MT149 H6_B2P7 3.41 0.05 0.856 21.69 44 44 88 0.634
MT150 H7_B2P7 5.65 0.33 0.839 12.19 35 50 85 0.647
MT151 H8_B2P7 6.68 0.11 0.926 12.22 21 43 64 0.756
MT152 H9_B2P7 6.46 0.67 0.953 21.21 22 30 52 0.808
MT153 A1_B2P8 6.66 0.22 0.976 10.10 8 56 64 0.797
MT154 A10_B2P8 4.93 1.02 0.991 10.82 13 47 60 0.817
MT155 A11_B2P8 6.06 0.77 0.986 10.96 9 58 67 0.83
MT156 A12_B2P8 5.56 0.09 0.982 10.10 11 54 65 0.771
MT157 A2_B2P8 6.71 0.31 0.929 20.92 10 54 64 0.800
MT158 A3_B2P8 0.87 0.02 0.495 44.91 7 91 98 0.517
MT159 A4_B2P8 5.81 1.12 0.984 22.20 11 43 54 0.829
MT160 A5_B2P8 7.34 0.14 0.99 13.80 6 64 70 0.834
MT161 A6_B2P8 6.17 0.55 0.96 10.68 11 52 63 0.752 hypothetical protein
(cgl1708)
MT162 A7_B2P8 6.34 0.36 0.978 13.85 9 51 60 0.783
MT163 A8_B2P8 5.61 1.06 0.962 13.74 12 54 66 0.824
MT164 A9_B2P8 0.74 0.12 0.411 24.65 6 93 99 0.345
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MT165 B1_B2P8 5.73 0.17 0.927 23.56 13 48 61 0.798 aminopeptidase N
(pepN, cgl2426)
MT166 B2_B2P8 5.09 0.24 0.979 9.91 11 53 64 0.830
MT167 B3_B2P8 4.95 0.38 0.962 10.86 10 51 61 0.834
MT168 B4_B2P8 5.64 0.28 0.948 10.10 10 58 68 0.823 citrate-
transporter/symporter
(cgl0067, citP)
MT169 B5_B2P8 0.61 0.01 0.362 33.38 9 94 103 0.270
MT170 B6_B2P8 5.53 0.17 0.978 14.27 14 44 58 0.839
MT171 B7_B2P8 5.14 1.43 0.979 22.28 14 35 49 0.848
MT172 B8_B2P8 5.76 0.48 0.984 11.61 10 50 60 0.842
MT173 A1_B2P19 6.63 0.09 0.915 14.82 12 28 40 0.841
MT174 A10_B2P19 7.23 0.92 0.985 22.58 10 34 44 0.741
MT175 A11_B2P19 0.92 0.02 0.47 20.32 7 88 95 0.368
MT176 A12_B2P19 7.55 0.63 0.975 12.01 13 41 54 0.743
MT177 A2_B2P19 0.87 0.01 0.483 43.11 13 81 94 0.399
MT178 A3_B2P19 7.74 0.17 0.9 34.50 11 44 55 0.821
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MT179 A4_B2P19 7.37 0.09 0.946 20.36 9 46 55 0.753
MT180 A5_B2P19 6.93 0.88 0.944 24.47 6 28 34 0.765
MT181 A6_B2P19 7.05 0.33 0.901 21.10 22 25 47 0.789
MT182 A7_B2P19 7.07 0.41 0.905 18.82 25 26 51 0.808
MT183 A8_B2P19 6.79 0.12 0.943 24.09 14 34 48 0.796
MT184 A9_B2P19 8.10 0.65 0.974 13.91 6 30 36 0.777
MT185 B1_B2P19 6.01 0.73 0.86 28.18 19 37 56 0.780
MT186 B10_B2P19 6.45 0.87 0.98 11.34 14 32 46 0.820
MT187 B11_B2P19 6.64 0.30 0.979 7.56 14 23 37 0.807
MT188 B12_B2P19 7.55 1.08 0.98 18.51 10 31 41 0.792
MT189 B2_B2P19 6.16 0.14 0.915 13.21 8 35 43 0.803
MT190 B3_B2P19 5.46 0.84 0.902 19.17 28 20 48 0.854
MT192 B5_B2P19 6.49 0.50 0.873 21.02 11 22 33 0.462
MT193 B6_B6P19 5.91 0.70 0.859 12.35 27 37 64 0.669
MT194 B7_B6P19 5.99 0.46 0.988 18.68 8 27 35 0.801
MT195 B8_B2P19 6.25 0.77 0.977 18.97 8 27 35 0.719
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MT196 B9_B2P19 0.89 0.02 0.517 20.29 9 87 96 0.396
MT197 C1_B2P19 5.94 1.65 0.929 30.79 9 23 32 0.825
MT198 C10_B2P19 6.05 0.43 0.981 8.73 12 27 39 0.756
MT199 C11_B2P19 6.07 0.12 0.98 11.00 16 25 41 0.753
MT200 C12_B2P19 0.97 0.11 0.418 17.81 5 90 95 0.294
MT201 C2_B2P19 5.72 0.06 0.928 19.75 6 26 32 0.798
MT202 C3_B2P19 5.17 0.51 0.931 13.16 10 24 34 0.840
MT203 C4_B2P19 6.82 0.48 0.937 13.61 2 40 42 0.836
MT204 C5_B2P19 6.41 0.63 0.982 13.07 21 27 48 0.792
MT205 C6_B6P19 5.67 0.30 0.98 12.60 8 34 42 0.773
MT206 C7_B6P19 5.69 0.26 0.983 11.55 12 24 36 0.731
MT207 C8_B2P19 6.49 0.89 0.98 15.00 19 19 38 0.801
MT208 C9_B2P19 6.69 0.72 0.984 9.82 14 22 36 0.788
MT209 D1_B2P19 5.82 0.52 0.929 13.04 13 18 31 0.825
MT210 D10_B2P19 5.65 0.21 0.98 8.59 16 28 44 0.777
MT211 D11_B2P19 5.78 0.31 0.985 7.90 14 26 40 0.779
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MT212 D12_B2P19 7.11 0.55 0.78 13.84 9 21 30 0.466
MT213 D2_B2P19 5.04 0.60 0.918 21.29 6 29 35 0.806
MT214 D3_B2P19 4.16 0.66 0.939 16.24 21 18 39 0.781
MT215 D4_B2P19 6.92 1.23 0.918 13.03 2 44 46 0.768
MT216 D5_B2P19 6.04 1.41 0.986 14.29 9 27 36 0.747
MT217 D6_B6P19 5.23 0.28 0.98 19.02 19 24 43 0.772
MT218 D7_B6P19 5.40 0.21 0.979 12.56 17 24 41 0.741
MT219 D8_B2P19 6.40 0.20 0.981 17.90 15 20 35 0.746
MT220 D9_B2P19 6.98 0.91 0.915 21.72 14 12 26 0.611
MT221 E1_B2P19 6.41 0.81 0.952 18.31 15 17 32 0.760
MT222 E10_B2P19 6.28 0.63 0.916 13.96 9 23 32 0.617
MT223 E11_B2P19 6.03 0.23 0.895 18.94 23 19 42 0.611
MT224 E12_B2P19 5.73 0.81 0.933 26.79 19 21 40 0.614
MT225 E2_B2P19 5.09 0.39 0.9 15.14 18 32 50 0.803
MT226 E3_B2P19 5.03 0.81 0.887 25.68 16 18 34 0.856
MT227 E4_B2P19 6.65 1.00 0.934 20.28 11 30 41 0.834
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MT228 E5_B2P19 4.29 1.32 0.971 75.60 91 11 102 0.636
MT229 E6_B6P19 6.17 0.44 0.985 19.27 20 30 50 0.828
MT230 E7_B6P19 4.67 0.27 0.96 8.93 29 27 56 0.720
MT231 E8_B2P19 0.69 0.01 0.486 27.55 7 87 94 0.382
MT232 E9_B2P19 5.38 0.13 0.854 14.23 12 26 38 0.583
MT233 F1_B2P19 6.73 0.39 0.972 21.89 12 20 32 0.866
MT234 F2_B2P19 5.80 0.23 0.943 15.98 11 26 37 0.816
MT235 F3_B2P19 6.23 0.67 0.929 16.49 10 31 41 0.827
MT236 F4_B2P19 6.29 0.74 0.931 18.72 8 30 38 0.821
MT237 A1_B2P21 8.17 0.48 0.943 8.97 12 22 34 0.867
MT238 A10_B2P21 0.83 0.01 0.477 25.51 10 88 98 0.444
MT239 A11_B2P21 0.78 0.07 0.417 35.81 12 92 104 0.415
MT240 A12_B2P21 0.79 0.05 0.352 17.26 7 95 102 0.388
MT241 A3_B2P21 8.00 0.06 0.833 17.36 25 37 62 0.787
MT242 A4_B2P21 8.11 0.60 0.852 10.00 27 35 62 0.821
MT243 A5_B2P21 7.64 0.51 0.949 27.20 29 22 51 0.847
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MT244 A6_B2P21 5.78 3.23 0.959 35.37 28 17 45 0.864
MT245 A7_B2P21 7.47 0.12 0.982 8.70 25 14 39 0.882
MT246 A8_B2P21 8.45 0.73 0.976 9.79 25 20 45 0.871
MT247 A9_B2P21 7.20 0.96 0.948 17.21 11 30 41 0.765
MT248 B1_B2P21 6.59 0.31 0.959 12.84 10 13 23 0.876
MT249 B10_B2P21 5.87 0.10 0.983 18.71 17 26 43 0.763
MT250 B11_B2P21 6.10 0.29 0.969 19.31 12 27 39 0.775
MT251 B12_B2P21 6.85 0.68 0.95 12.97 16 32 48 0.753
MT252 B2_B2P21 7.72 0.99 0.929 9.22 14 23 37 0.864
MT253 B3_B2P21 0.77 0.01 0.465 17.00 18 94 112 0.453
MT254 B4_B2P21 6.54 1.24 0.913 36.33 30 25 55 0.819
MT255 B5_B2P21 7.07 0.96 0.921 20.84 19 13 32 0.930
MT256 B6_B2P21 6.74 0.67 0.935 19.84 31 15 46 0.920
MT257 B7_B2P21 6.39 0.12 0.912 24.32 30 15 45 0.917
MT258 B8_B2P21 7.60 0.56 0.924 12.98 23 17 40 0.895
MT259 B9_B2P21 6.64 0.95 0.948 19.51 7 38 45 0.764
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MT260 C1_B2P21 6.22 0.16 0.952 14.97 12 12 24 0.871
MT261 C10_B2P21 5.55 0.15 0.919 32.22 21 32 53 0.692
MT262 C11_B2P21 5.25 0.05 0.911 23.01 21 29 50 0.667
MT263 C12_B2P21 6.34 0.56 0.922 14.60 16 29 45 0.736
MT264 C2_B2P21 7.41 1.24 0.949 10.80 15 19 34 0.857
MT265 C3_B2P21 6.05 0.43 0.929 10.41 29 7 36 0.886
MT266 C4_B2P21 3.66 0.57 0.927 27.87 24 22 46 0.869
MT267 C5_B2P21 1.37 0.05 0.471 18.18 35 61 96 0.430
MT268 C6_B2P21 6.02 0.37 0.927 10.15 16 15 31 0.862
MT269 C7_B2P21 6.14 0.16 0.935 9.99 17 20 37 0.848
MT270 C8_B2P21 0.64 0.02 0.334 21.76 15 86 101 0.338
MT271 C9_B2P21 6.12 1.00 0.933 12.63 14 31 45 0.741
MT272 D10_B2P21 4.92 0.09 0.923 9.75 18 27 45 0.743
MT273 D11_B2P21 4.98 0.16 0.945 15.39 22 23 45 0.741
MT274 D12_B2P21 5.75 0.90 0.965 21.58 31 17 48 0.741
MT275 D2_B2P21 5.76 - 0.571 - 30 39 69 0.628
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MT276 D4_B2P21 6.92 0.91 0.927 11.21 16 20 36 0.864
MT277 D5_B2P21 6.07 1.16 0.832 15.50 12 21 33 0.880
MT278 D6_B2P21 1.57 1.67 0.696 63.41 31 41 72 0.654
MT279 D7_B2P21 5.23 0.35 0.902 13.95 19 23 42 0.811
MT280 D8_B2P21 6.91 0.57 0.926 19.44 12 26 38 0.833
MT281 D9_B2P21 5.54 1.12 0.918 15.94 21 29 50 0.737
MT282 E1_B2P21 5.81 0.38 0.881 8.86 13 7 20 0.907
MT283 E10_B2P21 4.40 0.24 0.68 11.43 18 21 39 0.831
MT284 E11_B2P21 5.00 0.48 0.976 15.98 11 31 42 0.645
MT285 E12_B2P21 0.63 0.01 0.459 22.05 8 96 104 0.433
MT286 E2_B2P21 6.93 0.87 0.941 10.84 12 15 27 0.920
MT287 E5_B2P21 6.12 0.56 0.978 7.94 18 20 38 0.759
MT288 E6_B2P21 0.70 0.02 0.452 18.99 9 90 99 0.502
MT289 E7_B2P21 5.53 0.48 0.985 12.49 11 34 45 0.761
MT290 E8_B2P21 6.59 0.69 0.983 13.43 11 31 42 0.764
MT291 E9_B2P21 5.94 0.83 0.977 10.28 17 29 46 0.646
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MT292 F1_B2P21 6.21 0.24 0.465 18.69 15 85 100 0.475
MT293 F10_B2P21 5.30 0.34 0.985 10.80 11 29 40 0.642
MT294 F11_B2P21 5.44 0.37 0.963 12.43 4 51 55 0.621
MT295 F12_B2P21 5.62 0.79 0.985 15.40 14 33 47 0.627
MT297 F3_B2P21 5.94 0.72 0.95 18.40 28 24 52 0.859
MT298 F4_B2P21 7.37 0.63 0.992 7.25 13 21 34 0.907
MT299 F5_B2P21 6.66 0.03 0.961 24.37 47 23 70 0.724
MT300 F6_B2P21 2.08 - 0.612 - 11 86 97 0.572
MT301 F7_B2P21 5.71 0.05 0.932 22.16 19 22 41 0.692
MT302 F8_B2P21 7.22 0.57 0.983 15.94 10 30 40 0.750
MT303 F9_B2P21 6.51 0.70 0.99 8.95 12 40 52 0.632
MT304 G1_B2P21 6.90 0.41 0.988 9.66 20 21 41 0.890
MT305 G10_B2P21 0.69 0.01 0.432 15.56 8 96 104 0.413
MT306 G11_B2P21 5.59 0.16 0.99 7.97 12 33 45 0.628
MT307 G12_B2P21 6.47 0.60 0.994 16.88 16 38 54 0.619
MT308 G2_B2P21 7.85 0.68 0.974 7.99 14 17 31 0.908
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MT309 G3_B2P21 6.83 0.50 0.931 15.80 15 14 29 0.936
MT310 G4_B2P21 7.37 0.26 0.985 7.32 17 39 56 0.615
MT311 G5_B2P21 6.53 1.14 0.99 22.56 18 22 40 0.759
MT312 G6_B2P21 6.22 0.48 0.961 16.03 16 21 37 0.727
MT313 G7_B2P21 5.94 0.05 0.977 15.61 18 24 42 0.728
MT314 G8_B2P21 8.61 0.61 0.987 18.89 15 47 62 0.635
MT315 G9_B2P21 7.54 0.60 0.993 17.55 20 42 62 0.624
MT316 H1_B2P21 7.93 0.49 0.992 11.75 3 58 61 0.901
MT317 H10_B2P21 7.23 0.90 0.986 16.03 13 45 58 0.638
MT318 H2_B2P21 8.34 1.17 0.989 13.51 18 17 35 0.908
MT319 H3_B2P21 7.78 0.44 1 13.94 16 20 36 0.897
MT320 H4_B2P21 7.95 1.81 0.984 25.74 18 42 60 0.640
MT321 H5_B2P21 8.37 0.17 0.972 15.76 7 47 54 0.654
MT322 H6_B2P21 8.03 0.78 0.993 16.62 22 23 45 0.747
MT323 H7_B2P21 7.39 0.35 1 14.36 20 21 41 0.759
MT324 H8_B2P21 7.63 0.46 0.972 17.82 20 39 59 0.642
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MT325 H9_B2P21 7.50 0.28 0.965 16.17 10 49 59 0.655
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